GUIDELINES Final Year by Ali Raza

In the name of Almighty Allah, the Most Gracious, the Most Beneficent
FINAL YEAR MBBS GUIDELINES

Updated 18-04-2023
HUMAN FOUNTAINS –
FINAL Year MBBS GUIDELINES
BY ALI RAZA CHAUDARY

Remember my parents in your prayers.
PAGE 2 OF 115
HUMAN FOUNTAINS –

SECOND EDITION (2023)
2ND EDITION will be available in May 2023

Pioneer of Topically Solved SEQs and MCQs
(from recommended books)
PAGE 3 OF 115
HUMAN FOUNTAINS –

SAILENT FEATURES OF EPISODE FINAL

YEAR 2ND EDITION (in addition to 1st Ed.)
 COLORFUL EDITION with important investigations (Investigation of Choice) and
treatment (Treatment of Choice) highlighted
 GOOD page quality
 TOPICALLY ARRANGED all UHS (verified) SEQs and MCQs (up-to-date)
 Colorful STICKY NOTES Covering Important MCQs of UHS
 UHS ORIGINAL MCQs with Explanations (2007-2022)
PAGE 4 OF 115
HUMAN FOUNTAINS –
CONTENTS
CONTENTS
DESCRIPTION PAGE #
GENERAL OVERVIEW 7
RECOMMENDED BOOKS 8
MEDICINE 9
TABLE OF SPECIFICATIONS 9
GENERAL GUIDELINES 9
MEDICINE I: 11
1. PULMONARY SYSTEM 11
2. CARDIOVASCULAR SYSTEM 13
3. GASTROINTESTINAL SYSTEM 16
4. LIVER, PANCREAS & GALL BLADDER 19
5. CENTRAL NERVOUS SYSTEM 22
6. HEMATOLOGY 24
7. RHEUMATOLOGY 26
MEDICINE II: 28
8. INFECTIOUS DISEASES 28
9. NEPHROLOGY & CLINICAL BIOCHEMISTRY 30
10. ENDOCRINOLOGY 33
11. PSYCHIATRY 35
12. DERMATOLOGY 37
13. NUTRITION 38
PAEDIATRIC MEDICINE 39
1. ENDOCRINOLOGY & GENETICS 40
2. NEPHROLOGY 42
3. RESPIRATORY SYSTEM 42
4. CARDIOLOGY & HEMATOLOGY 44
5. ONCOLOGY 45
6. GASTROINTESTINAL SYSTEM 46
7. IMMUNIZATION & INFECTIONS 47
8. NEUROLOGY & NEUROMUSCULAR DISORDERS 49
9. MENINGITIS 50
10. NEONATOLOGY & OTHERS 50
SURGERY 52
SURGERY I: 54
1. SURGICAL ANATOMY 54
2. A&E SURGERY; TISSUE REPAIR 55
3. SURGICAL NUTRITION 56
4. FLUID & ELECTROLYTES; SHOCK 57
5. ANESTHESIA & PAIN MANAGEMENT 59
6. SURGICAL & SPECIAL INFECTIONS 61
7. VASCULAR DISORDERS 62
8. SKIN, SUBCUTANEOUS TISSUE & BURNS 66
9. PRINCIPLES OF ONCOLOGY 68
10. PRINCIPLES OF RADIOLOGY 69
PAGE 5 OF 115
HUMAN FOUNTAINS –

SURGERY II: 70
11. UPPER GASTROINTESTINAL SYSTEM 70
12. LOWER GASTROINTESTINAL SYSTEM 74
13. UROGENITAL SYSTEM 81
14. MUSCULOSKELETAL SYSTEM 85
15. THORAX 86
16. HEART AND GREAT VESSELS 87
17. HEAD & NECK (ORODENTAL SURGERY) 88
18. BREAST 90
19. NEUROSURGERY 92
GYNAECOLOGY & OBSTETRICS 94
GYNAECOLOGY 96
1. ANATOMY OF GENITAL TRACT 96
2. DISORDERS OF MENSTRUATION 97
3. ABORTIONS & ECTOPIC PREGNANCY 98
4. INFERTILITY & ENDOMETRIOSIS 99
5. INFECTIONS OF GENITAL TRACT 100
6. UROGYNAECOLOGY 100
7. BENIGN TUMOURS OF GENITAL TRACT 101
8. MALIGNANCIES OF GENITAL TRACT 102
9. COMMON GYNAECOLOGICAL PROCEDURES 104
10. CONTRACEPTION 104
OBSTETRICS 105
11. PHYSIOLOGY OF PREGNANCY 105
12. ANTENATAL CARE & INVESTIGATION 106
13. ASSESSMENT OF FETAL WELL BEING 108
14. MEDICAL DISORDERS IN PREGNANCY 109
15. EMERGENCY & POSTPARTUM DISORDERS 110
16. INTRAPARTUM CARE – NORMAL LABOUR 112
17. ABNORMAL LABOUR 113
PAGE 6 OF 115
HUMAN FOUNTAINS –
GENERAL OVERVIEW
GENERAL OVERVIEW
FINAL YEAR FINALLY! Sounds Good? Congratulations 80% doctors! And now its
last ride of this hectic job! Well honestly speaking, Final year is hectic but interesting year
of MBBS. All the things at single place!!! It really does not matter, what you have done in
your last 4 years but this year really matters.
If you guys have studied Pharmacology, Pathology and Microbiology well in

previous years, final year is gonna be an easy pezy thing for you.
Basically, there are four subjects in Final Year. Two of them are majors including
MEDICINE (I + II) & SURGERY (I + II). Other two are minors i.e. GYNAECOLOGY &
OBSTETRICS & PAEDIATRICS. Throughout the year, your main focus will be on
Medicine. For remaining three, believe me, medicine will provide a solid base. I will try my
best to make the things easy for you. Keep this file with you while studying (best is to get
a printed copy of this file). From 3rd year onwards, you have to follow the guidelines for
covering the syllabus as you cannot do all the things at once and if you can, it will not be
easy to revise such BIG and GIANT syllabus at the end of the year.
Unlike previous years, cramming is not the main game (concepts are) here but
still you have to cram things in order to score well and get desired HOUSEJOB (aka
internship). Well! Syllabus will really get over your nerves. But stay strong and donot
waste your time in jumping from books to books. Grab any one book which you wanna
choose as a main course and go with the flow.
The one very important thing for final year students is to do past papers from
very first day. They will provide you with solid base for your concepts too! Clinical scenarios
are usually from our hospital setting. So doing past papers in the first go will make you
confident and help with all the internal assessments, sendups and prof throughout the
year! For this purpose I with my 8 colleagues (exclusively Nishtarians batch N67-
2022), have published the best past papers book of time (EPISODE FINAL YEAR) in
2022 including both SEQs & MCQs. 800 copies were sold when it had just hit the shelves.
For feedback, you can contact anyone from N67 or your immediate seniors, they will surely
let you know about it. This book has been life-saving in whole prof. 2nd edition (2023) is
going to be more comprehensive and beautiful in terms of explained MCQs, sticky
notes throughout the book and colourful edition. It will hit the shelves in coming
May (2023).
As I always used to say, we don‟t need perfection. We need to be a good doctor.

And the main thing which differentiates between a good doctor and only doctor is just your
knowledge and its application while treating your patients. Don‟t panic. Take interest in the
things. So let me mention the marks distribution. It will be as follow:
1. MEDICINE (200 + 300 = 500)

2. PAEDIATRICS (100 + 100 = 200)
3. SURGERY (250 + 250 = 500)
4. GYNAECOLOGY AND OBSTETRICS (150 + 150 = 300)
PAGE 7 OF 115
HUMAN FOUNTAINS –
RECOMMENDED BOOKS
RECOMMENDED BOOKS
 MEDICINE
1. Davidson‟s Principles and Practice of Medicine, 23rd Ed.
 PAEDIATRICS
1. Basis of Pediatrics by Pervez Akbar Khan, Revised 10th Ed.
 SURGERY
1. Short Practice of Surgery by Bailey & Love‟s, 27th Ed.
 GYNAECOLOGY & OBSTETRICS
1. Gynaecology by Ten Teachers, 20th Ed.

2. Obstetrics by Ten Teachers, 20th Ed.
 PAST PAPERS (INCLUDING MCQS + SEQS)
1. Episode Final Year by Dr. Ali Raza Chaudary & Dr. Hasaan Abdullah, 2nd Ed.
(will be available by May 2023)
NOTE
Buy the MATT version of Books instead of buying Original Books. Do not
buy short books, they will only waste your time and will not cover the
entire syllabus
PAGE 8 OF 115
HUMAN FOUNTAINS –
MEDICINE
MEDICINE
UHS TABLE OF SPECIFICATIONS
THEORY
MEDICINE – I
# Topic MCQS SEQS
(45 x 1) (9 x 5)
1 Pulmonary System 7 1
2 Cardiovascular System 7 2
3 Gastrointestinal System 7 2
4 Liver, Pancreas & Gall bladder 6 1
5 Central Nervous System 7 1
6 Hematology 5 1
7 Rheumatology 6 1
MEDICINE – II
# Topic MCQS SEQS
(40 x 1) (9 x 5)
1 Infectious diseases 7 2
2 Nephrology & Clinical Biochemistry 10 2
3 Endocrinology 5 2
4 Psychiatry 10 2
5 Dermatology 6 1
6 Nutrition 2 -
SUBJECT DETAILS
PAPER MCQS SEQS SUBTOTAL TOTAL
WRITTEN
Medicine - I 45 (1 each) 9 (5 each) 90
Medicine - II 40 (1 each) 9 (5 each) 85 200
Internal Assessment 25
OSCE/VIVA
9 static & 4 interactive stations (5
OSCE 65
each)
Short Case 4 (30 each) 120 300
Long Case 1 (90 each) 90
SUBJECT TOTAL 500
GENERAL GUIDELINES
So, I guess you guys remember that story of 3P‟s for MS. Let me recall again! There are
3P‟s i.e. Physiology, Pharmacology and Pathology in MBBS which are very important to
have a grip on MS i.e. Medicine and Surgery in Clinical Years.
So, now you are done with all P‟s and it‟s time for MS. Medicine is the most important
subject of final year and you cannot leave this subject untouched at any cost. You must
PAGE 9 OF 115
HUMAN FOUNTAINS –
MEDICINE
have to do this with your whole heart so that you would be prepared to face any clinical
scenario in your prof. Luckily, it will help you cover 80-90% of your Paediatrics and 50% of
Surgery portion too. I will share all these details in the guidelines.
SUBJECT DIVISION
Medicine has been divided into two parts but in annual exam you have to pass it jointly
(not separately)
 Medicine-I (M1) covers 7 topics
 Medicine-II (M2) covers 6 topics (mainly 5)
The topics you have to prepare for prof exclusively are 82 in M1 and 69 in M2. For more
details, check detailed guidelines. M2 is comparatively easy and short subject (as
compared to M1).
BOOKS TO FOLLOW
DAVIDSON 23RD ED. + EPISODE FINAL YEAR 2nd ED. PAST PAPERS
WHY NOT ANY OTHER BOOK THAN DAVIDSON? People! Paper setters use Davidson as
main course book. Do not rush over the short books like Irfan Masood, Step-up when your
recommended book is enough to cover things well.
WE HAVE TO DO WHOLE DAVIDSON? No, only the topics I am mentioning below
(which are clinically important in our hospital setting or you can say in PAKISTAN)
WHAT WE ARE SUPPOSED TO PREPARE? Mainly you have to cram investigations and
treatment (NO NEED TO CRAM ANY DOSE UNLESS ASKED IN PAST PAPERS). Give a read
to clinical features and history for making diagnosis (beautifully portrayed in EPISODE
FINAL YEAR as DIAGNOSTIC CLUE – example attached below)
HOW TO COVER MCQS

EFY-2nd edition (Published by Zubair Books Lahore) has covered all the important
aspects of MCQs in elaborative form with related explanations from main books (example
attached) and arranged topically. A lot of MCQs are repeated in prof. So, do not take a
risk of leaving them before your Annuals. Do get this from the market as it hit the shelves
in May 2023.
PAGE 10 OF 115
HUMAN FOUNTAINS –
MEDICINE
 MEDICINE-I
1. PULMONARY SYSTEM
MCQs SEQs Total Marks Books
Davidson Ed. 23rd
7 1 12
Unit 17
It is very extensive topic but you have to do it selectively as per weightage. Just do the
mentioned topics and ignore the rest. The book content seems to be extensive. Just
summarize and highlight the things to make them short. There is no need to remember
doses at the level of FINAL YEAR MBBS.
TOPICS EXCLUSIVELY FOR SEQS + MCQS
FIRST PRIORITY
1. ASTHMA Pg. 567-573
a. Pathophysiology and clinical features (for making diagnosis, summarized in
EFY)
b. Diagnosis + Box 17.19 How to make a diagnosis of asthma (vv.imp)
c. Management + Fig 17.22 Management approach in adults based on asthma
control (vv.imp)
d. Management of acute severe asthma + Box 17.22 Immediate assessment of
acute severe asthma + Fig. 17.24 Immediate treatment of patients with
acute severe asthma + Box 17.23 Indications for assisted ventilation in
acute severe asthma (vvvv.imp)
e. You may leave
i. Box 17.20 Levels of asthma control
ii. Box 17.21 Asthma in pregnancy
2. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) Pg. 573-578
EFY)
b. Box 17.24 Risk factors for development of COPD (v.imp)
c. Investigations + Box 17.26 Spirometric classification of COPD severity based
on post-bronchodilator FEV1 (vv.imp)
d. Management + Box 17.27 Prescription of long-term-oxygen-therapy in
COPD (vv.imp)
e. Acute exacerbation of COPD (vvvv.imp)
f. You may leave
i. Box 17.25 Modified Medical Research Council (MRC) dyspnoea scale
ii. Box 17.28 Calculation of the BODE index
iii. Box 17.29 Obstructive pulmonary disease in old age
3. BRONCHIECTASIS Pg 578-579
EFY)
b. Investigations (vv.imp)
c. Management (vv.imp)
PAGE 11 OF 115
HUMAN FOUNTAINS –
MEDICINE
4. COMMUNITY ACQUIRED PNEUMONIA Pg 582-585

a. Box 17.36 Organisms causing community-acquired pneumonia (vv.imp)
b. Clinical features (for making diagnosis, summarized in EFY)
c. Fig. 17.32 Hospital CURB-65 (vv.imp)
d. Investigations + Box 17.38 Investigations in community-acquired
pneumonia (vv. Imp)
e. Management + Box 17.39 Indications for referral to ITU + Box 17.40
Antibiotic treatment for community-acquired pneumonia + Box 17.41
Complications of pneumonia (vv.imp)
f. You may leave
i. Box 17.35 Factors that predispose to pneumonia
ii. Box 17.37 Differential diagnosis of pneumonia
5. TUBERCULOSIS Pg. 588-595
EFY)
b. Investigations + Box 17.51 Diagnosis of tuberculosis (vv.imp)
c. Management + Box 17.52 Treatment of new tuberculosis patients (World
Health Organisation recommendations) + Box 17.53 Main adverse reactions
of first-line antituberculous drugs (vv.imp)
d. Control and prevention (just a single read) but Directly observed therapy
(vv.imp)
e. You may leave
i. Epidemiology
ii. 17.45 Factors increasing the risk of tuberculosis
iii. 17.46 Natural history of untreated primary tuberculosis
iv. 17.48 Cryptic tuberculosis
6. PNEUMOTHORAX Pg. 625-627
a. Clinical features (for making diagnosis, summarized in EFY)
b. Box 17.90 Classification of pneumothorax (vv.imp)
c. Investigations (vv.imp)
d. Management + Fig. 17.73 Management of spontaneous pneumothorax
(vv.imp)
SECOND PRIORITY
7. LUNG CANCER Pg. 599-603
a. Pathophysiology and clinical features (for making diagnosis)
b. Box 17.64 Non-metastatic extrapulmonary manifestations of lung cancer
(imp)
c. Investigations (imp)
d. Management (Just a quick read)
e. You may leave
i. Box 17.62 Common cell types in lung cancer
ii. Box 17.63 Causes of large bronchus obstruction
iii. Fig. 17.51 Tumour stage and 5-year survival in non-small-cell lung
cancer
8. SARCOIDOSIS Pg. 608-610
a. Clinical features + Box 17.72 Presentation of sarcoidosis (for making
diagnosis, summarized in EFY)
b. Investigations + 17.73 Chest X-ray changes in sarcoidosis (v.imp)
PAGE 12 OF 115
HUMAN FOUNTAINS –
MEDICINE
c. Management – prepare it stage-based on CXR (v.imp)

9. HYPERSENSITIVITY PNEUMONITIS Pg. 616-617
EFY)
b. Investigations + Diagnosis (imp)
c. Management (imp)
10.PULMONARY EMBOLISM Pg. 619-621
a. Clinical features + Box 17.83 Features of pulmonary thromboemboli (for
making diagnosis, summarized in EFY)
b. Investigations + Fig. 17.67 Algorithm for the investigation of patients with
suspected pulmonary thromboembolism + Box 17.84 Pulmonary embolism
in pregnancy (vv.imp)
11.PULMONARY HYPERTENSION Pg. 621-622
d. You may leave Box 17.85 Classification of pulmonary hypertension
TOPICS (OPTIONAL) FOR MCQS ONLY
 Cystic fibrosis (Pg. 580-581)
 Invasive pulmonary aspergillosis (Pg. 597-598)
 Idiopathic pulmonary fibrosis (Pg. 605-608)
 Box 17.80 Lung diseases caused by exposure to inorganic dusts (Pg. 615)
 Box 17.81 Examples of lung diseases caused by organic dusts (Pg. 616)
ORIGINAL UHS MCQS WITH EXPLANATIONS
Consult MEDICINE-I UNIT 1 in EPISODE FINAL YEAR ED. 2ND
2. CARDIOVASCULAR SYSTEM
Davidson Ed. 23rd
7 2 17
Unit 16
It is again very extensive topic but you have to do it selectively as per weightage. But
there will be 2 SEQs from this portion so you cannot leave this topic in prof. Just do the
mentioned topics and ignore the rest. The book content seems to be extensive. Just
summarize and highlight the things to make them short. There is no need to remember
FIRST PRIORITY
1. HEART FAILURE Pg. 461-468
a. Pathogenesis and clinical assessment (for making diagnosis, summarized in
EFY)
c. Management of acute heart failure + Box 16.15 Management of acute
pulmonary oedema (vvv.imp)
d. Management of chronic heart failure (only give a quick read to drugs) + Box
16.16 General measures for the management of heart failure (vv.imp)
PAGE 13 OF 115
HUMAN FOUNTAINS –
MEDICINE
e. You may leave

i. Box 16.12 Mechanisms of heart failure
ii. Box 16.13 Factors that may precipitate or aggravate heart failure in
pre-existing heart disease
iii. Box 16.14 Differential diagnosis of peripheral oedema
iv. Box 16.17 Congestive cardiac failure in old age
2. ANGINA PECTORIS Pg. 487-493
a. Pathogenesis and clinical features (for making diagnosis, summarized in
EFY)
b. Investigations + Fig. 16.56 Forms of exercise-induced ST depression
(vvv.imp)
c. Management + Fig. 16.55 A scheme for the investigation and treatment of
stable angina on effort. + Box 16.42 Advice to patients with stable angina
(vvv.imp)
d. You may leave
i. Box 16.38 Factors influencing myocardial oxygen supply and demand
ii. Box 16.41 Risk stratification in stable angina
iii. Box 16.43 Duration of action of some nitrate preparations
iv. Box 16.44 Calcium channel antagonists used for the treatment of
angina
v. Box 16.45 Comparison of percutaneous coronary intervention (PCI)
and coronary artery bypass grafting (CABG)i
3. ACUTE CORONARY SYNDROME (ACS) Pg. 493-501
a. Pathogenesis and clinical features + Box 16.49 Clinical features of acute
coronary syndromes (for making diagnosis, summarized in EFY)
b. Investigations + Fig. 16.65 The serial evolution of ECG changes in
transmural myocardial infarction. + Fig. 16.66 Recent anterior non-ST
elevation (subendocardial) myocardial infarction. + Fig. 16.67 Acute
transmural anterior myocardial infarction + Fig. 16.68 Acute transmural
inferolateral myocardial infarction. + Fig. 16.69 Changes in plasma cardiac
biomarker concentrations after myocardial infarction (vvvv.imp)
c. Management + Box 16.51 Late management of myocardial infarction + Fig.
16.70 Summary of treatment for acute coronary syndrome (ACS) + Box
16.52 Relative contraindications to thrombolytic therapy (vvvvv.imp)
d. You may leave
i. Box 16.47 Criteria for diagnosis of an acute myocardial infarction
(MI)
ii. Box 16.48 Criteria for diagnosis of a prior myocardial infarction
iii. Fig. 16.62 Risk stratification in acute coronary syndrome: the GRACE
score
iv. Box 16.50 Common arrhythmias in acute coronary syndrome
v. Box 16.53 Myocardial infarction in old age
4. HYPERTENSION Pg. 508-514
a. Box 16.64 Definition of hypertension
b. Box 16.65 Causes of secondary hypertension
c. Pathogenesis and clinical features (for making diagnosis, summarized in
EFY)
PAGE 14 OF 115
HUMAN FOUNTAINS –
MEDICINE
d. Investigations + Box 16.68 Investigation of hypertension + Box 16.69

Specialised investigation of hypertension (vv.imp)
e. Management + Box 16.72 The influence of comorbidity on choice of
antihypertensive drug therapy
f. Box 16.71 Optimal target blood pressures (imp)
g. Accelerated hypertension
h. You may leave
i. Box 16.66 Hypertensive retinopathy
ii. Box 16.67 How to measure blood pressure
iii. Fig. 16.77 Example of cardiovascular risk prediction chart for non-
diabetic men
iv. Fig. 16.78 Management of hypertension: British Hypertension Society
guidelines
v. Box 16.70 Hypertension in old age
5. RHEUMATIC FEVER/RHEUMATIC HEART DISEASE Pg. 515-517
EFY)
b. Box 16.75 Jones criteria for the diagnosis of rheumatic fever (vvvv.imp)
c. Investigations +16.76 Investigations in acute rheumatic fever (vv.imp)
d. Management (vvv.imp)
6. INFECTIVE ENDOCARDITIS (IE) Pg. 527-531
a. Pathogenesis and clinical features + Fig. 16.89 Clinical features that may be
present in endocarditis (for making diagnosis, summarized in EFY)
b. Box 16.95 Diagnosis of infective endocarditis (vvvvv.imp)
a. Management + Box 16.98 Indications for cardiac surgery in infective
endocarditis (vv.imp)
b. You may leave
i. Box 16.94 Microbiology of infective endocarditis
ii. Box 16.96 Antimicrobial treatment of common causative organisms in
infective endocarditis
iii. Box 16.97 Conditions for the short-course treatment of endocarditis
caused by fully sensitive streptococci
7. DISEASES OF THE PERICARDIUM Pg. 542-544
a. Pathogenesis and clinical features + Box 16.109 Clinical features of
constrictive pericarditis + Box 16.110 Clinical features of cardiac tamponade
(for making diagnosis, summarized in EFY)
b. Box 16.108 Causes of acute pericarditis and pericardial effusion
c. Investigations and management of acute pericarditis, pericardial effusion,
constrictive pericarditis and cardiac tamponade
d. You may leave Tuberculous pericarditis
SECOND PRIORITY
8. CHEST PAIN ON EXERTION Pg. 454
a. Box 16.5 New York Heart Association (NYHA) functional classification (vv.imp)
9. MITRAL VALVE DISEASE Pg. 517-521
b. Mitral Stenosis
i. Pathogenesis and clinical features + Box 16.77 Clinical features of
mitral stenosis (for making diagnosis, summarized in EFY)
PAGE 15 OF 115
HUMAN FOUNTAINS –
MEDICINE
ii. Investigations + Box 16.78 Investigations in mitral stenosis (vv.imp)

iii. Management + Box 16.79 Criteria for mitral valvuloplasty (vv.imp)
c. Mitral Regurgitation
mitral regurgitation (for making diagnosis, summarized in EFY)
ii. Investigations + Box 16.82 Investigations in mitral regurgitation
iii. Management + Box 16.83 Medical management of mitral
regurgitation
d. You may leave
i. Box 16.80 Causes of mitral regurgitation
10.AORTIC VALVE DISEASE Pg. 521-525
a. Aortic Stenosis
ii. Pathogenesis and clinical features + Box 16.85 Clinical features of
aortic stenosis (for making diagnosis, summarized in EFY)
iii. Investigations + Box 16.86 Investigations in aortic stenosis (vv.imp)
iv. Management (vv.imp)
b. Aortic Regurgitation
aortic regurgitation (for making diagnosis, summarized in EFY)
ii. Investigations + Box 16.90 Investigations in aortic regurgitation
(imp)
iii. Management (imp)
c. You may leave
i. Box 16.84 Causes of aortic stenosis
ii. Box 16.87 Aortic stenosis in old age
iii. Box 16.88 Causes of aortic regurgitation
11.HYPERTROPHIC CARDIOMYOPATHY Pg. 539-540
a. Pathogenesis and clinical features + Fig. 16.105 Clinical features of
hypertrophic cardiomyopathy (for making diagnosis, summarized in EFY)
b. Box 16.106 Risk factors for sudden death in hypertrophic cardiomyopathy
c. Investigations
c. Management
 Atrial flutter (Pg. 470)
 Atrial fibrillation (Pg. 470-473)
 Supraventricular tachycardia (Pg. 473)
 Torsades de pointes (Pg. 476-477)
 Aortic dissection (Pg. 506-508)
 Coarctation of the aorta (Pg. 534)
3. GASTROINTESTINAL SYSTEM
Davidson Ed. 23rd
7 2 17
Unit 21 (main), 18, 11
PAGE 16 OF 115
HUMAN FOUNTAINS –
MEDICINE
It is again very very extensive topic but only a few topics are high yield. There will be 2
SEQs from this portion in medicine and it will also help you to cover a lot of topics in GIT
Surgery so you cannot leave this topic in prof. Just do the mentioned topics and ignore the
rest. The book content seems to be extensive. Just summarize and highlight the things to
make them short. There is no need to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) Pg. 791-794 (UNIT 21)
EFY)
b. Fig. 21.27 Types of hiatus hernia
c. Complications (vv.imp)
d. Investigations (vvvv.imp)
e. Management + Fig. 21.30 Treatment of gastro-oesophageal reflux disease:
a „step-down‟ approach (vvvvvv.imp)
f. You may leave
i. Box 21.29 Important features of hiatus hernia
ii. Box 21.30 Gastro-oesophageal reflux disease in old age
iii. Other causes of oesophagitis
2. ACHALASIA OF THE OESOPHAGUS Pg. 794-795 (UNIT 21)
EFY)
b. Investigations (vvvv.imp)
c. Management (vvvvvv.imp)
3. CARCINOMA OF THE OESOPHAGUS Pg. 796-797 (UNIT 21)
b. Investigations
c. Management
4. PEPTIC ULCER DISEASE (PUD) Pg. 798-802 (UNIT 21)
a. Gastric and duodenal ulcer
i. Pathophysiology and clinical features (for making diagnosis,
summarized in EFY)
ii. Investigations + Box 21.34 Methods for the diagnosis of Helicobacter
pylori infection (vv.imp)
iii. Management + Box 21.36 Indications for Helicobacter pylori
eradication + Box 21.37 Indications for surgery in peptic ulcer
(vvv.imp)
iv. Complications of peptic ulcer disease + Box 21.39 Differential
diagnosis and management of gastric outlet obstruction (vvv.imp)
b. Zollinger–Ellison syndrome
i. Pathophysiology and clinical features (for making diagnosis)
ii. Investigations
iii. Management
c. You may leave Box 21.38 Peptic ulcer disease in old age
5. COELIAC DISEASE Pg. 805-807 (UNIT 21)
EFY)
PAGE 17 OF 115
HUMAN FOUNTAINS –
MEDICINE
b. Box 21.42 Disease associations of coeliac disease (any 8-10 only)

c. Box 21.43 Important causes of subtotal villous atrophy (any 5 only)
d. Investigations (vvvv.imp)
e. Management (vvvv.imp)
f. Complications (vv.imp)
6. INFLAMMATORY BOWEL DISEASE (IBD) Pg. 813-824 (UNIT 21)
EFY)
b. Box 21.51 Comparison of ulcerative colitis and Crohn‟s disease (imp)
c. Box 21.53 Assessment of disease severity in ulcerative colitis (imp)
d. Complications + Fig. 21.52 Systemic complications of inflammatory bowel
disease (vv.imp)
e. Investigations (vvvv.imp)
f. Management + Box 21.56 Drugs used in the treatment of inflammatory
bowel disease (only column of „class‟) + Box 21.57 Medical management of
fulminant ulcerative colitis + Box 21.60 Indications for surgery in ulcerative
colitis (vvvv.imp)
g. You may leave
i. Box 21.52 Factors associated with development of inflammatory
bowel disease
ii. Box 21.54 Conditions that can mimic ulcerative or Crohn‟s colitis
iii. Box 21.55 Differential diagnosis of small bowel Crohn‟s disease
iv. Box 21.58 Monitoring of inflammatory bowel disease (IBD)
v. Box 21.59 How to give anti-tumour necrosis factor (TNF) therapy in
inflammatory bowel disease IBD in special circumstances
vi. Box 21.61 Inflammatory bowel disease in adolescence
vii. Box 21.62 Pregnancy and inflammatory bowel disease (IBD)
viii. Refractory Crohn‟s disease
ix. Microscopic colitis
7. IRRITABLE BOWEL SYNDROME (IBS) Pg. 824-826 (UNIT 21)
EFY)
b. Investigations + Box 21.63 Rome III criteria for diagnosis of irritable bowel
syndrome + Box 21.64 Supporting diagnostic features and alarm features in
irritable bowel syndrome (vvvv.imp)
c. Management + Box 21.65 Dietary management of irritable bowel syndrome
+ Fig. 21.54 Management of irritable bowel syndrome + Box 21.66
Complementary and alternative therapies for irritable bowel syndrome
(vvv.imp)
SECOND PRIORITY
8. ACUTE UPPER GASTROINTESTINAL HEMORRHAGE Pg. 780-782 (UNIT 21)
a. Fig. 21.19 Causes of acute upper gastrointestinal hemorrhage
b. Management (vv.imp)
c. You may leave Box 21.16 Modified Blatchford score: risk stratification in
acute upper gastrointestinal bleeding
9. ABDOMINAL TUBERCULOSIS Pg. 812-813 (UNIT 21)
a. Investigations
b. Management
PAGE 18 OF 115
HUMAN FOUNTAINS –
MEDICINE
10.CARCINOID TUMOUR Pg. 678-679 (UNIT 18)

a. Pathophysiology and clinical features + Box 18.51 Clinical features of the
carcinoid syndrome (for making diagnosis, summarized in EFY)
b. Investigations
c. Management
11.PSEUDOMEMBRANOUS COLITIS Pg. 264 (UNIT 11)
b. Investigations
c. Management
 Dermatitis herpetiformis (Pg. 807)
 Topical sprue (Pg. 807-808)
 Whipple‟s disease (Pg. 809)
 Ischaemic gut injury (Pg. 827)
 Diverticulosis (Pg. 833-834)
4. LIVER, PANCREAS & GALL BLADDER

Davidson Ed. 23rd
6 1 11
Unit 22 (main), 30
It is very extensive topic but hold a small weightage. There will be 1 SEQ from this portion
in medicine but it will also help you to cover topics in GIT Surgery. Just do the mentioned
topics and ignore the rest. The book content seems to be extensive. Just summarize and
highlight the things to make them short. There is no need to remember doses at the level
of FINAL YEAR MBBS.
FIRST PRIORITY
1. ACUTE HEPATITIS (ACUTE LIVER FAILURE) Pg. 856-859 (UNIT 22)
a. Pathophysiology and clinical assessment (for making diagnosis, summarized
in EFY)
b. Box 22.8 Classification of acute liver failure
c. Box 22.9 How to assess clinical grade of hepatic encephalopathy
d. Investigations + Box 22.10 Investigations to determine cause of acute liver
failure
e. Management + Box 22.12 Monitoring in acute liver failure
f. Box 22.13 Complications of acute liver failure (vvv.imp)
g. You may leave Box 22.11 Adverse prognostic criteria in acute liver failure
2. ASCITES Pg 862-864 (UNIT 22)
a. Pathophysiology (quick read)
b. Investigations + Box 22.22 Ascitic fluid: appearance and analysis
c. Management
d. Complications
i. Hepatorenal Syndrome (vv.imp)
ii. Spontaneous Bacterial Peritonitis (vvvvv.imp)
PAGE 19 OF 115
HUMAN FOUNTAINS –
MEDICINE
3. HEPATIC ENCEPHALOPATHY Pg. 864-865 (UNIT 22)

a. Pathophysiology (for making diagnosis, summarized in EFY)
b. Box 22.24 Differential diagnosis of hepatic encephalopathy
c. Box 22.25 Factors precipitating hepatic encephalopathy (vv.imp)
d. Investigations (vv.imp)
e. Management (vvv.imp)
4. VARICEAL BLEEDING Pg. 869-871 (UNIT 22)
a. Management of acute variceal bleeding + Box 22.32 Emergency
management of bleeding + Fig. 22.21 Management of acute bleeding from
oesophageal varices (vv.imp)
5. VIRAL HEPATITIS Pg. 871-879 (UNIT 22)
a. Clinical features of acute infection + Box 22.33 Causes of viral hepatitis +
Box 22.34 Features of the main hepatitis viruses (for making diagnosis,
summarized in EFY)
b. Box 22.35 Complications of acute viral hepatitis
c. Investigations
d. Management
e. Hepatitis A
i. Investigations
ii. Management
f. Hepatitis B
i. Box 22.36 Source of hepatitis B infection and risk of chronic infection
ii. Investigations + Box 22.37 The five phases of chronic hepatitis B
virus (HBV) infection + Box 22.38 How to interpret the serological
tests of acute hepatitis B virus infection (vv.imp)
iii. Management of acute hepatitis B
iv. Management of chronic hepatitis B
v. Prevention
vi. Co-infection with HIV
g. Hepatitis C
i. 22.40 Risk factors for the acquisition of chronic hepatitis C infection
ii. Investigations
iii. Management + Box 22.41 Direct-acting antiviral agents for hepatitis
C (only one drug in each class) (v.imp)
h. You may leave
i. Box: 22.39 At-risk groups meriting hepatitis B vaccination in low-
endemic areas
ii. Hepatitis D (Delta virus)
iii. Hepatitis E
iv. Other forms of viral hepatitis
v. Fig. 22.28 Direct-acting antiviral agents
6. PYOGENIC LIVER ABSCESS Pg. 879-880 (UNIT 22)
a. Pathophysiology and clinical features + 22.43 Causes of pyogenic liver
abscesses (for making diagnosis, summarized in EFY)
PAGE 20 OF 115
HUMAN FOUNTAINS –
MEDICINE
7. NON-ALCOHOLIC FATTY LIVER DISEASE Pg. 882-885 (UNIT 22)

EFY)
d. You may leave
i. Box 22.48 Simple non-invasive scores for non-alcoholic fatty liver
disease (NAFLD)/fibrosis
ii. Fig. 22.31 Assessment and risk stratification of patients with non-
alcoholic fatty liver disease (NAFLD)
8. PRIMARY BILIARY CIRRHOSIS/CHOLANGITIS Pg. 887-888 (UNIT 22)
EFY)
b. Diagnosis and Investigations (vvv.imp)
c. Management (vvvv.imp)
d. You may leave Overlap syndromes
SECOND PRIORITY
9. HEPATOCELLULAR CARCINOMA Pg. 890-892 (UNIT 22)
b. Investigations (vvv.imp)
c. Management (imp)
d. You may leave Fig. 22.36 Management of hepatocellular carcinoma
complicating cirrhosis
10.HEMOCHROMATOSIS Pg. 595-596 (UNIT 22)
a. Hereditary haemochromatosis
i. Pathophysiology and clinical features (for making diagnosis,
summarized in EFY)
ii. Investigations (imp)
iii. Management (imp)
b. Secondary haemochromatosis
c. You may leave Box 22.56 Causes of haemochromatosis
11.CHOLEDOCHOLILITHIASIS (CBD STONES) Pg. 906-907 (UNIT 22)
b. Investigations (vvv.imp)
c. Management (vvvv.imp)
d. You may leave Recurrent pyogenic cholangitis
12.ACUTE CHOLANGITIS Pg. 905 (UNIT 22)
13.OBSTETRIC CHOLESTASIS Pg. 1284 (UNIT 30)
 Box 22.17 Congenital non-haemolytic hyperbilirubinaemia (Pg. 860)
 Autoimmune hepatitis (Pg. 886-887)
 Wilson‟s disease (Pg. 896-897)
 Gilbert‟s syndrome (Pg. 897)
 Budd–Chiari syndrome (Pg. 898-899)
PAGE 21 OF 115
HUMAN FOUNTAINS –
MEDICINE
5. CENTRAL NERVOUS SYSTEM

Davidson Ed. 23rd
7 1 12
Unit 25 & 26
It is very extensive topic but hold a small weightage. Just do the mentioned topics and
ignore the rest. The book content seems to be extensive. Just summarize and highlight the
things to make them short. There is no need to remember doses at the level of FINAL
YEAR MBBS.
FIRST PRIORITY
1. EPILEPSY Pg. 1097-1104 (UNIT 25)
a. Pathophysiology and Clinical features + Box 25.28 Classification of seizures
(2010 International League Against Epilepsy classification) + Box 25.29
Trigger factors for seizures (for making diagnosis, summarized in EFY)
b. Investigations + Box 25.34 Investigation of epilepsy + Box 25.35
Indications for brain imaging in epilepsy (vv.imp)
c. Management + Box 25.36 How to administer first aid for seizures + Box
25.39 Guidelines for antiepileptic drug therapy + Box 25.40 Guidelines for
choice of antiepileptic drug (vv.imp)
d. Status epilepticus (do it from pg. 1080-1081 + 25.12 Management of status
epilepticus) (vvv.imp)
e. You may leave
i. Box 25.30 Causes of focal seizures
ii. Box 25.31 Causes of generalised tonic–clonic seizures
iii. Epilepsy syndromes + Box 25.32 Electroclinical epilepsy syndromes
+ Box 25.33 Common generalised epilepsy syndromes
iv. Box 25.37 Epilepsy: outcome after 20 years
v. Box 25.38 UK driving regulations
vi. Box 25.41 Epilepsy in pregnancy
vii. Box 25.43 Epilepsy in adolescence
viii. Non-epileptic attack disorder („dissociative attacks‟)
2. IDIOPATHIC PARKINSON’S DISEASE Pg. 1112-1114 (UNIT 25)
a. Pathophysiology and Clinical features + Box 25.55 Physical signs in
Parkinson‟s disease (for making diagnosis, summarized in EFY)
b. 25.54 Causes of parkinsonism (v.imp)
c. Investigations
d. Management + Box 25.56 Dopamine agonists (vv.imp)
3. MENINGITIS Pg. 1118-1121 (UNIT 25)
a. Box 25.62 Causes of meningitis
b. Viral meningitis
i. Clinical features
ii. Investigations
iii. Management
c. Bacterial meningitis (vv.imp)
i. Pathophysiology and Clinical features (for making diagnosis,
summarized in EFY)
PAGE 22 OF 115
HUMAN FOUNTAINS –
MEDICINE
ii. Box 25.63 Bacterial causes of meningitis (vvv.imp)

iii. Box 25.64 Complications of meningococcal sepsis (v.imp)
iv. Investigations + Fig. 25.34 The investigation of meningitis (vv.imp)
v. Management + Box 25.65 Treatment of pyogenic meningitis of
unknown cause (ignore doses) + Box 25.66 Chemotherapy of
bacterial meningitis when the cause is known (ignore doses)
(vvv.imp)
d. Tuberculous meningitis
i. Pathophysiology and Clinical features + Box 25.68 Clinical features
and staging of tuberculous meningitis (for making diagnosis,
summarized in EFY)
ii. Investigations (vv.imp)
iii. Management (vv.imp)
e. You may leave
i. Box 25.67 Chemoprophylaxis following meningococcal exposure
ii. Other forms of meningitis
4. GUILLAIN-BARRE SYNDROME (GBS) Pg. 1140 (UNIT 25)
5. STROKE (CEREBROVASCULAR INFARCTION) Pg. 1153-1160 (UNIT 26)
a. Pathophysiology and Clinical features (for making diagnosis, summarized in
EFY)
b. Box 26.1 Risk factors for stroke
c. Fig. 26.10 Clinical and radiological features of the stroke syndromes
d. Box 26.4 Characteristic features of stroke and non-stroke syndromes
(„stroke mimics‟)
e. Investigations + Box 26.5 Investigation of a patient with an acute stroke +
Box 26.7 Indications for immediate CT/MRI in acute stroke
f. Management + Fig. 26.11 Emergency management of stroke + Fig. 26.12
Complications of acute stroke + Box 26.8 How to manage a patient with
acute stroke + Fig. 26.13 Strategies for secondary prevention of stroke
g. You may leave
i. Box 26.2 Causes of intracerebral haemorrhage and associated risk
factors
ii. Box 26.3 Differential diagnosis of stroke and transient ischaemic
attack
iii. Box 26.6 Causes and investigation of acute stroke in young patients
iv. Box 26.9 Anticoagulation in old age
SECOND PRIORITY
6. MIGRAINE Pg. 1095-1096 (UNIT 25)
EFY)
b. Management (imp)
7. TRIGEMINAL NEURALGIA (TIC DOULOUREUX) Pg. 1096-1097 (UNIT 25)
EFY)
b. Management (imp)
PAGE 23 OF 115
HUMAN FOUNTAINS –
MEDICINE
8. MULTIPLE SCLEROSIS (MS) Pg. 1106-1110 (UNIT 25)

a. Pathophysiology and Clinical features + Box 25.48 Clinical features of
multiple sclerosis (for making diagnosis, summarized in EFY)
b. Investigations + Fig. 25.29 Investigations in a patient suspected of having
multiple sclerosis
c. Management + Box 25.49 Disease-modifying treatments in multiple
sclerosis (only names of drugs)
d. Box 25.50 Treatment of complications in multiple sclerosis
e. You may leave
i. Box 25.47 The Macdonald criteria for diagnosis of multiple sclerosis
(2011)
ii. Box 25.51 Multiple sclerosis in pregnancy
9. MOTOR NEURON DISEASE Pg. 1116-1117 (UNIT 25)
a. Clinical features + Box 25.60 Clinical features of motor neuron disease (for
making diagnosis)
b. Fig. 25.33 Patterns of involvement in motor neuron disease (vv.imp)
c. Investigations
d. Management
10.SUBARACHNOID HAEMORRHAGE Pg. 1160-1162 (UNIT 26)
 Tension-type headache (Pg. 1095)
 Cluster headache (Pg. 1096)
 Huntington‟s disease (Pg. 1115)
 Essential tremor (Pg. 1115)
6. HEMATOLOGY
Davidson Ed. 23rd
5 1 10
Unit 23
It is small topic with very little weightage. Just do the mentioned topics and ignore the
FIRST PRIORITY
1. IRON DEFICIENCY ANEMIA Pg. 940-953
a. Investigations + Box 23.30 Investigations to differentiate anaemia of
chronic disease from iron deficiency anaemia (vv.imp)
c. You may leave Box 23.29 Haematological physiology in pregnancy
PAGE 24 OF 115
HUMAN FOUNTAINS –
MEDICINE
2. MEGALOBLASTIC ANEMIA Pg. 943-945

a. Box 23.31 Clinical features of megaloblastic anaemia (for making diagnosis,
summarized in EFY)
b. Vitamin B12
i. Vitamin B12 absorption
ii. Box 23.32 Investigations in megaloblastic anaemia
iii. Box 23.33 Neurological findings in B12 deficiency
iv. Causes of vitamin B12 deficiency
c. Folate
i. Folate absorption
ii. Folate deficiency
iii. Box 23.34 Causes of folate deficiency
d. Management (vv.imp)
3. HEMOLYTIC ANEMIA Pg. 945-951
a. Causes of haemolytic anaemia + Fig. 23.19 Causes and classification of
haemolysis
b. Box 23.36 Investigation results indicating active haemolysis
c. Hereditary spherocytosis
d. Glucose-6-phosphate dehydrogenase deficiency + Box 23.38 Glucose-6-
phosphate dehydrogenase deficiency
e. Autoimmune haemolytic anaemia (vv.imp)
f. You may leave
i. Hereditary elliptocytosis
ii. 23.37 Management of the splenectomised patient
iii. Pyruvate kinase deficiency
iv. Pyrimidine 5′ nucleotidase deficiency
v. Non-immune haemolytic anaemia
vi. Paroxysmal nocturnal haemoglobinuria
4. MULTIPLE MYELOMA Pg. 966-968
a. Fig. 23.31 Clinical and laboratory features of multiple myeloma (for making
b. Box 23.58 Classification of multiple myeloma (only name of types)
c. Clinical features and investigations (vv.imp)
e. You may leave Box 23.59 Haematological malignancy in old age
5. IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) Pg. 971
a. Clinical features and investigations (vv.imp)
6. APLASTIC ANEMIA (AA) Pg. 968-969
a. Primary idiopathic acquired aplastic anaemia
i. Clinical features and investigations + Box 23.60 Camitta criteria
(vv.imp)
ii. Management
b. Secondary aplastic anaemia + Box 23.61 Causes of secondary aplastic
anaemia
SECOND PRIORITY
7. ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) (will be covered in PAEDIATRICS
GUIDELINES | POINT 5: ONCOLOGY)
PAGE 25 OF 115
HUMAN FOUNTAINS –
MEDICINE
8. CHRONIC MYELOID LEUKEMIA (CML) Pg. 958-959

a. Natural history and Clinical features (for making diagnosis, summarized in
EFY)
b. Investigations
c. Management + Box 23.49 Tyrosine kinase inhibition in chronic myeloid
leukaemia (vv.imp)
9. POLYCYTHEMIA RUBRA VERA Pg. 970
10.VON WILLEBRAND DISEASE (vWD) Pg. 974
d. You may leave Box 23.64 Classification of von Willebrand disease
11.VENOUS THROMBOEMBOLIC DISEASE Pg. 975-977
a. Fig. 23.33 Causes and consequences of venous thromboembolic disease and
its treatment.
b. Management of VTE
c. Prophylaxis of VTE + Box 23.66 Antithrombotic prophylaxis (vvv.imp)
d. You may leave Box 23.65 Factors predisposing to venous thrombosis
 Anaemia of chronic disease (Pg. 943)
 Beta-thalassaemia (Pg. 953-954)
 Box 23.55 Clinical stages of Hodgkin lymphoma (Ann Arbor classification) (pg.
962)
 Box 23.63 Severity of haemophilia (ISTH criteria) (Pg. 972)
 Thrombotic thrombocytopenic purpura (Pg. 979)
7. RHEUMATOLOGY
Davidson Ed. 23rd
6 1 11
Unit 24
It is small topic with very little weightage. Just do the mentioned topics and ignore the
FIRST PRIORITY
1. GOUT Pg. 1012-1016
EFY)
c. Management + Fig. 24.24 Uric acid metabolism + Box24.44 Indications for
urate-lowering drugs (vvv.imp)
d. You may leave
i. Epidemiology
ii. Box 24.42 Causes of hyperuricaemia and gout
PAGE 26 OF 115
HUMAN FOUNTAINS –
MEDICINE
iii. Box 24.43 Gout in old age

2. SEPTIC ARTHRITIS Pg. 1019-1020
EFY)
c. Management + Box 24.50 Emergency management of suspected septic
arthritis (ignore doses) (vv.imp)
d. You may leave Box 24.49 Joint and bone infection in old age
3. RHEUMATOID ARTHRITIS (RA) Pg. 1021-1026
EFY)
b. Box 24.53 Extra-articular manifestations of rheumatoid disease (imp)
c. Box 24.54 Felty‟s syndrome
d. Investigations + Box 24.52 Criteria for diagnosis of rheumatoid arthritis +
Box 24.55 Investigations and monitoring of rheumatoid arthritis (vv.imp)
e. Management + Fig. 24.36 Calculation of the Disease Activity Score 28
(DAS28) + Fig. 24.37 Algorithm for the management of rheumatoid arthritis
f. You may leave Box 24.56 Rheumatoid arthritis in pregnancy
4. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Pg. 1034-1037
EFY)
b. Investigations + Box 24.63 Criteria for the classification of systemic lupus
erythematosus (vvvv.imp)
5. SYSTEMIC SCLEROSIS (SCLERODERMA) Pg. 1037-1038
EFY)
c. Management (vvv.imp)
SECOND PRIORITY
6. OSTEOARTHRITIS (OA) Pg. 1007-1012
a. Pathophysiology + Box 24.37 Symptoms and signs of osteoarthritis + Box
24.38 Characteristics of generalised nodal osteoarthritis (for making
b. Investigations
c. Management (imp)
d. You may leave
i. Epidemiology
ii. Clinical features
iii. Box 24.36 Risk factors for osteoarthritis
iv. Box 24.39 Causes of early-onset osteoarthritis
v. Box 24.40 Osteoarthritis in old age
7. ANKYLOSING SPONDYLITIS Pg. 1030-1031
c. Management (v.imp)
d. Box 24.61 Extra-articular features of axial spondyloarthritis and ankylosing
spondylitis (vv.imp)
PAGE 27 OF 115
HUMAN FOUNTAINS –
MEDICINE
8. GIANT CELL ARTERITIS Pg. 1042-1043

b. Investigations
c. Management + Box 24.67 Emergency management of giant cell arteritis (imp)
 Box 24.41 Crystal-associated arthritis and deposition in connective tissue (Pg.
1013)
 Box 24.60 Comparison of diagnostic criteria for axial spondyloarthritis (ASAS) and
ankylosing spondylitis (modified New York) (Pg. 1028)
 Reactive arthritis (Pg. 1031-1032)
 Mixed connective tissue disease (Pg. 1038)
 Polymyositis and dermatomyositis (Pg. 1039-1040)
 Neurological disease (Pg. 1058)
 MEDICINE-II
8. INFECTIOUS DISEASES
Davidson Ed. 23rd
7 2 17
Unit 11 (main), 12, 13, 25
All topic of M2 are extensive (2 SEQs) but you have to play smart. Just do the mentioned
of FINAL YEAR MBBS.
FIRST PRIORITY
1. CHICKENPOX (VARICELLA) Pg. 238-239
b. Diagnosis (v.imp)
c. Management and Prevention + Box 11.30 Therapy for herpes simplex and varicella
zoster virus infection + Box 11.31 Indications for varicella zoster immunoglobulin
(VZIG) in adults (v.imp)
2. SHINGLES (HERPES ZOSTER) Pg. 239-240
b. Management (v.imp)
3. INFECTIOUS MONONUCLEOSIS (GLANDULAR FEVER) Pg. 241-242
b. Box 11.32 Causes of infectious mononucleosis syndrome
d. Management (v.imp)
e. Box 11.33 Complications of Epstein–Barr virus infection (imp)
PAGE 28 OF 115
HUMAN FOUNTAINS –
MEDICINE
4. DENGUE Pg. 243-244

a. Clinical features + Box 11.34 Clinical features of dengue fever (for making
b. Diagnosis (imp)
c. Management and Prevention (v.imp)
d. You may leave Box 11.35 WHO case definitions of dengue, 2015
5. LEPTOSPIROSIS Pg. 257-259
a. Clinical features + Fig. 11.23 Clinical syndromes of leptospirosis (for
b. Diagnosis (imp)
c. Management and Prevention (vv.imp)
6. TYPHOID AND PARATYPHOID (ENTERIC) FEVERS Pg. 260-261
a. Clinical features + Box 11.42 Clinical features of typhoid fever (for making
b. Complications + Box 11.43 Complications of typhoid fever (v.imp)
c. Investigations
e. Prevention
f. Salmonella spp. Infection (pg. 262-263)
7. MALARIA Pg. 273-278
a. Pathogenesis and Clinical features + Box 11.53 Relationships between life
cycle of parasite and clinical features of malaria + Fig. 11.34 Features of
Plasmodium falciparum infection (for making diagnosis, summarized in EFY)
c. Management + Box 11.54 Severe manifestations/complications of
falciparum malaria and their immediate management + Box 11.55 Malaria
treatment (ignore doses) (vvvv.imp)
d. Prevention + Box 11.56 Chemoprophylaxis of malaria (ignore doses)
(vv.imp)
8. MENINGITIS (already covered in MEDICINE-I GUIDELINES | POINT 5:
CENTRAL NERVOUS SYSTEM)
9. COVID-19 INFECTION
This topic is missing in Davidson Ed. 23rd. So you can prepare it EITHER form EFY
Ed. 2nd MEDICINE II UNIT 1 TOPIC 1.18. OR Davidson Ed. 24th (Pg. 293-298
TOPIC SARS-CoV2)
SECOND PRIORITY
10.MUMPS Pg. 240
b. Diagnosis
11.HERPES SIMPLEX VIRUS I AND II Pg. 247-248
b. Complications (imp)
c. Diagnosis
d. Management (v.imp)
12.CHOLERA Pg. 264-265
PAGE 29 OF 115
HUMAN FOUNTAINS –
MEDICINE
c. Diagnosis and Management (v.imp)

d. Prevention
13.BACILLARY DYSENTERY (SHIGELLOSIS) Pg. 265
b. Management and Prevention (vv.imp)
14.AMEBIASIS Pg. 286-287
a. Pathology and Clinical features (for making diagnosis, summarized in EFY)
d. Prevention
15.GIARDIASIS Pg. 287
a. Clinical features and investigations
16.ECHINOCOCCUS GRANULOSUS (TAENIA ECHINOCOCCUS) AND HYDATID
DISEASE Pg. 298-299
a. Clinical features + Fig. 11.58 Hydatid disease (for making diagnosis,
summarized in EFY)
c. Management and Prevention (vv.imp)
17.HIV (AIDS) (UNIT 12) – only do mentioned topics
a. Diagnosis and Investigations (Pg. 310-311)
b. Box 12.8 Clinical features of primary infection (Pg. 312)
c. Box 12.17 Commonly used antiretroviral drugs (Pg. 324)
18.ACQUIRED SYPHILIS Pg. 337-338 (UNIT 13)
a. Box 13.6 Classification of syphilis
b. Early syphilis
c. Late syphilis
19.TETANUS Pg. 1125-1126 (UNIT 25)
b. Investigations
c. Management + Box 25.71 Treatment of tetanus (vv.imp)
d. Prevention (imp)
 Brucellosis (Pg. 254-255)
 Visceral leishmaniasis (kala-azar) (Pg. 283-284)
Consult MEDICINE-II UNIT 1 in EPISODE FINAL YEAR ED. 2ND
9. NEPHROLOGY & CLINICAL BIOCHEMISTRY

Davidson Ed. 23rd
10 2 20
Unit 14, 15
All topic of M2 are extensive (2 SEQs) but you have to play smart. Just do the mentioned
of FINAL YEAR MBBS.
PAGE 30 OF 115
HUMAN FOUNTAINS –
MEDICINE

FIRST PRIORITY
1. GLOMERULONEPHRITIS Pg. 397-401 (UNIT 15)
a. Fig. 15.11 Glomerulonephritis associated with antibody production + Box
15.15 Glomerulonephritis categorised by clinical presentation and
histological classification (for making diagnosis, summarized in EFY)
b. Box 15.14 Poor prognostic indicators in glomerular disease
c. Diseases typically presenting with nephrotic syndrome
i. Minimal change nephropathy (vvv.imp)
ii. Focal segmental glomerulosclerosis
iii. Membranous nephropathy
d. Diseases typically presenting with mild nephritic syndrome
i. IgA nephropathy (v.imp)
ii. Henoch–Schönlein purpura (vv.imp)
iii. Mesangiocapillary glomerulonephritis
e. Diseases typically presenting with rapidly progressive glomerulonephritis
i. Anti-glomerular basement membrane disease (vv.imp)
ii. Infection-related glomerulonephritis (vvvv.imp)
f. Box 15.17 Causes of glomerulonephritis associated with low serum
complement
2. ACUTE KIDNEY INJURY (ACUTE RENAL FAILURE) Pg. 411-415 (UNIT 15)
a. Pathophysiology and Clinical features + Box 15.25 Categorising acute kidney
injury based on history, examination and investigations (for making
diagnosis, summarized in EFY) (vvv.imp)
b. Management + Box 15.26 Management of acute kidney injury (vvv.imp)
c. Recovery from AKI (give a read)
d. You may leave Box 15.27 Acute kidney injury in old age
3. CHRONIC KIDNEY DISEASE (CKD) Pg. 415-420 (UNIT 15)
a. Pathophysiology and Clinical features + Box 15.28 Common causes of
chronic kidney disease (for making diagnosis, summarized in EFY)
b. Investigations + Box 15.29 Suggested investigations in chronic kidney
disease (vv.imp)
c. Management (quick read is enough, don‟t cram the whole stuff)
d. Box 15.33 Causes of anaemia in chronic kidney disease (vv.imp)
e. Preparing for renal replacement therapy (vvvv.imp) + Box 15.35 Indications
for dialysis with examples for AKI and CKD (pg. 422) (vv.imp)
f. You may leave
i. Epidemiology
ii. Box 15.30 Criteria for referral of chronic kidney disease patients to a
nephrologist
iii. Box 15.31 Exemplar medicine sick-day card
iv. Box 15.32 Foods high in potassium
4. HYPONATREMIA Pg. 357-358 (UNIT 14)
a. Pathophysiology and Clinical features + Box 14.12 Symptoms and severity
of hyponatraemia (for making diagnosis, summarized in EFY)
b. Box 14.10 Causes of hyponatraemia (vv.imp)
PAGE 31 OF 115
HUMAN FOUNTAINS –
MEDICINE
c. Box 14.11 Causes and diagnosis of syndrome of inappropriate antidiuretic

hormone secretion (vv.imp)
d. Investigations
e. Management + Fig. 14.8 Algorithm for the diagnosis of hyponatraemia
(vvv.imp)
5. HYPERKALEMIA Pg. 362-363 (UNIT 14)
EFY)
b. Box 14.16 Causes of hyperkalaemia
c. Investigations
d. Management + Box 14.17 Treatment of severe hyperkalaemia (vv.imp)
6. METABOLIC ACIDOSIS Pg. 364-366 (UNIT 14)
a. Box 14.18 Principal patterns of acid–base disturbance (vvv.imp)
b. Pathophysiology and Clinical features (for making diagnosis, summarized in
EFY)
c. Box 14.19 Causes of metabolic acidosis (vvv.imp)
d. Box 14.20 Causes of renal tubular acidosis (imp)
e. Investigations
f. Management
7. METABOLIC ALKALOSIS Pg. 366-367 (UNIT 14)
a. Pathophysiology and Clinical features + Fig. 14.11 Generation and
maintenance of metabolic alkalosis during prolonged vomiting (for making
b. Investigations
c. Management
8. CALCULATIONS (also mentioned in EFY)
 
a. Anion gap = (Na+ + K+) – (HCO3 + Cl ) (Normal: 8–12 mEq/L or mmol/L)
  
b. HCO3 deficit = Weight x 0.5 (HCO3 desired – HCO3 measured)
SECOND PRIORITY
9. ADULT POLYCYSTIC KIDNEY DISEASE (APKD) Pg. 405-406 (UNIT 15)
a. Clinical features + Box 15.21 Adult polycystic kidney disease: common
clinical features (for making diagnosis, summarized in EFY)
c. Management
d. Complications (vv.imp) (from EFY)
10.UROLITHIASIS (will be covered in SURGERY-II GUIDELINES | POINT
13: UROGENITAL SYSTEM)
11.RENAL CELL CANCER (will be covered in SURGERY-II GUIDELINES | POINT
13: UROGENITAL SYSTEM)
 Alport‟s syndrome (Pg. 403-404)
 Respiratory acidosis (Pg. 367)
 Respiratory alkalosis (Pg. 367)
PAGE 32 OF 115
HUMAN FOUNTAINS –
MEDICINE
10. ENDOCRINOLOGY
Davidson Ed. 23rd
5 2 15
Unit 18 & 20 (main), 30
Just like other topics of M2, this topic is also extensive but comparatively holds less
weightage. Just do the mentioned topics and ignore the rest. The book content seems to
be extensive. Just summarize and highlight the things to make them short. There is no
need to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. DIABETES MELLITUS (UNIT 20) – only do mentioned topics
a. Pg. 726: Box 20.2 Diagnosis of diabetes and pre-diabetes (vv.imp)
b. Pg. 727-728: Establishing the diagnosis of diabetes (imp)
c. Pg. 735-738: Diabetic ketoacidosis
i. Pathogenesis and clinical assessment + Box 20.14 Clinical features of
diabetic ketoacidosis (for making diagnosis, summarized in EFY)
ii. Box 20.13 Average loss of fluid and electrolytes in adult diabetic
ketoacidosis of moderate severity (v.imp)
iii. Investigations + Box 20.15 Indicators of severe diabetic ketoacidosis
(imp)
iv. Management + Box 20.16 Emergency management of diabetic
ketoacidosis (it is a bit complex but summarized well in EFY)
(vv.imp)
d. Pg. 739: Box 20.17 Emergency management of hyperglycemic hyperosmolar
state (it is a bit complex but summarized well in EFY) (vv.imp)
e. Pg. 741: Box 20.20 Emergency treatment of hypoglycaemia (it is a bit
complex but summarized well in EFY) (vv.imp)
f. Pg. 744: Box 20.23 Dietary management of diabetes (imp)
g. Pg. 745: Box 20.25 Recommendations for management of diabetes during
Ramadan (optional but important for vivas)
h. Pg. 745-748: Drugs to reduce hyperglycaemia (only names and route of
administration e.g. oral or IV; no need for details)
i. Pg. 756: Box 20.35 Complications of diabetes (vvv.imp)
j. Pg. 757-758: Diabetic nephropathy
i. Diagnosis and screening + Box 20.39 Screening for microalbuminuria
(v.imp)
ii. Management (vvv.imp)
k. Pg. 761 Box 20.43 Management options for peripheral sensorimotor and
autonomic neuropathies
l. Pg. 762: Fig. 20.24 Risk assessment and management of foot problems in
diabetes (imp)
2. HYPERTHYROIDISM OR THYROTOXICOSIS Pg. 635-639 (UNIT 18)
a. Clinical assessment + Box 18.7 Clinical features of thyroid dysfunction (for
b. Box 18.6 Causes of thyrotoxicosis & their relative frequencies (only causes)
PAGE 33 OF 115
HUMAN FOUNTAINS –
MEDICINE
c. Investigations + Fig. 18.5 Establishing the differential diagnosis in

thyrotoxicosis (vv.imp)
d. Management + Pg. 644 Box 18.14 Comparison of treatments for the
thyrotoxicosis of Graves‟ disease (vv.imp)
e. You may leave
i. Box 18.8 Prevalence of thyroid autoantibodies (%)
ii. Box 18.9 Non-specific laboratory abnormalities in thyroid dysfunction
iii. Box 18.10 The Burch–Wartofsky scoring system for thyrotoxic crisis
3. HYPOTHYROIDISM Pg. 639-642 (UNIT 18)
a. Clinical assessment + Box 18.7 Clinical features of thyroid dysfunction + Fig.
18.6 An approach to adults with suspected primary hypothyroidism (for
b. Box 18.11 Causes of hypothyroidism
d. Management + Box 18.12 Situations in which an adjustment of the dose of
levothyroxine may be necessary (vv.imp)
e. Symptoms of hypothyroidism with normal thyroid function tests (quick read)
4. SUBCLINICAL HYPOTHYROIDISM Pg. 642 (UNIT 18)
5. CUSHING’S SYNDROME Pg. 666-670 (UNIT 18)
a. Aetiology and Clinical assessment + Box 18.38 Classification of endogenous
Cushing‟s syndrome + Fig. 18.20 Cushing‟s syndrome (for making diagnosis,
summarized in EFY)
b. Investigations + Fig. 18.21 Sequence of investigations in suspected
spontaneous Cushing‟s syndrome + Fig. 18.22 Determining the cause of
confirmed Cushing‟s syndrome. (vvv.imp)
c. Management
6. ADRENAL INSUFFICIENCY Pg. 671-673 (UNIT 18)
a. Clinical assessment + Box 18.41 Causes of adrenocortical insufficiency +
Box 18.42 Clinical and biochemical features of adrenal insufficiency (for
b. Investigations (imp)
c. Management + Box 18.44 Management of adrenal crisis (vv.imp)
d. You may leave
i. Box 18.43 How and when to do an ACTH stimulation test
ii. Box 18.45 Glucocorticoids in old age
7. ACROMEGALY Pg. 685-687 (UNIT 18)
a. Clinical features + Fig. 18.30 Clinical features of acromegaly (for making
SECOND PRIORITY
8. HYPOCALCAEMIA Pg. 662-663 (UNIT 18)
a. Clinical assessment (for making diagnosis, summarized in EFY)
b. Management + Box 18.34 Management of severe hypocalcaemia (vv.imp)
9. PRIMARY HYPERPARATHYROIDISM Pg. 663-664 (UNIT 18)
a. Clinical and radiological features (for making diagnosis, summarized in EFY)
b. Box 18.35 Hyperparathyroidism (imp)
c. Investigations
PAGE 34 OF 115
HUMAN FOUNTAINS –
MEDICINE
d. Management (imp)
10.HYPOPARATHYROIDISM Pg. 664-665 (UNIT 18)
a. Management of hypoparathyroidism (imp)
11.PRIMARY HYPERALDOSTERONISM Pg. 674-675 (UNIT 18)
c. Management
d. You may leave Box 18.46 Causes of mineralocorticoid excess
12.PHAEOCHROMOCYTOMA Pg. 675-676 (UNIT 18)
a. Clinical features + Box 18.47 Clinical features of phaeochromocytoma (for
c. Management
13.PROLACTINOMA Pg. 684-685 (UNIT 18)
a. Management + Box 18.59 Dopamine agonist therapy: drugs used to treat
prolactinomas (only names)
14.CARCINOID TUMOURS (already covered in MEDICINE-I GUIDELINES |
POINT 3: GASTROINTESTINAL SYSTEM)
15.SHEEHAN SYNDROME Pg. 1280 (UNIT 30)
 Diabetes insipidus (Pg. 687-688)
 Box 18.63 Multiple endocrine neoplasia (MEN) syndromes (Pg. 689)
11. PSYCHIATRY
Davidson Ed. 23rd
10 2 20
Unit 28
Just like other topics of M2, this topic is also extensive but easy. Just do the mentioned
of FINAL YEAR MBBS.
FIRST PRIORITY
1. SCHIZOPHRENIA Pg. 1196-1198 (UNIT 28)
a. Pathogenesis and Clinical features + Box 28.23 Symptoms of schizophrenia
b. Diagnosis + Box 28.24 Differential diagnosis of schizophrenia (vv.imp)
d. Management + Box 28.25 Antipsychotic drugs (ignore doses) + Box 28.26
Adverse effects of antipsychotic drugs (vvv.imp)
e. Prognosis
2. DEPRESSION Pg. 1198-1199 (UNIT 28)
a. Pathogenesis (for making diagnosis, summarized in EFY)
b. Diagnosis
PAGE 35 OF 115
HUMAN FOUNTAINS –
MEDICINE
c. Investigations
d. Management + Box 28.27 Antidepressant drugs (ignore doses) (vv.imp)
e. Prognosis
3. BIPOLAR DISORDER Pg. 1199-1200 (UNIT 28)
a. Pathogenesis (for making diagnosis, summarized in EFY)
b. Diagnosis
d. Prognosis
4. OBSESSIVE COMPULSIVE DISORDER (OCD) Pg. 1201 (UNIT 28)
b. Diagnosis
5. SOMATOFORM DISORDERS Pg. 1202-1203 (UNIT 28)
a. Pathogenesis + 28.29 Common presentations of dissociative (conversion)
disorder (for making diagnosis, summarized in EFY) (vvv.imp)
a. Management + Box 28.30 General management principles for medically
unexplained symptoms (vvv.imp)
6. DELIRIUM Pg. 183-184 (UNIT 10)
a. Box 10.8 Risk factors for delirium (imp)
b. Presentation and clinical assessment (for making diagnosis, summarized in
EFY)
c. Fig. 10.4 Common causes and investigation of delirium
d. Investigations and management
e. You may leave Box 10.9 How to make a diagnosis of delirium: the 4AT
SECOND PRIORITY
7. ALCOHOL MISUSE AND DEPENDENCE Pg. 1194-1195 (UNIT 28)
a. Pathogenesis and Clinical features + Box 28.22 Presentation and
consequences of chronic alcohol misuse (for making diagnosis, summarized
in EFY)
b. Diagnosis
d. Prognosis
8. ANXIETY DISORDER Pg. 1200-1201 (UNIT 28)
a. Clinical features + Box 28.28 Classification of anxiety disorders (for making
b. Diagnosis
9. EATING DISORDERS Pg. 1203-1204 (UNIT 28)
a. Box 28.31 Medical consequences of eating disorders (single read)
b. Anorexia nervosa
i. Pathogenesis and clinical features (for making diagnosis, summarized
in EFY)
ii. Diagnosis + Box 28.32 Diagnostic criteria for eating disorders
(vv.imp)
iii. Management (vv.imp)
iv. Prognosis
c. Bulimia nervosa
i. Clinical features (for making diagnosis, summarized in EFY)
PAGE 36 OF 115
HUMAN FOUNTAINS –
MEDICINE
ii. Diagnosis + Box 28.32 Diagnostic criteria for eating disorders

(vv.imp)
iii. Investigations (imp)
v. Prognosis
10.PUERPERAL PSYCHIATRIC DISORDERS Pg. 1206-1207 (UNIT 28)
a. Post-partum blues
b. Postpartum depression (imp)
c. Puerperal psychosis (imp)
d. You may leave
i. Psychiatric disorders during pregnancy
ii. Box 28.33 Psychiatric illness and pregnancy
11.MIGRAINE (already covered in MEDICINE-I GUIDELINES | POINT 5:
 Lewy body dementia (Pg. 1194)
 Factitious disorder and malingering (Pg. 1205-1206)
12. DERMATOLOGY
Davidson Ed. 23rd
6 1 11
Unit 29
Unlike other topics of M2, this topic is smallest and holds very small weightage (1 SEQ
only). Just do the mentioned topics and ignore the rest. The book content seems to be
extensive. Just summarize and highlight the things to make them short. There is no need
to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. SCABIES Pg. 1241 (vv.imp)
2. ATOPIC ECZEMA Pg. 1245-1246
a. Pathogenesis and clinical features + Box 29.19 Atopic eczema: distribution
and character of rash (for making diagnosis, summarized in EFY)
b. Investigations + Box 29.21 Diagnostic criteria for atopic eczema
c. Management + Fig. 29.31 General management approaches: atopic eczema
(vv.imp)
d. Box 29.20 Complications of atopic eczema (imp)
3. PSORIASIS (Pg. 1247-1251)
a. Box 29.23 Exacerbating factors in psoriasis
c. Investigations
d. Management + Fig. 29.36 General management approaches: psoriasis
(vv.imp)
e. You may leave
i. Pathogenesis
PAGE 37 OF 115
HUMAN FOUNTAINS –
MEDICINE
ii. Fig. 29.37 Developments in understanding of key pathways and drug

targets in psoriasis
4. ERYTHEMA NODOSUM Pg. 1265 (v.imp)
SECOND PRIORITY
5. ACNE VULGARIS Pg. 1241-1243
EFY)
b. Investigations
c. Management (make it short) (imp)
6. TOXIC EPIDERMAL NECROLYSIS (TEN) Pg. 1254-1255
a. You may leave Box 29.26 Disease severity score for toxic epidermal
necrolysis: SCORTEN
7. DERMATITIS HERPETIFORMIS Pg. 1256
8. LUPUS ERYTHEMATOSUS Pg. 1262
 Impetigo (Pg. 1235-1236)
 Cellulitis and erysipelas (Pg. 1237)
 Fungal infections (Pg. 1239-1240)
 Pityriasis rosea (Pg. 1251)
 Lichen planus (Pg. 1252)
 Bullous pemphigoid (Pg. 1255-1256)
 Pyoderma gangrenosum (Pg. 1261-1262)
 Erythema multiforme (Pg. 1264)
 Acanthosis nigricans (Pg. 1265)
13. NUTRITION
Davidson Ed. 23rd
2 - 2
Unit 19
There will be no SEQ from this portion. Mentioned 2 MCQs are mostly from following
topics;
 Pg. 700: Box 19.7 Quantifying obesity with BMI and waist circumference for risk of
type 2 diabetes and cardiovascular disease
 Pg. 701: Box 19.8 Low-calorie diet therapy for obesity
 Pg. 716: Box 19.33 Scurvy – vitamin C deficiency
 Pg. 716-717: Iron
PAGE 38 OF 115
HUMAN FOUNTAINS –
PAEDIATRIC MEDICINE
PAEDIATRIC MEDICINE
PAEDIATRIC MEDICINE
# Topic MCQS SEQS
(40 x 1) (10 x 5)
1 Endocrinology & Genetics 3 1
2 Nephrology 1 1
3 Respiratory System 1 1
4 Cardiology & Hematology 8 2
5 Oncology 1 1
6 Gastrointestinal System 5 1
7 Immunization & Infections 5 1
8 Neurology & Neuromuscular Disorders 5 1
9 Meningitis 2 1
10 Neonatology & Others 9 -
WRITTEN
Paediatrics 40 (1 each) 10 (5 each) 90
100
OSCE/VIVA
OSCE 8 static stations (5 each) 40
Short Case 2 (15 marks each) 30
100
Long Case 1 (20 marks) 20
SUBJECT TOTAL 200
GENERAL GUIDELINES
Paediatrics is shortest and easiest subject of Final Year. Almost 70-75% of topics are
covered in Medicine. I‟ll be using the same reference of Medicine here in Paediatrics too.
Luckily, you can also prepare Paediatrics using EFY papers only. You just have to prepare
total 68 topics for Paediatrics.
BOOKS TO FOLLOW
PERVEZ AKBAR 10th ED. REVISED + EPISODE FINAL YEAR 2nd ED. PAST PAPERS
WE HAVE TO DO WHOLE PERVEZ AKBAR? No, only a few topics which you have not
done in Medicine.
PAGE 39 OF 115
HUMAN FOUNTAINS –
HOW TO COVER MCQS

in May 2023.
1. ENDOCRINOLOGY & GENETICS

Pervez Akbar Ed. 10th ®
3 1 8
Unit 19 & 22
It is a small topic in Paediatrics. Unlike Medicine, there are limited topics in UHS syllabus.
Some of the topics are already covered in Medicine i.e. there is no need to prepare them
from Pervez Akbar separately (details mentioned below). Just do the mentioned topics.
There is no need to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. SHORT STATURE Pg. 448-451 (UNIT 19)
a. Definition
b. Types
c. Etiology
d. Assessment of child with short stature
e. Investigations (imp)
f. Common causes of short stature (only prepare following)
i. Constitutional growth delay (vvv.imp)
ii. Familial (genetic) short stature
iii. Growth hormone deficiency
iv. Hypothyroidism
2. CONGENITAL HYPOTHYROIDISM Pg. 454-456 (UNIT 19)
a. Definition
PAGE 40 OF 115
HUMAN FOUNTAINS –
b. Incidence (leave)
c. Etiology (imp)
d. Clinical findings (for making diagnosis, summarized in EFY)
e. Diagnosis (v.imp)
f. Treatment (vvvv.imp)
g. Follow up (vvv.imp)
h. Prognosis (vv.imp)
i. Neonatal screening (imp)
3. DIABETIC KETOACIDOSIS (DKA) (already covered in MEDICINE-II
GUIDELINES | POINT 10: ENDOCRINOLOGY)
4. RICKETS Pg. 472-476 (UNIT 19)
a. Definition
b. Main points
c. Vitamin D metabolism (leave)
d. Pathology
e. Causes of Rickets (imp)
f. Types of Rickets + Table 19.5 Types and biochemical changes in Rickets
(vv.imp)
g. Clinical findings (for making diagnosis, summarized in EFY)
h. Diagnosis (imp)
i. Differential diagnosis
j. Management (v.imp)
k. Complication (imp)
l. Prevention (imp)
m. Prognosis
SECOND PRIORITY
5. CUSHING SYNDROME (already covered in MEDICINE-II GUIDELINES |
POINT 10: ENDOCRINOLOGY)
6. CONGENITAL ADRENAL HYPERPLASIA Pg. 461-464 (UNIT 19)
a. Pathogenesis and clinical findings (for making diagnosis, summarized in
EFY)
b. Diagnosis (imp)
c. Prenatal diagnosis
d. Prenatal treatment
e. Management (v.imp)
f. Prognosis
7. TURNER SYNDROME Pg. 501-502 (UNIT 22)
a. Clinical findings (for making diagnosis, summarized in EFY)
b. Management (v.imp)
TOPICS (MUST) FOR MCQS ONLY
 Down‟s syndrome (Pg. 498-500)
 Klinefelter syndrome (Pg. 502)
Consult PAEDIATRICS UNIT 1 in EPISODE FINAL YEAR ED. 2ND
PAGE 41 OF 115
HUMAN FOUNTAINS –
2. NEPHROLOGY
1 1 6
Unit 23
It is again a small topic. Unlike Medicine, there are limited topics in UHS syllabus. Some of
the topics are already covered in Medicine and Surgery i.e. there is no need to prepare
them from Pervez Akbar separately (details mentioned below). Just do the mentioned
topics. There is no need to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. ACUTE POST-STREPTOCOCCAL GLOMERULO-NEPHRITIS (PSGN) (already
covered in MEDICINE-II GUIDELINES | POINT 9: NEPHROLOGY & CLINICAL
BIOCHEMISTRY)
2. NEPHROTIC SYNDROME (already covered in MEDICINE-II GUIDELINES |
POINT 9: NEPHROLOGY & CLINICAL BIOCHEMISTRY) + Only definitions from
Pervez Akbar Pg. 522
a. Classification according to response to steroids therapy
b. Remission
c. Relapse
3. URINARY TRACT INFECTION (UTI) Pg. 536-538
a. Definition
c. Localization + Table 23.3: Clues to localize the UTI (imp)
d. Etiology (vvv.imp)
c. Pathogenesis and clinical findings (for making diagnosis, summarized in
EFY)
f. Management (vv.imp)
g. Preventive measures (imp)
h. Complications (v.imp)
i. Follow up
j. Prognosis
SECOND PRIORITY
4. WILM’S TUMOUR (will be covered in SURGERY-II GUIDELINES | POINT 13:
UROGENITAL SYSTEM)
3. RESPIRATORY SYSTEM
1 1 6
Unit 11(main), 4, 8
It is again a small topic. Unlike Medicine, there are limited topics in UHS syllabus. Some of
the topics are already covered in Medicine i.e. there is no need to prepare them from
PAGE 42 OF 115
HUMAN FOUNTAINS –
Pervez Akbar separately (details mentioned below). Just do the mentioned topics. There is
no need to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. CROUP (ACUTE LARYNGOTRACHEOBRONCHITIS) Pg. 247-248 (UNIT 11)
a. Epidemiology (leave)
b. Etiology (imp)
c. Pathophysiology and clinical findings (for making diagnosis, summarized in
EFY)
d. Diagnosis (v.imp)
e. Complications (v.imp)
f. Differential diagnosis (imp)
g. Management (vv.imp)
2. BRONCHIOLITIS Pg. 250-252 (UNIT 11)
a. Definition
c. Etiology (imp)
d. Pathogenesis and clinical findings (for making diagnosis, summarized in
EFY)
f. Complications (v.imp)
g. Differential diagnosis (imp)
h. Risk factors for severe disease (imp)
i. Management (vv.imp)
j. Prognosis
k. Prevention
3. PNEUMONIA (already covered in MEDICINE-I GUIDELINES | POINT 1:
PULMONARY SYSTEM)
4. ACUTE SEVERE ASTHMA (already covered in MEDICINE-I GUIDELINES |
POINT 1: PULMONARY SYSTEM)
5. FOREIGN BODY INHALATION AND CHOKING Pg. 115-117 (UNIT 8)
d. Prevention
SECOND PRIORITY
6. CYSTIC FIBROSIS Pg. 266-269 (UNIT 11)
a. Definition
b. Pathogenesis and clinical findings (for making diagnosis, summarized in
EFY)
c. Complications (v.imp)
d. Table 11.6 Conditions associated with false positive and false negative sweat
test results (leave)
e. Management (imp)
f. Prognosis
7. ACUTE RESPIRATORY INFECTIONS (ARI) Pg. 51 (UNIT 4) – whole table
PAGE 43 OF 115
HUMAN FOUNTAINS –

 Acute epiglottitis (Pg. 246-247)
 Pleural effusion (Pg. 256-257)
4. CARDIOLOGY & HEMATOLOGY

8 2 18
Unit 13
It is the most important topic in Paediatrics holding highest weightage (2 SEQs). Most of
the times these 2 SEQs are from Cardiology (Unit 13) portion. Some of the topics are
already covered in Medicine and Surgery i.e. there is no need to prepare them from Pervez
Akbar separately (details mentioned below). Just do the mentioned topics. There is no
need to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. TETRALOGY OF FALLOT (TOF) Pg. 307-309 Cyanotic (UNIT 13)
a. Components
b. Pathophysiology and clinical findings (for making diagnosis, summarized in
EFY)
c. Diagnosis (v.imp)
d. Complications (v.imp)
f. Course and prognosis
2. VENTRICULAR SEPTAL DEFECT (VSD) Pg. 314-316 Acyanotic (UNIT 13)
a. Pathophysiology and clinical findings (for making diagnosis, summarized in
EFY)
d. Prognosis
e. Complications (v.imp)
3. PATENT DUCTUS ARTERIOSUS (PDA) Pg. 316-317 Acyanotic (UNIT 13)
EFY)
d. Prognosis and Complications (v.imp)
4. ATRIAL SEPTAL DEFECT (ASD) Pg. 317 Acyanotic (UNIT 13)
EFY)
5. MYOCARDITIS Pg. 328-329
EFY)
PAGE 44 OF 115
HUMAN FOUNTAINS –
c. Differential diagnosis (imp)
d. Management (vvv.imp)
e. Prognosis
6. RHEUMATIC FEVER/RHEUMATIC HEART DISEASE (already covered in
MEDICINE-I GUIDELINES | POINT 2: CARDIOVASCULAR SYSTEM)
7. INFECTIVE ENDOCARDITIS (already covered in MEDICINE-I GUIDELINES |
POINT 2: CARDIOVASCULAR SYSTEM)
SECOND PRIORITY
8. MITRAL STENOSIS (already covered in MEDICINE-I GUIDELINES | POINT
2: CARDIOVASCULAR SYSTEM)
9. IRON DEFICIENCY ANEMIA (already covered in MEDICINE-I GUIDELINES |
POINT 6: HEMATOLOGY)
10.APLASTIC ANEMIA (already covered in MEDICINE-I GUIDELINES | POINT
6: HEMATOLOGY)
11.IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) (already covered in
MEDICINE-I GUIDELINES | POINT 6: HEMATOLOGY)
12.TUBERCULOUS LYMPHADENITIS (will be covered in SURGERY-I
GUIDELINES | POINT 7: VASCULAR DISORDERS)
 Transposition of Great Vessels (Pg. 309-311) Cyanotic
5. ONCOLOGY
1 1 6
Unit 17
It is the SMALLEST topic in Paediatrics. There are 99% chances that SEQ will be from
ACUTE LYMPHOBLASTIC LEUKEMIA. There is no need to remember doses at the level
of FINAL YEAR MBBS.
FIRST PRIORITY
1. ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) Pg. 422-424
a. Etiology
b. Clinical findings (for making diagnosis, summarized in EFY)
c. Diagnosis (v.imp)
d. Differential diagnosis (vv.imp)
e. Management – all phases in detail (vvvv.imp)
f. Prognosis (vvv.imp)
SECOND PRIORITY
2. HODGKIN’S LYMPHOMA Pg. 426-427
EFY)
b. Diagnosis (imp)
PAGE 45 OF 115
HUMAN FOUNTAINS –
c. Management
d. Prognosis
6. GASTROINTESTINAL SYSTEM
5 1 10
Unit 6, 10, 12
It is again the most important topic in Paediatrics but holds small highest weightage (1
SEQ). Most of the times SEQ is from ACUTE DIARRHEA (70% probability). Some of the
topics are already covered in Medicine and Surgery i.e. there is no need to prepare them
from Pervez Akbar separately (details mentioned below). Just do the mentioned topics.
FIRST PRIORITY
1. MARASMUS Pg. 94-95 (UNIT 6)
2. KWASHIORKOR Pg. 95-96 (UNIT 6)
3. MANAGEMENT IN SEVERE MALNUTRITION & EMERGENCY TREATMENT
(FIRST PHASE) Pg. 96-97 (UNIT 6)
4. ACUTE DIARRHEA Pg. 180-186 (UNIT 10)
a. Definition
c. Etiology + Table 10.1: Causative agents of gastroenteritis
d. Table 10.2: Miscellaneous & non-infectious causes of acute diarrhea (leave)
e. Epidemiology (leave)
f. Pathogenesis (leave)
g. Evaluation of patient with acute diarrhea (single read)
h. Pathophysiology (leave)
i. Classification of dehydration and clinical findings (for making diagnosis,
summarized in EFY)
j. Grading of stools (leave)
k. Oral rehydration salt (ORG) + Table 10.4: Composition of WHO low osmolar
ORS (total osmolarity is 245 mOsm/L) (vv.imp)
l. Investigations + Table 10.5: Assessment of diarrhea for dehydration (v.imp)
m. Complications (imp)
n. Management (do prepare the doses here) (vvvvvvvv.imp)
i. Treatment plan A (for no dehydration) + Table 10.6: Signs when the
child should be referred to hospital
ii. Treatment plan B (for some dehydration) + Table 10.7: Amount of
ORS to be given to the child
iii. Treatment plan C (treat severe dehydration quickly) + Table 10.8:
Division of IV fluid
iv. Hospital management of severe dehydration
v. Zinc supplementation
vi. Table 10.9: Antibiotics chosen to the at different causes (leave)
o. Prevention (vv.imp)
PAGE 46 OF 115
HUMAN FOUNTAINS –
p. Hypernatremic dehydration (leave)

5. CELIAC DISEASE (already covered in MEDICINE-I GUIDELINES | POINT 3:
GASTROINTESTINAL SYSTEM)
SECOND PRIORITY
6. LACTOSE INTOLERANCE Pg. 275 (UNIT 12)
7. WILSON’S DISEASE (HEPATOCELLULAR DEGENERATION) Pg. 299-300
(UNIT 12)
c. Differential diagnosis (v.imp)
d. Complications
e. Management (vvvv.imp)
f. Prognosis
8. INTUSSUSCEPTION (will be covered in SURGERY-II GUIDELINES | POINT
12: LOWER GASTROINTESTINAL SYSTEM)
 Cow milk protein allergy (Pg. 275-276)
 Table 6.1 Caloric Requirements (Pg. 77)
 Table 6.3 Protein Requirements (Pg. 78)
 Vitamins (Pg. 78)
 Malnutrition (Pg. 90-94)
7. IMMUNIZATION & INFECTIONS

5 1 10
Unit 3, 10
It is again the most important topic in Paediatrics but holds small highest weightage (1
SEQ). Most of the times SEQ is from EPI SCHEDULE (80% probability). Some of the
topics are already covered in Medicine i.e. there is no need to prepare them from Pervez
Akbar separately (details mentioned below). Just do the mentioned topics.
FIRST PRIORITY
1. LATEST EPI VACCINATION SCHEDULE (Prepare it from EFY 2ND ED.
PAEDIATRICS UNIT 7 TOPIC 7.7.) (vvvvv.imp) – also prepare doses
2. POLIOMYELITIS VACCINE Pg. 37 (UNIT 3)
a. Efficacy of vaccine
b. Duration of immunity
c. Advantages of OPV vaccine
d. Side effects of OPV (imp)
e. Contraindications of OPV (vvv.imp)
f. OPV not contraindicated
g. IPV in Pakistan
PAGE 47 OF 115
HUMAN FOUNTAINS –
3. POLIOMYELITIS Pg. 195-198 (UNIT 10)

a. Etiology
b. Epidemiology (leave)
c. Incubation period
EFY)
d. Clinical classification of paralytic poliomyelitis (leave)
e. Diagnosis (imp)
f. Differential diagnosis (imp)
g. Complications and sequelae (imp)
h. Management
i. Prognosis
j. Prevention (imp)
4. PERTUSSIS (WHOOPING COUGH) Pg. 202-205 (UNIT 10)
b. Pathology and clinical findings (for making diagnosis, summarized in EFY)
c. Diagnosis (imp)
d. Differential diagnosis
e. Management (imp)
f. Prevention (imp)
g. Prognosis
SECOND PRIORITY
5. EXAMPLES OF DIFFERENT VACCINES Pg. 36 (UNIT 3)
6. BCG VACCINE Pg. 36-37 (UNIT 3)
a. Normal course of BCG (imp)
b. Complications of BCG vaccine (imp)
7. DIPHTHERIA, TETANUS & PERTUSSIS (DTaP) VACCINE Pg. 37-38 (UNIT 3)
a. Contraindications and precautions (imp)
b. Adverse effects (imp)
c. Vaccines available
8. MEASLES IMMUNIZATION Pg. 38 (UNIT 3)
a. Active immunization
b. Vaccine efficacy
c. Duration of immunity (imp)
d. Dose of vaccine (imp)
e. Adverse effects
9. HEPATITIS B VACCINE Pg. 38-39 (UNIT 3)
a. Efficacy
b. Dose (imp)
c. Infants born to HBsAg-positive mothers (vv.imp)
d. For infants born to mother of unknown HBsAg status (imp)
e. Post-exposure prophylaxis (imp)
10.MEASLES Pg. 208-212 (UNIT 10)
a. Definition
b. Etiology
c. Epidemiology (leave)
c. Pathology and clinical findings (for making diagnosis, summarized in EFY)
PAGE 48 OF 115
HUMAN FOUNTAINS –
d. Diagnosis (imp)
e. Differential diagnosis
f. Complications (imp)
g. Management (imp)
h. Role of vitamin A in measles (vvv.imp)
i. Prognosis
j. Prevention (imp)
k. SSPE (leave)
11.DENGUE (already covered in MEDICINE-II GUIDELINES | POINT 8:
INFECTIOUS DISEASES)
12.TETANUS (already covered in MEDICINE-II GUIDELINES | POINT 8:
8. NEUROLOGY & NEUROMUSCULAR DISORDERS

5 1 10
Unit 14, 15
It is very extensive topic but holds small highest weightage (1 SEQ). Some of the topics
are already covered in Medicine i.e. there is no need to prepare them from Pervez Akbar
separately (details mentioned below). Just do the mentioned topics. There is no need to
remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. CEREBRAL MALARIA (already covered in MEDICINE-II GUIDELINES |
POINT 8: INFECTIOUS DISEASES)
2. EPILEPSY (already covered in MEDICINE-I GUIDELINES | POINT 5:
3. GUILLAIN-BARRE SYNDROME (GBS) (already covered in MEDICINE-I
GUIDELINES | POINT 5: CENTRAL NERVOUS SYSTEM)
4. CEREBRAL PALSY Pg. 366-369 (UNIT 14)
a. Definition
c. Etiology
d. Pathology
e. Classification (leave)
f. Table 14.17: Different forms of cerebral palsy (approx% of CP) (only
names) (vv.imp)
g. Associated deficits (imp)
h. Clinical findings (for making diagnosis, summarized in EFY)
i. Diagnosis (imp)
j. Differential diagnosis
k. Management and prevention (imp)
l. Prognosis
PAGE 49 OF 115
HUMAN FOUNTAINS –
SECOND PRIORITY
5. FEBRILE CONVULSIONS Pg. 344-346 (UNIT 14)
a. Definition
b. Criteria for febrile seizures (vv.imp)
c. Exclusion to the diagnosis (imp)
d. Incidence (leave)
e. General considerations (leave)
f. Etiology
g. Clinical findings + Table 14.11: Febrile convulsions (for making diagnosis)
h. Diagnosis
i. Management (vv.imp)
j. Risk factors for recurrence of febrile seizures (vv.imp)
k. Prognosis (imp)
6. DUCHENNE MUSCULAR DYSTROPHY (DMD) Pg. 378-379 (UNIT 15)
b. Diagnosis (imp)
c. Management (imp)
9. MENINGITIS
(already covered in
MEDICINE-I GUIDELINES
2 1 7
| POINT 5: CENTRAL
NERVOUS SYSTEM)
This is the smallest and already done (in Medicine) topic of Paediatrics. There is no need to
prepare it separately in Paediatrics.
1. PYOGENIC MENINGITIS (already covered in MEDICINE-I GUIDELINES
| POINT 5: CENTRAL NERVOUS SYSTEM)
2. TUBERCULOUS MENINGITIS (already covered in MEDICINE-I GUIDELINES
| POINT 5: CENTRAL NERVOUS SYSTEM)
10. NEONATOLOGY & OTHERS

5 - 9 Unit 2 & 9 OR EFY 2nd Ed.
Paediatrics Unit 10
There will be no SEQ from this portion (most likely) but you must prepare the following
topics for MCQs from Pervez Akbar or EFY 2nd Ed. (summarized)
PAGE 50 OF 115
HUMAN FOUNTAINS –
FIRST PRIORITY
 Pg. 15: Table 2.2: Formulas for approximate average weight of normal infants and
children
 Pg. 16: Table 2.4: Formulas for approximate average height of normal infants and
children
 Pg. 16: Table 2.5: Head circumference at different ages
 Developmental Stages (from EFY Unit 10)
 Pg. 145-148: Neonatal sepsis
 Pg. 152-160: Jaundice neonatorum
 Pg. 167-169: Infant of diabetic mother (IDM)
SECOND PRIORITY
 Pg. 119: Definitions
 Pg. 123-124: Steps of resuscitation
 Pg. 126: Hypothermia
 Pg. 129: Table 9.3: The general principal for calculating the caloric expenditure/day
 Pg. 131: Table 9.5: APGAR score
 Pg. 138-139: Respiratory Distress Syndrome (RDS)
 Pg. 169-171: Neonatal seizures
PAGE 51 OF 115
HUMAN FOUNTAINS –
SURGERY
SURGERY
SURGERY – I
# Topic MCQS SEQS
(50 x 1) (10 x 5)
1 Surgical Anatomy 3 1
2 A&E Surgery; Tissue Repair 6 1
3 Surgical Nutrition 3 1
4 Fluid & Electrolytes; Shock 6 1
5 Anesthesia & Pain Management 3 1
6 Surgical & Special Infections 6 1
7 Vascular Disorders 9 1
8 Skin, Subcutaneous Tissue & Burns 9 1
9 Principles of Oncology 2 1
10 Principles of Radiology 3 1
SURGERY – II
# Topic MCQS SEQS
(60 x 1) (13 x 5)
1 Upper Gastrointestinal System 14 2
2 Lower Gastrointestinal System 12 2
3 Urogenital System 10 2
4 Musculoskeletal System 6 1
5 Thorax 4 1
6 Heart and Great Vessels 2 1
7 Head & Neck (Orodental Surgery) 6 2
8 Breast 4 1
9 Neurosurgery 2 1
WRITTEN
Surgery - I 50 (1 each) 10 (5 each) 100
Surgery - II 60 (1 each) 13 (5 each) 125 250
OSCE/VIVA
9 static & 2 interactive stations
OSCE 55
(5 each)
Short Case 2 (50 each) 100 250
Long Case 1 (70 each) 70
SUBJECT TOTAL 500
PAGE 52 OF 115
HUMAN FOUNTAINS –
SURGERY
GENERAL GUIDELINES
Surgery is the second major subject of Final Year MBBS. Like for Medicine, you cannot
leave this subject untouched at any cost. If you are done with Medicine, it will help you out
in Surgery-II a lot. It is an interesting subject, only and only if you show interest while
doing it.
SUBJECT DIVISION
Surgery has been divided into two parts but in annual exam you have to pass it jointly
(not separately)
 Surgery-I (S1) covers General Surgery
 Surgery-II (S2) covers Systemic Surgery
You have to prepare 95 topics for S1 and 142 topics for S2.
S2 is the lengthiest subject of final year in terms of weightage (13 SEQs and 60 MCQs)
while S1 is also comparatively (to other subjects of final year) lengthy (10 SEQs and 50
MCQs). But if you work smartly, syllabus can be covered in 1-1.5 month time schedule.
Your main focus should be on surgeries and their indications.
BOOKS TO FOLLOW
BAILEY’S & LOVE 27TH ED. + EPISODE FINAL YEAR 2nd ED. PAST PAPERS
WHY NOT ANY OTHER BOOK THAN BAILEY’S & LOVE? People! Paper setters use
Bailey‟s and Love as main course book. Do not rush over the short books like Dogar. I
know a lot of you guys have heard about Dogar. It is really not a good book. Most of the
times people are forced to do such book in which the things are not updated. I suggest
you to make effort for Surgery too by doing Bailey‟s and Love. The main problem doing
Bailey‟s and Love is that most of the people don‟t know how to cover syllabus and find
topics from such an extensive book. But don‟t worry, I‟ll provide you with detailed
guidelines. JUST SAY NO TO DOGAR (It really gives you tough time in prof exams.)
WE HAVE TO DO COMPLETE BAILEY’S & LOVE? No, only the topics I am mentioning
below (which are clinically important in our hospital setting or you can say in PAKISTAN)
HOW TO COVER MCQS

in May 2023.
PAGE 53 OF 115
HUMAN FOUNTAINS –
SURGERY
 SURGERY-I
1. SURGICAL ANATOMY
Bailey’s & Love Ed. 27th
3 1 8 Chapter 49, 50, 51, 53,
60, 63, 67, 66, 76
As general surgery is so general that this topic is scattered in whole Bailey‟s and Love (in
the relevant chapters). There are 2 ways to prepare it i.e. either do it as whole from EFY
2nd Ed. or prepare topics (chapterwise) from B&L. Just do the mentioned topics.
FIRST PRIORITY
1. THYROID GLAND (CHAPTER 50)
a. Surgical anatomy | Pg. 800-802
b. + EFY 2nd Ed. SURGERY-I UNIT 1 TOPIC 1.2.
2. BREAST (CHAPTER 53)
a. Comparative and surgical anatomy | Pg. 860-861 (vv.imp)
3. STOMACH AND DUODENUM (CHAPTER 63)
a. Gross anatomy of the stomach and duodenum | Pg. 1106-1107
i. Blood supply
 Arteries (v.imp)
 Veins
ii. Lymphatics
iii. Nerves
b. Lymphatic drainage of the stomach | Pg. 1135-1136 (imp)
c. + EFY 2nd Ed. SURGERY-I UNIT 1 TOPIC 1.5.
4. GALL BLADDER AND BILE DUCTS (CHAPTER 67)
a. Surgical anatomy and physiology | Pg. 1188-1190
i. Figure 67.1 The anatomy of the gallbladder and bile ducts (imp)
ii. Figure 67.2 (a) Usual anatomy of Calot‟s triangle (vv.imp)
iii. Lymphatics
iv. Surgical physiology (imp)
v. Functions of the gallbladder (leave)
5. HERNIA (CHAPTER 60)
a. Summary box 60.8: Inguinal hernia | Pg. 1029
PAGE 54 OF 115
HUMAN FOUNTAINS –
SURGERY
b. Basic anatomy of the inguinal canal | Pg. 1029-1030 (vv.imp)

c. Figure 60.10 The close relationships of direct inguinal, indirect inguinal and
femoral hernias | Pg. 1030
d. Basic anatomy of femoral hernia | Pg. 1034-1035
e. Summary box 60.11: Femoral hernia | Pg. 1035
f. + EFY 2nd Ed. SURGERY-I UNIT 1 TOPIC 1.10. + 1.11.
SECOND PRIORITY
6. SALIVARY GLANDS (CHAPTER 49)
a. The sublingual glands
i. Anatomy | Pg. 778-779
ii. Summary box 49.2 | Pg. 779
b. The submandibular glands
i. Anatomy | Pg. 780
ii. Summary box 49.3: Important anatomical relationships of the
submandibular glands | Pg. 780 (vv.imp)
c. The parotid gland
i. Anatomy | Pg. 785 (imp)
d. + EFY 2nd Ed. SURGERY-I UNIT 1 TOPIC 1.1.
7. PARATHYROID GLANDS (CHAPTER 51)
a. Anatomy of the parathyroid glands | Pg. 823-824
8. SPLEEN (CHAPTER 66)
a. Anatomy | Pg. 1176
9. KIDNEY AND URETERS (CHAPTER 76)
a. Surgical anatomy | Pg. 1398
Consult SURGERY-I UNIT 1 in EPISODE FINAL YEAR ED. 2ND
2. A&E SURGERY; TISSUE REPAIR

6 1 11
Chapter 17, 20, 22-30
A&E stands for Accidents & Emergency. This topic is very extensive one. And most of the
topics are in overlapping with S2. So, I am not mentioning references for those
overlapping topics to avoid confusion (as consulting B&L is a big deal). Just do the
mentioned topics and leave the rest.
FIRST PRIORITY
1. EARLY ASSESSMENT & MANAGEMENT OF SEVERE TRAUMA (CHAPTER 23)
a. Summary box 23.3: „Whole body CT‟ (WBCT) | Pg. 324
b. Summary box 23.4: The cABCDE of trauma care | Pg. 326 (vv.imp)
c. Secondary survey | Pg. 326
2. DISASTER SURGERY (CHAPTER 29)
a. Triage | Pg. 412
b. TABLE 29.1 | Triage categories Pg 412 (vv.imp)
PAGE 55 OF 115
HUMAN FOUNTAINS –
SURGERY
3. TRAUMATIC BRAIN INJURY (will be covered in SURGERY-II GUIDELINES |

POINT 19: NEUROSURGERY)
4. TORSO TRAUMA (will be covered in SURGERY-II GUIDELINES | POINT 15:
THORAX)
SECOND PRIORITY
5. PREOPERATIVE CARE (CHAPTER 17)
a. Valvular heart disease | Pg. 258
b. Nil by mouth and regular medications | Pg. 259
c. Diabetes mellitus | Pg. 260
d. Thrombophilia | Pg. 260
e. TABLE 17.3 Risk factors for thrombosis | Pg. 260
6. POSTOPERATIVE CARE (CHAPTER 20)
a. Classification of postoperative complications | Pg. 292
b. Summary box 20.2: Respiratory complications | Pg. 293
c. Summary box 20.3: Cardiovascular complications | Pg. 294
d. Summary box 20.4: Renal and urinary complications | Pg. 295
e. Wound dehiscence | Pg. 297
f. Summary box 20.7: Risk factors in wound dehiscence | Pg. 297
g. Summary box 20.9: Main complications after abdominal surgery | Pg. 298
7. MAXILLOFACIAL TRAUMA (CHAPTER 26)
a. Maxillary fractures | Pg. 360
b. Figure 26.10 Maxillary fractures as classified by Le Fort. | Pg. 360 (v.imp)
c. Summary box 26.6: Maxillary fractures | Pg. 360
8. EXTREMITY TRAUMA (will be covered in SURGERY-II GUIDELINES | POINT
14: MUSCULOSKELETAL SYSTEM)
9. CONFLICT SURGERY (CHAPTER 30)
a. TABLE 30.3 Classification of blast injuries | Pg. 430 (vv.imp)
 TABLE 22.1 Examples of patterns of injury (Pg. 314)
 TABLE 22.2 Criteria for damage control surgery and early total care (Pg. 319)
 Summary box 23.5: Early total care versus damage control surgery (Pg. 326)
 Summary box 23.6: Venous lactate is essential marker of resuscitation (Pg. 327)
3. SURGICAL NUTRITION
3 1 8
Chapter 19
It is a very small topic holding sufficient weightage and will be covered in very short time.
Just do the mentioned topics and leave the rest.
FIRST PRIORITY
1. NUTRITIONAL ASSESSMENT Pg. 279-280 (vvvvv.imp)
a. Laboratory techniques
PAGE 56 OF 115
HUMAN FOUNTAINS –
SURGERY
b. Body weight and anthropometry

c. Clinical
d. + EFY 2nd Ed. SURGERY-I UNIT 3 TOPIC 3.1.
2. ARTIFICIAL NUTRITIONAL SUPPORT Pg. 284-288
a. ENTERAL FEEDING
i. Enumerate the techniques (all headings)
 Sip feeding (a single read)
 Tube-feeding techniques (vvv.imp)
 Fine-bore tube insertion
 Gastrostomy (vvv.imp)
 Jejunostomy (vvv.imp)
ii. Complications + Summary box 19.3: Complications of enteral
nutrition (vvv.imp)
iii. Indications (Missing | EFY 2nd Ed. SURGERY-I UNIT 3 TOPIC 3.3.)
b. TOTAL PARENTERAL NUTRITION
i. Route of delivery: peripheral or central venous access (imp)
ii. Complications of parenteral nutrition + Summary box 19.4:
Complications of parenteral nutrition (vvvv.imp)
iii. Refeeding syndrome (v.imp)
iv. Nutrition support teams (leave)
SECOND PRIORITY
3. NUTRITIONAL REQUIREMENTS Pg. 281-282
a. TABLE 19.4 Monitoring feeding regimes (imp)
b. Macronutrient requirements (imp)
c. Calculations (Missing | EFY 2nd Ed. SURGERY-I UNIT 3 TOPIC 3.2.)
 Summary box 19.1: Metabolic response to starvation (Pg. 279)
 Summary box 19.2: Metabolic response to trauma and sepsis (Pg. 279)
 Fluid and nutritional consequences of intestinal resection (Pg. 283-284)
4. FLUID & ELECTROLYTES; SHOCK

6 1 11
Chapter 2 (main), 19
It is a comparatively small topic and will be covered in very short time. Just do the
mentioned topics and leave the rest.
FIRST PRIORITY
1. SHOCK Pg. 12-15
a. Definition Pg. 12 (under the heading shock) (imp)
b. Pathophysiology (a single read or leave)
c. Classification of shock
i. Summary box 2.1: Classification of shock (imp)
ii. Hypovolaemic shock (vv.imp)
PAGE 57 OF 115
HUMAN FOUNTAINS –
SURGERY
iii. Cardiogenic shock (v.imp)

iv. Obstructive shock (v.imp)
v. Distributive shock (vv.imp)
vi. Endocrine shock
d. TABLE 2.1 Cardiovascular and metabolic characteristics of shock (vv.imp)
e. Severity of shock
i. Compensated shock
ii. Decompensation
 Mild shock
 Moderate shock
 Severe shock
iii. Pitfalls (v.imp)
 Capillary refill
 Tachycardia
 Blood pressure
iv. TABLE 2.2 Clinical features of shock (vvv.imp)
f. Consequences (v.imp)
i. Unresuscitatable shock
ii. Multiple organ failure
 Summary box 2.2: Effects of organ failure (vv.imp)
2. RESUSCITATION Pg. 15-18
a. Conduct of resuscitation (a single read)
b. Fluid therapy (vvv.imp)
i. Types of fluids (v.imp)
ii. Dynamic fluid response (vv.imp)
c. Vasopressor and inotropic support (vv.imp)
d. Monitoring
i. Summary box 2.3: Monitoring for patients in shock (imp)
ii. TABLE 2.3 Monitors for organ/systemic perfusion (vv.imp)
iii. Cardiovascular
 Central venous pressure (imp)
 Cardiac output
iv. Systemic and organ perfusion
 Base deficit and lactate (v.imp)
 Mixed venous oxygen saturation (v.imp)
e. End points of resuscitation (vvv.imp)
3. HAEMORRHAGE Pg. 18-20
a. Pathophysiology + Figure 2.1 Trauma-induced coagulopathy (vv.imp)
b. Definitions
i. Revealed and concealed haemorrhage
ii. Primary, reactionary and secondary haemorrhage
iii. Surgical and non-surgical haemorrhage
c. Degree and classification + TABLE 2.4 Traditional classification of
haemorrhagic shock (vvv.imp)
d. Management
i. Identify haemorrhage
ii. Immediate resuscitative manoeuvres
iii. Identify the site of haemorrhage
PAGE 58 OF 115
HUMAN FOUNTAINS –
SURGERY
iv. Haemorrhage control (vv.imp)

v. Summary box 2.4: Damage control surgery (vvv.imp)
vi. Damage control resuscitation (vvv.imp)
4. TRANSFUSION Pg. 20-23
a. TABLE 2.5 History of blood transfusion (leave)
b. Blood and blood products (read for MCQs i.e. values are important)
i. Whole blood
ii. Packed red cells
iii. Fresh-frozen plasma
iv. Cryoprecipitate
v. Platelets
vi. Prothrombin complex concentrates
vii. Autologous blood
c. Indications for blood transfusion (vv.imp)
i. Transfusion trigger
ii. TABLE 2.6 Perioperative red blood cell transfusion criteria (vv.imp)
d. Blood groups and cross-matching (read for MCQs)
i. ABO system
ii. Rhesus system
e. Transfusion reactions (imp)
f. Cross-matching (imp)
g. Complications of blood transfusion
i. Complications from a single transfusion (vvv.imp)
ii. Complications from massive transfusion (vvv.imp)
h. Management of coagulopathy (vv.imp)
i. Blood substitutes (leave)
j. TABLE 2.7 ABO blood group system (Pg. 22)
SECOND PRIORITY
5. GASTRIC-OUTLET OBSTRUCTION (already covered in MEDICINE-I
GUIDELINES | POINT 3: GASTROINTESTINAL SYSTEM) + EFY 2nd Ed.
SURGERY-I UNIT 4 TOPIC 4.1.
 TABLE 19.1 Average daily water balance of a healthy adult in a temperate climate
(70 kg) (Pg. 280)
5. ANAESTHESIA & PAIN MANAGEMENT

3 1 8
Chapter 18
It is again a very small topic holding sufficient weightage and will be covered in very short
time. Just do the mentioned topics and leave the rest.
1. GENERAL ANAESTHESIA Pg. 270-273
a. Introductory paragraphs (vv.imp for MCQs)
PAGE 59 OF 115
HUMAN FOUNTAINS –
SURGERY
b. Summary box 18.2: The general anaesthetic triad (vvv.imp)

c. Summary box 18.3: Special terms in anaesthesia
d. Management of airway during anaesthesia
i. Supraglottic airways (leave)
ii. Summary box 18.4 Techniques for maintaining an airway (v.imp)
iii. Summary box 18.5: Complications of intubation (vv.imp)
e. Muscle relaxation and artificial ventilation + TABLE 18.2 Properties of
commonly used muscle relaxants (vv.imp)
f. Ventilation during anaesthesia + Summary box 18.6: Intermittent positive
pressure ventilation (imp)
g. Monitoring and care during anaesthesia (vv.imp)
h. Anaesthesia for day case surgery (leave)
2. LOCAL ANAESTHESIA Pg. 273-277
a. TABLE 18.3 The common local anaesthetic drugs (first 3 doses are v.imp)
b. Regional anaesthesia + Summary box 18.7: Types of anaesthesia (imp)
c. Common local anaesthesia techniques
i. Topical anaesthesia (imp)
ii. Nerve blocks
 Transversus abdominis plane block
 Intravenous regional anaesthesia (Bier‟s block) (vvv.imp)
iii. Spinal anaesthesia (vv.imp)
iv. Epidural anaesthesia (vv.imp)
v. Difference between spinal anaesthesia and epidural anaesthesia
(Missing | EFY 2nd Ed. SURGERY-I UNIT 5 TOPIC 5.2.)
vi. Summary box 18.8: Local anaesthetics (imp)
d. Chronic pain management
i. Introductory paragraphs + Summary box 18.9: Types of pain (imp)
ii. Chronic pain control in benign disease
 Introductory paragraphs (leave)
 Drugs in chronic non-malignant pain (leave)
 Treatment of pain dependent on sympathetic nervous system
activity (leave)
 Summary box 18.10: Pain control in benign disease (imp)
iii. Pain control in malignant disease
 World Health Organisation Pain Stepladder (vvv.imp) – in
introductory paragraphs
 Infusion of subcutaneous, intravenous, intrathecal or epidural
opiate drugs (vv.imp)
 Neurolytic techniques in cancer pain (v.imp)
 Summary box 18.11: Options for controlling severe pain in
malignant disease (vvv.imp)
 TABLE 18.1 Key features of commonly used intravenous anaesthetic agents (Pg.
269)
PAGE 60 OF 115
HUMAN FOUNTAINS –
SURGERY
6. SURGICAL & SPECIAL INFECTIONS

6 1 11
Chapter 5 (main), 6
It is comparatively lengthy and important topic not only for exams but for general
knowledge too. Just do the mentioned topics and leave the rest.
FIRST PRIORITY
1. MICROBIOLOGY OF SURGICAL INFECTION Pg. 44-47 (CHAPTER 5)
a. Common bacteria causing surgical infection
i. Streptococci (vv.imp for MCQs)
ii. Staphylococci (imp for MCQs)
iii. Clostridia (imp)
iv. Aerobic gram-negative bacilli (imp)
v. Bacteroides (imp)
b. Sources of infection (imp)
c. Summary box 5.3: Classification of sources of infection (imp)
d. Summary box 5.4: Factors that determine whether a wound will become
infected (vv.imp)
e. The decisive period (vv.imp)
f. Reduced resistance to infection (a single read)
g. Summary box 5.5: Risk factors for increased risk of wound infection
(vv.imp)
2. MAJOR AND MINOR SURGICAL SITE INFECTION (SSI) Pg. 47-50
(CHAPTER 5)
a. Summary box 5.6: Major wound infections (imp)
b. TABLE 5.1 Southampton wound grading system (vv.imp)
c. TABLE 5.2 The ASEPSIS wound score (vv.imp)
d. Localised infection
i. Abscess + Summary box 5.7: Abscesses (vv.imp)
ii. Cellulitis and lymphangitis + Summary box 5.8: Cellulitis and
lymphangitis (imp)
e. Specific local wound infections
i. Gas gangrene + Summary box 5.9: Gas gangrene (vv.imp)
ii. Clostridium tetani (vv.imp)
iii. Synergistic spreading gangrene (Synonym: subdermal gangrene,
necrotising fasciitis) (vv.imp) + Pg. 597-598: Necrotising fasciitis +
Summary box 40.1: Necrotising fasciitis
3. SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) Pg. 51

(CHAPTER 5)
a. TABLE 5.3 Definitions of systemic inflammatory response syndrome (SIRS)
and sepsis (imp)
b. Summary box 5.11: Definitions of infected states (imp)
4. PREVENTION OF SURGICAL INFECTION Pg. 52-55 (CHAPTER 5)
a. Preoperative preparation (imp)
PAGE 61 OF 115
HUMAN FOUNTAINS –
SURGERY
i. Scrubbing and skin preparation (imp)

b. Prophylactic antibiotics + Summary box 5.12: Antibiotic prophylaxis (imp)
c. TABLE 5.4 SSI rates relating to wound contamination with and without using
antibiotic prophylaxis (v.imp) (prepare values)
d. Postoperative wound infections (imp)
e. Summary box 5.13: Surgical incisions through infected or contaminated
tissues (vv.imp)
5. ANTIMICROBIAL TREATMENT OF SURGICAL INFECTION Pg. 55-56
(CHAPTER 5)
a. Principles + Summary box 5.14: Principles for the use of antibiotic therapy
(v.imp)
b. Antibiotics used in treatment and prophylaxis of surgical infection (leave)
SECOND PRIORITY
6. HIV Pg. 51-52 (CHAPTER 5)
a. Involvement of surgeons with HIV or hepatitis patients (universal
precautions) (vv.imp)
b. After contamination (read)
7. MYCETOMA Pg. 71-75 (CHAPTER 6)
a. Introduction (leave)
b. Epidemiology and pathogenesis (leave)
c. Summary box 6.15: Mycetoma – pathogenesis (imp)
d. Clinical presentation (for making diagnosis, summarized in EFY)
e. Spread (imp)
f. Differential diagnosis (leave)
g. Diagnosis (only headings) + Summary box 6.16: Mycetoma – diagnosis
i. Imaging: Plain radiograph, Ultrasound, MRI, CT scan
ii. Histopathological diagnosis
iii. Fine needle aspiration cytology (FNAC)
iv. Culture
h. Management + Surgical treatment + Summary box 6.17: Mycetoma –
management
8. HIDRADENITIS SUPPURATIVA Pg. 595 (CHAPTER 40)
9. ASEPTIC TECHNIQUES & STERILIZATION (Missing | EFY 2nd Ed. SURGERY-I
UNIT 6 TOPIC 6.1.)
10.INGROWING TOE NAIL (Missing | EFY 2nd Ed. SURGERY-I UNIT 6 TOPIC 6.9.)
11.CARBUNCLE (Missing | EFY 2nd Ed. SURGERY-I UNIT 6 TOPIC 6.7.)
7. VASCULAR DISORDERS
9 1 14
Chapter 6, 56, 57, 58
It is a very lengthy and important topic. These topics are also included in S2, so preparing
them here will suffice for both. Just do the mentioned topics.
PAGE 62 OF 115
HUMAN FOUNTAINS –
SURGERY

FIRST PRIORITY
1. ARTERIAL STENOSIS AND OCCLUSION (CHRONIC LOWER LIMB ISCHEMIA)
Pg. 942-953 (CHAPTER 56)
a. Cause and effect (leave)
b. Features of chronic arterial stenosis or occlusion in the leg (vv.imp)
i. Intermittent claudication (vv.imp)
ii. Rest pain (vv.imp)
iii. Ulceration and gangrene (v.imp)
iv. Colour, temperature, sensation and movement (imp)
v. Arterial pulses (vv.imp)
vi. Summary box 56.1: Features of chronic lower limb arterial stenosis
or occlusion (vv.imp)
vii. Relationship of clinical findings to site of disease + TABLE 56.1
Relationship of clinical findings to site of disease (v.imp)
c. Investigation of arterial occlusive disease (only headings)
d. Management of arterial stenosis or occlusion
i. General (read)
ii. Non-surgical management
 Drugs (imp)
 Transluminal angioplasty and stenting (no need to read;
headings are enough)
iii. Operations for arterial stenosis or occlusion
 Site of disease and type of operation (imp)
 Technical details (leave)
 Results of operation (leave)
 Other sites of atheromatous occlusive disease (leave)
 Summary box 56.2: Indications for carotid endarterectomy in
symptomatic patients (imp)
2. ACUTE ARTERIAL OCCLUSION (CHAPTER 56)
a. Embolic occlusion (imp)
b. Acute limb ischaemia
ii. Treatment
 Embolectomy (vv.imp)
 Thrombolysis (vv.imp)
c. Compartment syndrome (vv.imp)
d. Acute mesenteric ischaemia (imp)
e. Other forms of embolism (leave)
f. Air embolism (leave)
g. Therapeutic embolisation (leave)
3. ANEURYSM Pg. 960-967 (CHAPTER 56)
a. General
b. Summary box 56.4: Classification of aneurysms (imp)
c. Clinical features (for making diagnosis, summarized in EFY)
d. Abdominal aortic aneurysm
i. Asymptomatic abdominal aortic aneurysm (vv.imp)
PAGE 63 OF 115
HUMAN FOUNTAINS –
SURGERY
ii. Investigations (vv.imp)

iii. Choice of operation – open or endovascular repair (leave details)
e. Ruptured abdominal aortic aneurysm + Summary box 56.5: Management of
ruptured abdominal aortic aneurysm (vv.imp)
f. Symptomatic abdominal aortic aneurysm (read)
g. Postoperative complications (imp)
h. Peripheral aneurysm (leave)
i. Arteriovenous fistula (leave)
4. VARICOSE VEINS Pg. 974-982 (CHAPTER 57)
b. Symptoms + Signs (for making diagnosis, summarized in EFY)
c. Classification system | Pg. 974 (imp)
d. Investigation (imp)
e. Management
i. Compression (read)
ii. Endothermal ablation (only headings)
iii. Non-endothermal, non-tumescent ablation (only headings)
iv. Open surgery (only headings)
v. Adjunctive surgical techniques (only headings)
vi. Complications of standard varicose vein surgery (imp)
vii. Recurrent varicose veins (imp)
f. Summary box 57.1: Varicose veins (imp)
5. VENOUS THROMBOEMBOLISM Pg. 896-991 (CHAPTER 57)
a. Aetiology (read)
b. TABLE 57.2 Risk factors for venous thromboembolism (imp)
c. Pathology (leave)
d. TABLE 57.3 Abnormalities of thrombosis and fibrinolysis (thrombophilia) that
lead to an increased risk of venous thrombosis (imp)
e. Diagnosis (imp)
f. Investigation (imp)
g. TABLE 57.4 Modified Wells criteria for predicting deep vein thrombosis (DVT)
(leave)
h. Prophylaxis (vv.imp)
i. TABLE 57.5 Modified Wells criteria for predicting pulmonary embolism (PE)
(leave)
j. TABLE 57.6 Low-, medium- and high-risk patient groups for venous
thromboembolism (imp)
k. Treatment
i. Deep vein thrombosis (vv.imp)
ii. Pulmonary embolus
iii. Superficial thrombophlebitis
l. Summary box 57.3: Venous thromboembolism (v.imp)
SECOND PRIORITY
6. GANGRENE Pg. 952-953 (CHAPTER 56)
a. Separation of gangrene (v.imp)
b. Treatment of gangrene (v.imp)
c. Specific varieties of gangrene (leave)
PAGE 64 OF 115
HUMAN FOUNTAINS –
SURGERY
7. VENOUS LEG ULCER Pg. 982-985 (CHAPTER 57)

a. Pathophysiology of ulceration (leave)
c. Investigation (imp)
d. Management
i. Compression (imp)
ii. Superficial venous ablation or surgery (read)
iii. Other treatments (read)
e. Prevention of recurrence (imp)
f. Prognosis (leave)
g. Summary box 57.2: Venous leg ulcer (imp)
8. AXILLARY VEIN THROMBOSIS Pg. 992 (CHAPTER 57)
9. LYMPHOEDEMA Pg. 997-1000 (CHAPTER 58)
a. Definition
b. Summary box 58.1: Symptoms frequently experienced by patients with
lymphoedema
c. Summary box 58.2: What every patient with lymphoedema should receive
d. Pathophysiology (leave)
e. Classification + TABLE 58.1 Aetiological classification of lymphoedema +
TABLE 58.2 Clinical classification of lymphoedema
f. Risk factors for lymphoedema + TABLE 58.3 Risk factors for lymphoedema
(leave)
g. Symptoms and signs (for making diagnosis, summarized in EFY)
h. Summary box 58.3: Malignancies associated with lymphoedema
i. TABLE 58.4 Differential diagnosis of the swollen limb (leave)
10.FILARIASIS Pg. 1003-1005 (CHAPTER 58)
a. Summary box 58.4: Features of filariasis (imp)
11.INVESTIGATION OF LYMPHOEDEMA Pg. 1006-1007 (CHAPTER 58) (only
headings)
12.MANAGEMENT OF LYMPHOEDEMA Pg. 1007-1013 (CHAPTER 58)
a. Overview + Summary box 58.6: Initial evaluation of the patient with
lymphoedema (leave)
b. Relief of pain (imp)
c. Control of swelling (imp)
d. Skin care + Summary box 58.7: Skin care (imp)
e. Manual lymphatic drainage (leave)
f. Multilayer lymphoedema bandaging and compression garments (leave)
g. Summary box 58.8: Effects of multilayer lymphoedema bandaging (leave)
h. Exercise (leave)
i. Drugs (leave)
j. Surgery (leave)
k. Summary box 58.9: Surgical options for lymphoedema (v.imp)
13.TUBERCULOUS CERVICAL LYMPHADENITIS Pg. 77-78 (CHAPTER 6)
a. Introduction
b. Diagnosis
c. Summary box 6.22: Tuberculous cervical lymphadenitis (imp)
d. Investigations (imp)
e. Treatment (imp)
PAGE 65 OF 115
HUMAN FOUNTAINS –
SURGERY

 Summary box 56.3: Indications for amputation (Pg. 957)
8. SKIN, SUBCUTANEOUS TISSUE & BURNS

9 1 14
Chapter 3, 40, 41, 42
It is a very lengthy and important topic. You cannot skip this portion at any cost. Just do
the mentioned topics.
FIRST PRIORITY
1. WOUNDS, HEALING AND TISSUE REPAIR (CHAPTER 3)
a. Summary box 3.1: Factors influencing healing of a wound | Pg. 24 (imp)
b. Summary box 3.2: Classification of wound closure & healing | Pg. 25 (imp)
c. TABLE 3.1 Tidy versus untidy wounds | Pg. 26 (imp)
d. Summary box 3.3: Managing the acute wound Pg. | 27 (v.imp)
e. Pressure sores | Pg. 29-30 (vv.imp)
i. Summary box 3.5: Pressure sore frequency in descending order
ii. TABLE 3.2 Staging of pressure sores (vv.imp)
f. Scars + Summary box 3.7: Treatment of hypertrophic & keloid scars | Pg. 31
g. Contractures | Pg. 32
2. SKIN AND SUBCUTANEOUS TISSUE (CHAPTER 40)
a. Pyoderma gangrenosum | Pg. 596
b. Impetigo | Pg. 596
c. Erysipelas | Pg. 596-597
d. Basal cell carcinoma | Pg. 604-605 (vvv.imp)
i. Summary box 40.2: Basal cell carcinoma
ii. Epidemiology (leave)
iii. Pathogenesis (read)
iv. Macroscopic (imp)
v. Microscopic
vi. Prognosis (imp)
vii. Management (vv.imp)
e. Cutaneous squamous cell carcinoma | Pg. 605-608 (imp)
i. Summary box 40.3: Squamous cell carcinoma
iv. Macroscopic (imp)
v. Microscopic
vi. Prognosis (imp)
vii. Management (vv.imp)
viii. TABLE 40.1 TNM Classification and staging (leave)
f. Cutaneous malignant melanoma | Pg. 608-612
i. Summary box 40.4: Malignant melanoma
PAGE 66 OF 115
HUMAN FOUNTAINS –
SURGERY

iv. Macroscopic + Summary box 40.5: Macroscopic features in naevi
suggestive of malignant melanoma (v.imp)
v. Microscopic
vi. Management (vv.imp)
vii. Investigations (imp)
viii. Local treatment (imp)
ix. Regional lymph nodes (read)
x. Adjuvant therapy (read)
xi. Prognosis (imp)
xii. TABLE 40.2 AJCC 2009 melanoma staging (leave)
g. Capillary haemangioma (strawberry naevus) | Pg. 613
h. Capillary vascular malformations „port-wine‟ stains | Pg. 613
i. Glomus tumour | Pg. 614
j. Kaposi‟s sarcoma | Pg. 615
k. Ulcers + Figure 40.51 Some characteristic shapes of edges of ulcer | Pg. 616
(vv.imp)
l. Sinus | Pg. 616 (imp)
m. Fistula | Pg. 616 (imp)
3. BURNS (CHAPTER 41)
a. Summary box 41.2: Warning signs of burns to respiratory system | Pg. 617
b. Summary box 41.3: Dangers of smoke, hot gas or steam inhalation | Pg. 618
c. TABLE 41.1 The criteria for acute admission to burns unit | Pg. 620 (v.imp)
d. Immediate care of the burn patient | Pg. 620-621
i. Prehospital care (vv.imp)
ii. Hospital care (vv.imp)
iii. Airway (vv.imp)
iv. Breathing (vv.imp)
 Inhalational injury (vv.imp)
 Thermal burn injury to the lower airway
 Metabolic poisoning
 Mechanical block to breathing
e. Summary box 41.6: Major determinants of outcome of a burn | Pg. 620
f. Summary box 41.7: Initial management of the burned airway | Pg. 620
g. Summary box 41.8: Recognition of the potentially burned airway | Pg. 621
h. Summary box 41.9: Assessing the area of a burn | Pg. 621
i. Assessment of the burn wound Pg. 621-622
i. Assessing size (there is no need to prepare Lund and Browder chart,
instead Wallace Rule of Nine is important, prepare it from | EFY
2nd Ed. SURGERY-I UNIT 8 TOPIC 8.8.)
ii. Assessing depth from the history (imp)
 Superficial partial-thickness burns
 Deep partial-thickness burn
 Full-thickness burns
j. TABLE 41.2 Causes of burns and their likely depth | Pg. 621 (optional)
k. Summary box 41.10: Assessing the depth of a burn | Pg. 622 (imp)
l. Summary box 41.11: Fluids for resuscitation Pg. 623 (imp)
PAGE 67 OF 115
HUMAN FOUNTAINS –
SURGERY
m. Fluid resuscitation | Pg. 622-624

i. Parkland formula (in introductory paragraphs) (vv.imp)
ii. Crystalloid resuscitation (imp)
iii. Hypertonic saline (imp)
iv. Colloid resuscitation (leave)
v. Monitoring of resuscitation (vv.imp)
n. Treating the burn wound | Pg. 624-626
i. Escharotomy (vv.imp)
ii. TABLE 41.3 Key features of escharotomy placement (leave)
iii. Full-thickness burns and obvious deep dermal wounds
 TABLE 41.4 Options for topical treatment of deep burns (imp)
 Dressings with nanocrystalline silver (leave)
iv. Superficial partial-thickness wounds and mixed-depth wounds (read)
v. Summary box 41.12: Principles of dressings for burns (imp)
o. Additional aspects of treating burned patient | Pg. 626-627 (only headings)
p. Summary box 41.13: Nutrition in burns patients | Pg. 626 (imp)
q. Summary box 41.15: Surgical treatment of deep burns | Pg. 627
r. Summary box 41.16: Delayed reconstruction of burns | Pg. 628
s. Electrical injuries | Pg. 631
i. Summary box 41.17: Electrical burns
ii. Low-tension injuries
iii. High-tension injuries
t. Complications of burns (Missing | EFY 2nd Ed. SURGERY-I UNIT 8 TOPIC
8.10.)
SECOND PRIORITY
4. PLASTIC AND RECONSTRUCTIVE SURGERY (CHAPTER 42)
a. Summary box 42.1: Split-thickness skin grafts | Pg. 635
b. Classification | Pg. 635-639 (only headings)
c. TABLE 42.2 Common free tissue transfer donor sites | Pg. 646
9. PRINCIPLES OF ONCOLOGY
2 1 7
Chapter 10
It is a very small topic but important. There are limited topics which will be sufficient. Just
prepare them.
FIRST PRIORITY
1. Summary Box 10.3: Criteria for screening | Pg. 147 (vvv.imp)
2. TABLE 10.8 Examples of malignancies that may be cured without the need for
surgical excision | Pg. 152 (imp)
3. Summary box 10.5: The five Rs of radiotherapy | Pg. 154 (v.imp)
4. Summary box 10.6: Principles of combined treatment | Pg. 158 (vv.imp)
PAGE 68 OF 115
HUMAN FOUNTAINS –
SURGERY
5. Types, methods and complications of radiotherapy (Missing | EFY 2nd Ed.

SURGERY-I UNIT 9 TOPIC 9.5.)
6. Complications of chemotherapy (Missing | EFY 2nd Ed. SURGERY-I UNIT 9 TOPIC
9.4.)
SECOND PRIORITY
7. Summary box 10.4: The composition of multidisciplinary team | Pg. 148 (any 6-8)
8. TABLE 10.6 The advantages and disadvantages of multidisciplinary team | Pg. 149
9. Principles of cancer surgery | Pg. 148-150 Only headings (and examples from text)
10. TABLE 10.9 A summary of chemotherapeutic and biological agents currently used in
cancer treatment | Pg. 155-157 – only prepare first 3 columns of following
a. Drugs which interfere with mitosis
b. Drugs which interfere with DNA synthesis (antimetabolites)
c. Drugs which directly damage DNA or interfere with its function
d. Hormones (prepare 4th column too – specifically for breast cancer)
e. Antibodies directed to cell surface antigens (prepare 4 th column too –
specifically for breast cancer)
11. TABLE 10.12 An outline of the domains and interventions included within palliative
and supportive care | Pg. 159
12. Tumour markers Missing | EFY 2nd Ed. SURGERY-I UNIT 9 TOPIC 9.2.)
10. PRINCIPLES OF RADIOLOGY

3 1 8
Chapter 14 (main), 53
It is again a very small topic but important. There are limited topics which will be
sufficient. Just prepare them.
FIRST PRIORITY
1. Summary box 14.4: Ultrasound | Pg. 196
2. Summary box 14.5: Computed tomography | Pg. 196
3. Summary box 14.6: Magnetic resonance (MR) imaging | Pg. 199
4. Summary box 14.7: Radionuclide imaging | Pg. 200
5. Summary box 14.8: Types of imaging | Pg. 200
6. Summary box 14.9: Trauma imaging | Pg. 201
7. Mammography | Pg. 861 (CHAPTER 53)
SECOND PRIORITY
8. Summary box 14.10: Imaging techniques for joint disease | Pg. 202
9. Summary box 14.11: Imaging of aggressive lesions in bone | Pg. 203
10. Summary box 14.12: Imaging of soft-tissue lesions | Pg. 204
11. Summary box 14.13: Imaging of potentially infected bone and joint | Pg. 206
PAGE 69 OF 115
HUMAN FOUNTAINS –
SURGERY
 SURGERY-II
11. UPPER GASTROINTESTINAL SYSTEM
14 2 24
Chapter 61-63, 65-68
GIT is the core of Surgery-II. Because if you are done with GIT, your 45-50% syllabus of
S2 is prepared. Some of the topics are covered in Medicine but still you have to consult
them here again in order to review the surgical indications and techniques available for
them. No doubt, it is an extensive topic just as its emergency scope in the field of clinical
surgery. But you have to prepare some topics with whole heart and leave the rest.
FIRST PRIORITY
1. THE OESOPHAGUS (CHAPTER 62)
a. PERFORATION | Pg. 1072-1074
i. Summary box 62.3: Perforation of the oesophagus (read)
ii. Barotrauma (spontaneous perforation, Boerhaave‟s syndrome) (imp)
iii. Pathological perforation (leave)
iv. Penetrating injury (leave)
v. Foreign bodies (leave)
vi. Instrumental perforation + Summary box 62.4: Instrumental
perforation (vv.imp)
vii. Treatment of oesophageal perforations (only prepare last 2
paragraphs and leave the rest) + TABLE 62.1 Management options in
perforation of the oesophagus (vvv.imp)
b. CORROSIVE INJURY | Pg. 1075-1076 (imp)
c. GASTRO-OESOPHAGEAL REFLUX DISEASE | Pg. 1076-1083 | Most of the
topic is already covered in MEDICINE-I POINT 3 |
GASTROINTESTINAL SYSTEM. You just have to prepare mentioned topics
according to surgical point of view.
i. Aetiology (leave)
ii. Clinical features (leave)
iii. Diagnosis + Summary box 62.6: Diagnostic measurement in GORD
(leave)
iv. Management of uncomplicated GORD
 Medical management (leave)
 Surgery (leave)
 Endoscopic treatments (imp)
 Surgical treatments (vvv.imp)
 Which surgery? (vvv.imp)
 Laparoscopic fundoplication (vvv.imp)
v. Complications of GORD + Summary box 62.7: Peptic stricture (leave)
vi. Summary box 62.8: GORD (vv.imp)
PAGE 70 OF 115
HUMAN FOUNTAINS –
SURGERY
vii. Barrett‟s oesophagus (columnarlined lower oesophagus) + Summary

box 62.9: Barrett‟s oesophagus (leave)
d. CARCINOMA OF THE OESOPHAGUS | Pg. 1085-1095
i. Summary box 62.11: Carcinoma of the oesophagus (imp)
ii. Pathology and aetiology (read)
iii. Geographical variation in oesophageal cancer (leave)
iv. Clinical features (for making diagnosis, summarized in EFY)
v. Investigation (only headings enough) + Prepare ‘General Assessment
and Staging’ and ‘TABLE 62.2 TNM staging scheme for oesophageal
cancer’ in detail but leave Figure 62.43 Algorithm for the
management of oesophageal cancer
vi. Positron emission tomography with CT (leave)
vii. Treatment of malignant tumours (leave)
viii. Summary box 62.12: Treatment of carcinoma of oesophagus (v.imp)
ix. Treatments with curative intent
 SURGERY (vvv.imp) – extract out all important things
 Summary box 62.13: Oesophagogastric surgery (read)
 Two-phase oesophagectomy (abdomen and right chest, ivor
lewis) (leave)
 Transhiatal oesophagectomy (without thoracotomy) (leave)
 Neoadjuvant treatments with surgery (leave)
 Gastro-oesophageal reflux following oesophagogastric
resection (leave)
 Summary box 62.14: Postoesophagectomy (imp)
x. Non-surgical treatments + Summary box 62.15: Alternative
therapeutic approaches (imp)
xi. Palliative treatment + Summary box 62.16: Palliation (read)
e. ACHALASIA (already covered in MEDICINE-I POINT 3 | GASTRO-
INTESTINAL SYSTEM)
2. STOMACH AND DUODENUM (CHAPTER 63)
a. PEPTIC ULCER | Pg. 1116-1126 | Most of the topic is already covered in
MEDICINE-I POINT 3 | GASTROINTESTINAL SYSTEM. You just have to
prepare mentioned topics according to surgical point of view.
i. Introductory paragraphs (leave)
ii. Summary box 63.4: Peptic ulceration (a single read)
iii. Duodenal ulceration (leave)
iv. Gastric ulcers (leave)
v. Other peptic ulcers (leave)
vi. Clinical features of peptic ulcers (leave)
vii. Clinical examination (leave)
viii. Investigation of the patient with suspected peptic ulcer (leave)
ix. Treatment of peptic ulceration (leave)
x. Surgical treatment of uncomplicated peptic ulceration (imp)
xi. Operations for duodenal ulceration (only headings)
xii. Operations for gastric ulcer (only headings)
xiii. Sequelae of peptic ulcer surgery (only headings) + Only give a single
read to „Early and late dumping‟
PAGE 71 OF 115
HUMAN FOUNTAINS –
SURGERY
xiv. The complications of peptic ulceration

 Perforated peptic ulcer (vvvv.imp)
 Epidemiology (leave)
 Clinical features (for making diagnosis, summarized in
EFY)
 Investigations (vv.imp)
 Treatment (vvv.imp)
 Bleeding peptic ulcers | Pg. 1127-1128
 Medical and minimally interventional treatments (imp)
 Surgical treatment (vvv.imp)
 Gastric outlet obstruction (already covered in MEDICINE-I
POINT 3 | GASTRO-INTESTINAL SYSTEM)
3. THE GALLBLADDER AND BILE DUCTS (CHAPTER 67)
a. GALLSTONES (CHOLELITHIASIS) | Pg. 1198-1200
i. Causal factors in gallstone formation + Figure 67.27 Factors
associated with gallstone formation (imp)
ii. Clinical presentation (for making diagnosis, summarized in EFY)
iii. Summary box 67.2: Effects and complications of gallstones (vv.imp)
iv. Summary box 67.3: Differential diagnosis of acute cholecystitis (imp)
v. Diagnosis (vv.imp)
vi. Treatment (vv.imp)
vii. TABLE 67.1 Tokyo Consensus Guidelines for severity grading of acute
cholecystitis (leave)
b. EMPYEMA OF THE GALLBLADDER | Pg. 1200 (imp)
c. ACALCULOUS CHOLECYSTITIS | Pg. 1200 (read)
d. CHOLECYSTECTOMY | Pg. 1202-1206
i. Preparation for operation + Summary box 67.4: Preparation for
cholecystectomy (imp)
ii. Laparoscopic cholecystectomy (vv.imp)
iii. Open cholecystectomy (vv.imp)
iv. Indications for choledochotomy (imp)
v. Complications of cholecystectomy (v.imp) – just enumerate them
vi. Late symptoms after cholecystectomy (imp)
vii. Post-cholecystectomy choledocholithiasis (vvv.imp)
viii. Choledochotomy (imp)
ix. Stricture of the bile duct + Summary box 67.5: Causes of benign
biliary stricture + Summary box 67.6: Radiological investigation of
biliary strictures (leave)
4. THE PANCREAS (CHAPTER 68)
a. ACUTE PANCREATITIS | Pg. 1222-1230
i. Incidence (leave)
ii. Aetiology + Summary box 68.5: Possible causes of acute pancreatitis
(Optional)
iii. Summary box 68.6: Aetiology of acute pancreatitis (v.imp)
iv. Clinical presentation (for making diagnosis, summarized in EFY)
v. Investigations
 Summary box 68.7 Investigations in acute pancreatitis should
be aimed at answering three questions (imp)
PAGE 72 OF 115
HUMAN FOUNTAINS –
SURGERY
 Assessment of severity + TABLE 68.3 The Ranson and

Glasgow scoring systems to predict the severity of acute
pancreatitis (vv.imp)
 Imaging (vv.imp)
 Management (leave)
 TABLE 68.4 Early management of severe acute
pancreatitis (vv.imp)
 Systemic complications (leave)
 Local complications and their management (leave) + Only
prepare PSEUDOCYST + TABLE 68.6 Possible complications of
a pancreatic pseudocyst + Summary box 68.8: Distinguishing
a pseudocyst from a cystic neoplasm
 TABLE 68.5 Complications of acute pancreatitis (vv.imp)
vi. Outcomes and follow-up of acute pancreatitis (read)
b. CARCINOMA OF THE PANCREAS | Pg. 1233-1239
i. TABLE 68.8 Risk factors for development of pancreatic cancer (leave)
ii. Pathology (leave)
iii. Clinical features (for making diagnosis, summarized in EFY)
iv. Investigation (imp)
v. Management
 Surgical resection (only names of surgeries)
 Pancreatoduodenectomy (leave)
 Adjuvant therapy (leave)
 Palliation (leave)
 Summary box 68.10: Palliation of pancreatic cancer (vv.imp)
SECOND PRIORITY
5. THE PERITONEUM, OMENTUM, MESENTERY AND RETROPERITONEAL SPACE
(CHAPTER 61)
a. PERITONITIS | Pg. 1048-1052
i. Summary box 61.3: Causes of peritoneal inflammation (imp)
ii. Summary box 61.4: Paths to peritoneal infection (read)
iii. Microbiology (vv.imp)
 Bacteria from the gastrointestinal tract
 Non-gastrointestinal causes of peritonitis
 Summary box 61.5: Microorganisms in peritonitis
iv. Localised peritonitis (leave)
v. Diffuse (generalised) peritonitis (leave)
vi. Clinical features + Summary box 61.6: Clinical features of peritonitis
vii. Diagnostic aids (vv.imp)
viii. Management (only headings) + Summary box 61.7: Management of
peritonitis (vv.imp)
ix. Prognosis and complications + Summary box 61.8: Systemic
complications of peritonitis and abdominal complications of peritonitis
(vv.imp)
6. THE LIVER (CHAPTER 65)
a. SUMMARY BOX 65.7: Management of liver trauma | Pg. 1160
b. SUMMARY BOX 65.8: Complications of liver trauma | Pg. 1163
PAGE 73 OF 115
HUMAN FOUNTAINS –
SURGERY
c. VARICEAL BLEEDING (already covered in MEDICINE-I POINT 4 |

LIVER, PANCREAS & GALL BLADDER)
d. AMEBIC LIVER DISEASE (already covered in MEDICINE-II POINT 8 |
e. HYDATID DISESASE (already covered in MEDICINE-II POINT 8 |
7. THE SPLEEN (CHAPTER 66)
a. SPLENECTOMY | Pg. 1185-1187
i. Summary box 66.2: Indications for splenectomy (vv.imp)
ii. Preoperative preparation (read)
iii. Technique of open splenectomy (vv.imp)
iv. Technique of laparoscopic splenectomy (leave)
v. Postoperative complications (vv.imp) – just enumerate them
vi. Summary box 66.3: Splenectomy (read)
 Umbilical hernia in children (Pg. 1037)
 Pelvic abscess + Summary box 61.11: Clinical features of an abdominal/pelvic
abscess (Pg. 1055)
 Mesenteric injury (Pg. 1061)
 Mesenteric cysts + Summary box 61.13: Mesenteric cysts: clinical features (Pg.
1062-1064)
 Retroperitoneal (psoas) abscess (Pg. 1065)
 Mallory–Weiss syndrome (Pg. 1075)
 Summary box 63.6: Gastric cancer (Pg. 1131)
 Haemangiomas (Pg. 1171-1172)
 Hepatic adenoma (Pg. 1172)
 TABLE 65.5 Liver infections and their treatment (Pg. 1173)
 Figure 65.24 The Barcelona Clinic Liver Group staging system for the management
of hepatocellular carcinoma (HCC) (Pg. 1174)
 Splenic abscess (Pg. 1180)
 Choledochal cyst (Pg. 1197-1198)
 Summary box 67.7: Bile duct cancer (cholangiocarcinoma) (Pg. 1208)
 Summary box 67.9: Gallbladder cancer (Pg. 1210)
 Annular pancreas (Pg. 1219)
Consult SURGERY-II UNIT 1 in EPISODE FINAL YEAR ED. 2ND
12. LOWER GASTROINTESTINAL SYSTEM

12 2 22
Chapter 60, 69-74
As I told earlier, GIT is the core of Surgery-II because if you are done with GIT, your 45-
50% syllabus of S2 is prepared. Some of the topics are covered in Medicine but still you
have to consult them here again in order to review the surgical indications and techniques
available for them. No doubt, it is an extensive topic just as its emergency scope in the
PAGE 74 OF 115
HUMAN FOUNTAINS –
SURGERY
field of clinical surgery. But you have to prepare some topics with whole heart and leave
the rest.
FIRST PRIORITY
1. THE SMALL INTESTINE (CHAPTER 69)
a. CROHN’S DISEASE (REGIONAL ENTERITIS) | Pg. 1241-1248
ii. Pathogenesis (leave)
iii. Pathology (leave)
iv. Clinical features (for making diagnosis, summarized in EFY)
v. Summary box 69.2: Differences between ulcerative colitis (UC) and
Crohn‟s disease (CD) (v.imp)
vi. Summary box 69.3: Extraintestinal manifestations of Crohn‟s disease
(imp)
vii. Investigations (only headings) + Prepare „Laboratory‟ in detail
viii. Treatment
 Medical treatment (leave)
 Summary box 69.4: Principles of management of Crohn‟s
disease (CD) (imp)
 Endoscopic dilatation in Crohn‟s disease (read)
 Indications for surgery (vv.imp)
 Top-down approach to management of Crohn‟s disease (read)
 Surgery for Crohn‟s disease (v.imp) – make it short
b. TUBERCULOSIS OF THE INTESTINE | Pg. 1248-1249
i. Ulcerative tuberculosis
ii. Hyperplastic tuberculosis (vv.imp)
c. MECKEL’S DIVERTICULUM | Pg. 1252-1253
i. Summary box 69.7: Features of Meckel‟s diverticulum
ii. Meckel‟s diverticulectomy
d. STOMAS | Pg.1254-1255
i. Summary box 69.8: Stomas (v.imp)
ii. Loop ileostomy (leave)
iii. End ileostomy (leave)
iv. Stoma bags and appliances (leave)
v. Complications of stomas + Summary box 69.9: Stoma complications
(vv.imp)
2. THE LARGE INTESTINE (CHAPTER 70)
a. COLORECTAL CANCER | Pg. 1261-1266
i. Epidemiology (leave)
ii. Aetiology (leave)
iii. Summary box 70.3: Evidence for adenoma–carcinoma sequence
(imp)
iv. Pathology (leave)
v. Spread (imp)
vi. Staging colon cancer + Summary box 70.4: Dukes‟ staging for
colorectal cancer + Summary box 70.5: TNM classification for colonic
cancer
PAGE 75 OF 115
HUMAN FOUNTAINS –
SURGERY
vii. Clinical features (for making diagnosis, summarized in EFY)

viii. Investigation of colon cancer
 Screening (vv.imp)
 Endoscopy (imp)
 Radiology (vv.imp)
ix. Surgical treatment
 Preoperative preparation (read)
 Operations (just names)
x. Emergency surgery (read)
xi. Postoperative care (read)
xii. Adjuvant therapy (imp)
xiii. Metastatic disease (imp)
xiv. Prognosis (imp)
xv. Colorectal cancer follow-up (imp)
xvi. Summary box 70.6: Key elements of an enhanced recovery
programme (leave)
b. ULCERATIVE COLITIS | Pg. 1267-1271 | Most of the topic is already
covered in MEDICINE-I POINT 3 | GASTROINTESTINAL SYSTEM. You
just have to prepare mentioned topics according to surgical point of view.
iii. Extraintestinal manifestations (leave)
iv. Acute colitis (leave)
v. Cancer risk in colitis (leave)
vi. Investigations (imp)
vii. TABLE 70.2 Distinguishing ulcerative colitis (UC) and Crohn‟s disease
(CD). (leave)
viii. Summary box 70.7: Principles of management of ulcerative colitis
(read)
ix. Treatment
 Medical treatment (leave)
 Acute colitis (leave)
 Indications for surgery (vvv.imp)
 Operative treatment for UC (vv.imp) – only indications and
names of surgeries
c. COLOSTOMIES | Pg. 1277-1278
i. Summary box 70.11: Stomas (leave)
ii. Loop colostomy (imp)
iii. End colostomy (leave)
iv. Stoma bags and appliances (leave)
v. Complications of stomas + Summary box 70.12: Stoma
complications (leave)
3. INTESTINAL OBSTRUCTION (CHAPTER 71)
a. Summary box 71.1: Causes of intestinal obstruction | Pg. 1280
b. Summary box 71.2: Causes of strangulation | Pg. 1281
c. Adhesions | Pg. 1283
i. TABLE 71.1 The common causes of intra-abdominal adhesions (imp)
ii. Summary box 71.3: Prevention of adhesions
PAGE 76 OF 115
HUMAN FOUNTAINS –
SURGERY
d. Acute intussusceptions | Pg. 1283

i. Pathology (imp)
ii. TABLE 71.2 Types of intussusception in children (leave)
iii. Summary box 71.4: Intussusception (imp)
e. Volvulus | Pg. 1284-1285
i. Summary box 71.5: Volvulus (imp)
ii. Volvulus neonatorum (leave)
iii. Sigmoid volvulus (imp)
iv. Compound volvulus (read)
f. Summary box 71.6: Features of obstruction | Pg. 1285
g. Summary box 71.7: Cardinal clinical features of acute obstruction | Pg. 1285
h. Clinical features of strangulation + Summary box 71.8: Clinical features of
strangulation | Pg. 1286-1287
i. Clinical features of intussusceptions | Pg. 1287-1288
j. Clinical features of volvulus | Pg. 1288
k. Summary box 71.9: Radiological features of obstruction (on plain x-ray) |
Pg. 1288
l. Imaging in intussusceptions | Pg. 1289
m. Imaging in volvulus | Pg. 1289-1290
n. Summary box 71.10: Treatment of acute intestinal obstruction | Pg. 1290
o. Summary box 71.11: Principles of surgical intervention for obstruction | Pg.
1290
p. Summary box 71.12: Indications for early surgical intervention | Pg. 1290
q. TABLE 71.3 Differentiation between viable & non-viable intestine | Pg. 1291
r. Treatment of adhesions + Summary box 71.13: Treatment of adhesive
obstruction + Treatment of recurrent intestinal obstruction caused by
adhesions | Pg. 1292
s. Treatment of intussusception | Pg. 1293
t. Intestinal atresia | Pg. 1293-1294
u. Summary box 71.14: Management of left-sided large bowel obstruction | Pg.
1294
v. Treatment of caecal volvulus | Pg. 1295
w. Treatment of sigmoid volvulus | Pg. 1295-1296
4. THE VERMIFORM APPENDIX (CHAPTER 72)
a. ACUTE APPENDICITIS | Pg. 1301-1304
iii. Summary box 72.1: Risk factors for perforation of the appendix
(imp)
iv. Clinical features
 History (read)
 Summary box 72.2: Symptoms of appendicitis (imp)
 Signs (vv.imp)
 Summary box 72.3: Clinical signs in appendicitis (v.imp)
 Summary box 72.4: Signs to elicit in appendicitis (v.imp)
v. Special features, according to position of the appendix (read)
 Retrocaecal
 Pelvic
PAGE 77 OF 115
HUMAN FOUNTAINS –
SURGERY
 Postileal
vi. Special features, according to age (leave)
vii. Differential diagnosis (leave)
viii. TABLE 72.1 Differential diagnosis of acute appendicitis (imp)
ix. Investigation (leave)
x. Summary box 72.5: Preoperative investigations in appendicitis (imp)
xi. TABLE 72.2 The Alvarado (MANTRELS) score (imp)
xii. Treatment
 Non-operative management (read)
 Operative management (imp)
 Appendicectomy
 Conventional appendicectomy (vv.imp)
 Removal of the appendix (imp)
 Methods to be adopted in special circumstances (read)
 Retrograde appendicectomy (read)
 Laparoscopic appendicectomy (vv.imp)
 Problems encountered during appendicectomy (read)
 A normal appendix is found
 The appendix cannot be found
 An appendicular tumour is found
 An appendix abscess is found and the
 Appendix cannot be removed easily
 Appendicitis complicating Crohn‟s disease (read)
 Appendix abscess (v.imp)
 Pelvic abscess (read)
 Management of an appendix mass + Summary box 72.6:
Criteria for stopping conservative treatment of an appendix
mass (imp)
xiii. Postoperative complications (imp) – „only headings‟
xiv. Summary box 72.7: Check-list for unwell patient following
appendicectomy (leave)
5. THE RECTUM (CHAPTER 73)
a. CARCINOMAS | Pg. 1328-1338
i. Pathogenesis (leave)
ii. Clinical features (only headings) + Summary box 73.8: Early
symptoms of rectal cancer (for making diagnosis)
iii. Investigation (only headings)
iv. Differential diagnosis (leave)
v. Summary box 73.9: Diagnosis and assessment of rectal cancer
vi. Types of carcinoma spread (leave)
vii. Stages of progression – already done in colorectal cancer so leave
viii. Summary box 73.10: Pathology and staging of rectal cancer (imp)
ix. Treatment (only headings, no need for details) – just prepare
following in detail
 Summary box 73.11: Surgery for rectal cancer (imp)
 Summary box 73.12: Preoperative preparation (read)
PAGE 78 OF 115
HUMAN FOUNTAINS –
SURGERY
6. THE ANUS AND ANAL CANAL (CHAPTER 74)

a. PILONIDAL SINUS | Pg. 1347-1349
i. Aetiology and pathology (read)
ii. Clinical features (for making diagnosis, summarized in EFY)
iii. Conservative treatment (imp)
iv. Treatment of an acute exacerbation (abscess) (imp)
v. Surgical treatment of chronic pilonidal disease (imp)
vi. Recurrent pilonidal sinus (read)
b. ANAL FISSURE | Pg. 1351-1354
i. Definition (imp)
ii. Aetiology (read)
iii. Clinical features + Summary box 74.5: Anal fissure (for making
iv. Treatment (leave)
v. Operative measures (leave)
vi. Lateral anal sphincterotomy (leave)
vii. Anal advancement flap (leave)
viii. Hypertrophied anal papilla (leave)
ix. Proctalgia fugax (leave)
x. Summary box 74.6: Treatment of an anal fissure (imp)
c. HAEMORRHOIDS | Pg. 1354-1360
i. Primary internal haemorrhoids
 Theories of development (leave)
 Clinical features + Summary box 74.7: Haemorrhoids: clinical
features + Summary box 74.8: Four degrees of haemorrhoid
 Complications + Summary box 74.9: Complications of
haemorrhoids (vv.imp)
 Treatment of complications (leave)
 Management (imp)
 Operations
 Indications (v.imp)
 Technique (only names)
 Transanal haemorrhoidal dearterialisation (THD) or
haemorrhoid artery ligation operation (HALO) (leave)
 Postoperative care (leave)
 Postoperative complications (leave)
 Summary box 74.11: Complications of haemorrhoid-
ectomy (v.imp)
 Summary box 74.10: Treatment of haemorrhoids
(v.imp)
ii. External haemorrhoids
d. ANORECTAL ABSCESSES | Pg. 1362-1363
ii. Presentation (for making diagnosis, summarized in EFY)
iii. Differential diagnosis (read)
v. Summary box 74.13: Anorectal abscess (vv.imp)
PAGE 79 OF 115
HUMAN FOUNTAINS –
SURGERY
e. FISTULA-IN-ANO | Pg. 1363-1367

ii. Presentation (for making diagnosis, summarized in EFY)
iii. Classification (vv.imp)
iv. Clinical assessment (Goodsall‟s rule – vv.imp)
v. Special investigations (imp) – just enumerate them
vi. Surgical management (v.imp) – only names
vii. Advancement flaps (leave)
viii. Biological agents (leave)
ix. Summary box 74.14: Anorectal fistulae (imp)
SECOND PRIORITY
7. ABDOMINAL WALL, HERNIA AND UMBILICUS (CHAPTER 60)
a. SUMMARY BOX 60.2: Types of hernia by complexity | Pg. 1024
b. INGUINAL HERNIA | Pg. 1029-1034 (vv.imp)
i. Summary box 60.8: Inguinal hernia (already covered in
SURGERY-I POINT 1 | SURGICAL ANATOMY)
ii. Basic anatomy of the inguinal canal (already covered in
iii. Classification (read)
iv. Diagnosis of an inguinal hernia (read)
v. Diagnostic difficulties (leave)
vi. Investigations for inguinal hernia (v.imp)
vii. Management of inguinal hernia (vv.imp)
 Herniotomy (imp)
 Open suture repair (imp)
 Open flat mesh repair (vv.imp)
 Open plug/device/complex mesh repair (leave)
 Open preperitoneal repair (leave)
 Inguinal hernia repair (leave)
 Emergency inguinal hernia surgery (imp)
 Complications of inguinal hernia surgery (leave)
viii. Summary box 60.9: Operations for inguinal hernia (vv.imp)
ix. Summary box 60.10: Complications (vv.imp)
c. FEMORAL HERNIA | Pg. 1034-1036
i. Basic anatomy (already covered in SURGERY-I POINT 1 |
SURGICAL ANATOMY)
ii. Summary box 60.11: Femoral hernia (already covered in
iii. Diagnosis of femoral hernia (read)
iv. Summary box 60.12: Differential diagnosis (read)
v. Investigations (imp)
vi. Surgery for femoral hernia (only headings)
 Mesenteric ischaemia (Pg. 1253-1254)
 Enterocutaneous fistula + Summary box 69.10: Principles of management of
enterocutaneous fistulae (SNAP) (Pg. 1256)
 TABLE 70.1 Classification of intestinal polyps (Pg. 1259)
PAGE 80 OF 115
HUMAN FOUNTAINS –
SURGERY
 Adenomatous polyps (Pg. 1259)

 Summary box 70.9: Complications of diverticular disease (Pg. 1274)
 TABLE 70.3 Hinchey classification of complicated diverticulitis (Pg. 1274)
 Paralytic ileus (Pg. 1296-1297)
 Summary box 73.5: Rectal prolapse (Pg. 1322)
 Summary box 73.7: Polyps in the rectum (Pg. 1327)
 Imperforate anus (Pg. 1345-1347)
 Summary box 74.12: Pruritus ani (Pg. 1362)
 Summary box 74.16: Anal cancer (Pg. 1372)
13. UROGENITAL SYSTEM

10 2 20
Chapter 76-80
This topic is also an extensive and important topic (20 marks) of Surgery-2. But you have
to prepare some topics with whole heart and leave the rest.
FIRST PRIORITY
1. THE KIDNEY AND URETERS (CHAPTER 76)
a. STONES | Pg. 1405-1410
iii. Summary box 76.9: Urinary stones (v.imp)
iv. Stone management
 Emergency setting (v.imp)
 Elective setting (imp) – only headings/names of surgeries
 Summary box 76.10: Extracorporeal shockwave lithotripsy
 Medical treatment of stones (read and make it short) +
Summary box 76.11: Medical treatment of urinary stones
(imp)
b. URINARY TRACT OBSTRUCTION | Pg. 1410-1413
i. Congenital urinary tract obstruction (leave)
ii. Acquired urinary tract obstruction (leave)
iii. TABLE 76.1 Causes of upper urinary tract obstruction (leave)
iv. TABLE 76.2 Causes of lower urinary tract obstruction (leave)
v. Clinical features + Summary box 76.12: Idiopathic pelvi-ureteric
obstruction + Summary box 76.13: Ureteric dilatation in pregnancy
vi. Imaging (imp) – just enumerate them
vii. Summary box 76.14: Imaging (read)
viii. Treatment (only headings)
c. RENAL TRAUMA | Pg. 1413-1414
i. Prepare all text (but leave grading)
ii. Summary box 76.15: Renal trauma (imp)
PAGE 81 OF 115
HUMAN FOUNTAINS –
SURGERY
d. RENAL CELL CARCINOMA | Pg. 1416-1421

i. Introductory paragraphs (leave except last paragraph „Classical
triad‟)
ii. TABLE 76.4 Non-clear-cell renal cell carcinomas (leave)
iii. TABLE 76.5 Hereditary syndromes associated with renal cell
carcinoma (leave)
iv. Summary box 76.18: Renal cell carcinoma (RCC) (imp)
v. Staging (read)
vi. Pathology (leave)
vii. Surgery (imp)
 Partial nephrectomy (imp)
 Radical nephrectomy (read)
 Summary box 76.19: Surgery for renal tumours (imp)
viii. Active surveillance and ablative therapies (imp)
ix. Medical management using targeted therapies (imp)
x. Summary box 76.20: Targeted therapies for renal cancer (imp)
e. WILMS’ TUMOUR (NEPHROBLASTOMA) | Pg. 1421-1422
i. Pathology (leave)
iii. Treatment (imp)
iv. Prognosis (read)
v. Summary box 76.22: Nephroblastoma (Wilms‟ tumour) (imp)
2. THE PROSTATE AND SEMINAL VESICLES (CHAPTER 78)
a. BENIGN PROSTATIC HYPERPLASIA | Only prepare following topics
i. Summary box 78.2: Benign prostatic hyperplasia (BPH) | Pg. 1458
ii. Summary box 78.3: Consequences of benign prostatic hyperplasia
Pg. 1458
iii. Primary effects of BOO on the bladder | Last point on Pg. 1459 and
first point of Pg. 1460
iv. Summary box 78.4: Investigations of men with lower urinary tract
symptoms | Pg. 1461
v. Summary box 78.5: Options for treatment of LUTS secondary to BPH
| Pg. 1463
vi. Treatment (vv.imp) | Pg. 1464
 Conservative treatment
 Drugs
 Operative treatment
vii. Methods of performing prostatectomy (only headings) | Pg. 1464
viii. Complications (only headings) | Pg. 1466
ix. General complications (imp) | Pg. 1467
b. CARCINOMA OF THE PROSTATE | Pg. 1468-1474
i. Pathology (leave)
ii. Screening for prostate cancer + Summary box 78.6 (v.imp)
iii. Histological appearances (imp)
 Local spread
 Spread by the bloodstream
 Lymphatic spread
iv. Staging using the tumour, node, metastasis (TNM) system (imp)
PAGE 82 OF 115
HUMAN FOUNTAINS –
SURGERY
v. Summary box 78.7: The natural history of prostate cancer (leave)

vi. Clinical features + Summary box 78.8: The presentation of men with
prostate cancer (for making diagnosis, summarized in EFY)
vii. Investigations (only headings) + Prepare „Prostate-specific antigen‟ in
detail
viii. Treatment (leave)
ix. Summary box 78.9: Treatment and stage (imp)
x. Summary of treatment for carcinoma of the prostate (v.imp)
3. TESTIS AND SCROTUM (CHAPTER 80)
a. INCOMPLETELY DESCENDED TESTIS | Pg. 1498-1499
i. Definitions
ii. Incidence (leave)
iii. Pathology (leave)
iv. Consequences (only headings)
v. Summary box 80.1: Undescended testis (imp)
vi. Clinical features (for making diagnosis, summarized in EFY)
vii. Surgical treatment
 Orchidopexy (heading enough)
 Failure to bring the testis down
b. TORSION OF THE TESTIS | Pg. 1500-1501
i. Pathophysiology (leave)
iii. Differential diagnosis (imp)
v. Summary box 80.4: Testicular torsion (vv.imp)
c. VARICOCOELE | Pg. 1501-1502
i. Surgical anatomy (read)
ii. Aetiology (read)
iii. Clinical features (for making diagnosis, summarized in EFY)
iv. Varicocoele and spermatogenesis (read)
v. Treatment (imp)
vi. Summary box 80.5: Varicocoele (imp)
d. HYDROCOELE | Pg. 1502-1504
i. Aetiology (imp)
iv. Summary box 80.6: Hydrocoele (imp)
v. Filarial hydrocoeles and chylocoeles (read)
e. EPIDIDYMO-ORCHITIS | Pg. 1505-1506
i. Pathophysiology (leave)
iv. Chronic disease (leave)
v. Summary box 80.8: Acute epididymo-orchitis (imp)
vi. Tuberculous epididymo-orchitis (leave)
f. TUMOURS OF THE TESTES | Pg. 1506-1509
i. Classification and pathology (only names)
PAGE 83 OF 115
HUMAN FOUNTAINS –
SURGERY
iii. Investigation and staging (leave)

iv. Staging of testicular tumours (read)
v. Summary box 80.9: Testicular tumours (imp)
vi. Treatment (leave)
vii. Summary box 80.10: Testis tumour staging and treatment (imp)
viii. Testicular tumours in children (leave)
SECOND PRIORITY
4. THE URINARY BLADDER (CHAPTER 77)
a. ACUTE RETENTION | Pg. 1426-1427
ii. Treatment (only headings)
b. VESICOVAGINAL FISTULAE | Pg. 1439
i. Aetiology (imp)
iii. The „three-swab test‟ (read)
iv. Treatment (imp)
5. URETHRA AND PENIS (CHAPTER 79)
a. INJURIES TO THE MALE URETHRA | Pg. 1478-1484
i. Rupture of the bulbar urethra
 Clinical features (for making diagnosis, summarized in EFY)
 Management (vv.imp)
 Summary box 79.3: Bulbar urethral injury (v.imp)
ii. Rupture of the membranous urethra
 Clinical features (for making diagnosis, summarized in EFY)
 Complications (only names)
 Summary box 79.4: Pelvic fracture urethral disruption injury
(imp)
iii. Urethral stricture
 Causes (v.imp)
 Pathophysiology (leave)
 Clinical features + Summary box 79.5: Diagnosis of urethral
stricture (for making diagnosis, summarized in EFY)
 Complications (imp)
 Treatment (leave)
 Summary box 79.6: Treatment of urethral strictures (v.imp)
 Summary box 77.2: Management of bladder trauma (Pg. 1426)
 Summary box 77.5: Clinical management of spinal injury (Pg. 1428)
 Bladder stones (Pg. 1434-1436)
 Summary box 77.11: Urothelial cell carcinoma of the bladder (Pg. 1446)
 Summary box 77.12: Bladder cancer staging (Pg. 1447)
 Summary box 79.1: Posterior urethral valves (Pg. 1478)
 Summary box 79.2: Hypospadias (Pg. 1478)
 Phimosis in adults (Pg. 1486-1488)
 Paraphimosis (Pg. 1489)
 Summary box 79.9: Peyronie‟s disease (Pg. 1490)
 Summary box 79.11: Carcinoma of the penis (Pg. 1493)
PAGE 84 OF 115
HUMAN FOUNTAINS –
SURGERY
 Summary box 80.2: Retractile testis (Pg. 1499)

 Summary box 80.7: Cysts associated with the epididymis (Pg. 1505)
14. MUSCULOSKELETAL SYSTEM

6 1 11
Chapter 28, 32-35, 37-39
It is very extensive topic but holds a very small weightage. Most of students leave this
topic on choice because mostly the question is from fractures and management of fracture
can be written same in every question i.e. ORTHO SURVIVAL KIT (Prepare it from EFY
SURGERY II UNIT 4 TOPIC 4.1.). Just prepare following topics.
FIRST PRIORITY
1. EXTREMITY TRAUMA (CHAPTER 28)
a. Growth plate injury classification | Pg. 387
i. Figure 28.8 The AO classification system
ii. Figure 28.9 The Salter–Harris classification of growth plate injuries
b. Treatment | Pg. 388
i. Only introductory paragraph
c. Summary box 28.4: Reduction | Pg. 389
d. TABLE 28.11 Indications for surgery in limb trauma | Pg. 394
e. Scaphoid fracture | Pg. 396-397
f. Fractures of the proximal humerus | Pg. 400
g. Tibial shaft fractures | Pg. 401
h. Distal humerus (supracondylar fracture) | Pg. 403-404
i. Femoral shaft fractures | Pg. 405-406
j. Tibial shaft fractures | Pg. 406
k. Pathological fractures | Pg. 406-407
l. Summary box 28.7: Special considerations | Pg. 407
SECOND PRIORITY
2. SPORTS MEDICINE AND SPORTS INJURIES (CHAPTER 32)
a. Summary box 32.4: Knee injuries | Pg. 468
b. Summary box 32.5: Ankle injuries | Pg. 468
c. Summary box 32.6: Shoulder injuries | Pg. 469
d. TABLE 32.4 PRICE for the nonoperative management of the acute sports
injury | Pg. 470
3. THE SPINE (CHAPTER 33)
a. Lumbar disc herniation | Pg. 476
4. UPPER LIMB (CHAPTER 34)
a. Summary box 34.4: Frozen shoulder (adhesive capsulitis) | Pg. 493
b. Posterior dislocation of the shoulder | Pg. 497
c. Median nerve (carpal tunnel syndrome) + Summary box 34.15: Carpal
tunnel syndrome | Pg. 508
d. Ulnar nerve (Guyon‟s tunnel syndrome) | Pg. 508
PAGE 85 OF 115
HUMAN FOUNTAINS –
SURGERY
e. Ganglion cysts | Pg. 509

5. HIP AND KNEE (CHAPTER 35)
a. Summary box 35.3: Avascular necrosis of the femoral head | Pg. 513
6. MUSCULOSKELETAL TUMOURS (CHAPTER 37)
a. Summary box 37.1: Most common tumours metastasizing to bone (93%) |
Pg. 537
b. Summary box 37.2: Most common sites of bone metastases | Pg. 538
c. Summary box 37.3: Malignant bone tumours | Pg. 538
d. Summary box 37.4: Tumours producing bone | Pg. 539
e. Summary box 37.5: Tumours producing cartilage | Pg. 541
f. Summary box 37.6: Other bone tumours | Pg. 542
7. INFECTION OF THE BONES AND JOINTS (CHAPTER 38)
a. Acute osteomyelitis | Pg. 556-557
i. Diagnosis
ii. Management
iii. Summary box 38.9: Acute osteomyelitis
b. Chronic osteomyelitis | Pg. 557-559
i. Diagnosis
ii. Management
iii. Summary box 38.10: Chronic osteomyelitis
8. PAEDIATRIC ORTHOPAEDICS (CHAPTER 39)
a. Summary box 39.6: Diagnosis of developmental dysplasia of hip | Pg. 569
b. Summary box 39.7: Management of early developmental dysplasia of the
hip | Pg. 570
c. Summary box 39.8: Management of late-presenting DDH | Pg. 571
15. THORAX
4 1 9
Chapter 27, 55
It is a small topic holding a small weightage. This topic will also cover the Thorax portion
of A&Es in Surgery-I. You have to prepare a few topics but with whole heart.
FIRST PRIORITY
1. TORSO TRAUMA (CHAPTER 27)
a. TABLE 27.1 ATLS® principles of resuscitation | Pg. 365
b. Summary box 27.2: Investigation of chest injuries | Pg. 366
c. TABLE 27.3 The „deadly dozen‟ threats to life from chest injury | Pg. 367
(vv.imp)
d. Immediate life-threatening injuries | Pg. 367-368
i. Airway obstruction
ii. Tension pneumothorax (vv.imp)
iii. Pericardial tamponade + Summary box 27.4: Pericardial tamponade
(vv.imp)
PAGE 86 OF 115
HUMAN FOUNTAINS –
SURGERY
iv. Open pneumothorax („sucking chest wound‟) (v.imp)

v. Massive haemothorax (vv.imp)
vi. Flail chest (vv.imp)
e. Potentially life-threatening injuries | Pg. 369-371
vii. Thoracic aortic disruption (imp)
viii. Tracheobronchial injuries (read)
ix. Blunt myocardial injury (read)
x. Diaphragmatic injuries (imp)
xi. Oesophageal injury (read)
xii. Pulmonary contusion (read)
f. Emergency department thoracotomy or sternotomy | Pg. 371
g. Focused abdominal sonar for trauma and extended FAST + Summary box
27.5: Utilisation of eFAST | Pg. 372-373
h. Diagnostic peritoneal lavage | Pg. 373
i. Spleen | Pg. 374
j. TABLE 27.6 The stages of damage control surgery | Pg. 379
k. Summary box 27.9: Damage control | Pg. 380
SECOND PRIORITY
2. THORAX (CHAPTER 55)
a. Pneumothorax | Pg. 919-921
i. Primary spontaneous pneumothorax
ii. Secondary spontaneous pneumothorax
iii. Summary box 55.1: Indications for surgical intervention for
pneumothorax (vvv.imp)
iv. Inserting and managing a chest drain + Figure 55.8 Insertion of
chest drain: (a) triangle of safety (vvv.imp)
v. Summary box 55.2: Suction on a pleural tube
vi. Surgical management of pneumothorax (vv.imp)
b. TABLE 55.6 The international tumour–node–metastasis (TNM) staging
system | Pg. 927
c. Thymoma | Pg. 935
16. HEART AND GREAT VESSELS

2 1 7
Chapter 54
It is an extensive topic but shares a small weightage. There are two parts of this chapter
i.e. 1st is heart and 2nd is great vessels. The guidelines of former (Great vessels) part are
already explained and covered in SURGERY-I | Point 7: Vascular Disorders. There is
no need to prepare extra topics. Just prepare the topics I am mentioning here.
FIRST PRIORITY
1. VASCULAR DISORDERS (already covered in SURGERY-I | Point 7: Vascular
Disorders)
PAGE 87 OF 115
HUMAN FOUNTAINS –
SURGERY
SECOND PRIORITY
2. CARDIAC SURGERY (CHAPTER 54)
a. Summary box 54.1: Alternative uses of cardiopulmonary bypass (CPB) | Pg.
884 (imp)
b. Complications of CPB | Pg. 886
c. Summary box 54.5: Coronary angiography | Pg. 889 (imp)
d. Summary box 54.6: Indication for surgery | Pg. 889 (imp)
e. Selection of conduit | Pg. 890
i. Venous grafts
ii. Arterial grafts (imp)
iii. Summary box 54.7: Allen‟s test
f. Aortic dissection | Pg. 909-911
i. Aetiology
iii. Classification + Figure 54.28 Stanford classification of aortic
dissections (vv.imp)
iv. Investigations (vv.imp)
v. Management (vv.imp)
vi. Surgical options (vv.imp)
 Type A (or type I and II) dissections
 Type B (or type III) dissections
vii. Outcomes (read)
17. HEAD & NECK (ORODENTAL SURGERY)

6 2 16
Chapter 45, 47-51
This topic is very extensive part of Surgery-2. One of the two SEQs is mostly from
THYROID GLAND (70-80% probability). But you have to prepare some topics with whole
heart and leave the rest.
FIRST PRIORITY
1. ORAL CAVITY MALIGNANCY (CHAPTER 48)
a. Summary box 48.1: Risk factors associated with cancer of head and neck |
Pg. 760
b. Summary box 48.2: Conditions associated with malignant transformation |
Pg. 761
c. Summary box 48.3: Clinical features of oral cancer that warrant
investigation | Pg. 765
d. Investigations (only headings) | Pg. 765-767
e. Lip cancer | Pg. 767-769
f. Tongue cancer | Pg. 769-771
2. DISORDERS OF THE SALIVARY GLANDS (CHAPTER 49)
a. Cysts | Pg. 776
PAGE 88 OF 115
HUMAN FOUNTAINS –
SURGERY
b. Common disorders of the sublingual glands | Pg. 779

i. Cysts (imp)
ii. Plunging ranula (v.imp)
iii. Tumours (leave)
c. Obstruction and trauma | Pg. 780-783
i. Clinical symptoms (for making diagnosis, summarized in EFY)
ii. Management (v.imp)
iii. Submandibular gland excision (leave)
iv. Complications of submandibular gland excision (imp)
d. Tumours of the submandibular gland | Pg. 783-785
i. TABLE 49.1 Salivary gland tumours – frequency and distribution
(imp)
ii. Clinical features of high-grade malignant salivary tumours (vv.imp)
iii. Investigation (imp)
iv. Management of submandibular gland tumours (v.imp)
e. Tumours of the parotid gland | Pg. 787-797
i. Investigations (imp)
ii. Parotidectomy (only introductory paragraph)
 Superficial parotidectomy (leave) + Prepare „location of the
facial nerve trunk‟ in detail
 Extracapsular dissection (read)
 Radical parotidectomy (read)
iii. Complications of parotid gland surgery (only names) + No details
required except Frey‟s syndrome
3. THE THYROID GLAND (CHAPTER 50)
Most of the topic is already covered in MEDICINE-II POINT 10 |
ENCOCRINOLOGY. You just have to prepare mentioned topics according to
surgery point of view.
a. Summary box 50.1: Thyroid investigations | Pg. 803
b. TABLE 50.3 Classification of thyroid swellings | Pg. 805
c. TABLE 50.4 Indications for operation in thyroid swellings | Pg. 810
d. TABLE 50.5 Comparison of surgical options for Graves‟ disease | Pg. 810
e. Summary box 50.3: Thyroid operations | Pg. 810
f. Surgery for thyrotoxicosis | Pg. 813-816
i. Preoperative preparation (imp)
ii. Surgical technique of thyroidectomy (imp)
iii. New technology in thyroidectomy (leave)
iv. Alternative surgical techniques (leave)
v. Postoperative complications (names only)
vi. Postoperative care (read)
g. Radioiodine | Pg. 819-820
h. Malignant lymphoma | Pg. 821
SECOND PRIORITY
4. CLEFT LIP AND PALATE: DEVELOPMENTAL ABNORMALITIES OF THE FACE,
MOUTH AND JAWS (CHAPTER 45)
a. Summary box 45.2: Types of cleft palate | Pg. 690
b. Summary box 45.3: Antenatal diagnosis and counseling | Pg. 691
c. Summary box 45.4: Problems immediately after birth | Pg. 691
PAGE 89 OF 115
HUMAN FOUNTAINS –
SURGERY
d. Summary box 45.5: Surgical anatomy | Pg. 692

e. TABLE 45.3 Timing of primary cleft lip and palate procedures | Pg. 692
f. Summary box 45.6: Principles of surgery | Pg. 694
g. Summary box 45.7: Associated hearing and speech problems | Pg. 695
h. Summary box 45.8: Dental problems | Pg. 695
i. Summary box 45.9: Cleft lip revisional surgery | Pg. 697
5. PHARYNX, LARYNX AND NECK (CHAPTER 47)
a. Summary box 47.10: Indications for tracheostomy | Pg. 744
b. Emergency tracheostomy | Pg. 744-45
c. Summary box 47.11: Tracheostomy: postoperative management | Pg. 747
d. TABLE 47.2 Tracheostomy: complications | Pg. 748
e. Branchial cyst | Pg. 753-754
f. Branchial fistula | Pg. 754
g. Cystic hygroma | Pg. 754-755
h. Thyroglossal duct cysts | Pg. 755
i. Embryology (leave)
i. Chemodectoma (carotid body tumour)
ii. Investigations (imp)
j. Types of neck dissection | Pg. 758-759
6. THE PARATHYROID GLANDS (CHAPTER 51)
a. Summary box 51.1: Primary hyperparathyroidism | Pg. 832
b. Summary box 51.2: Secondary hyperparathyroidism | Pg. 835
c. Summary box 51.3: Tertiary hyperparathyroidism | Pg. 835
d. Summary box 51.4: Parathyroid carcinoma | Pg. 836
18. BREAST
4 1 9
Chapter 53
It is a small topic but shares a large weightage. Mainly your focus should be on
CARCINOMA OF BREAST (80% probability of an SEQ). You have to prepare a few topics
but with whole heart.
FIRST PRIORITY
1. CARCINOMA OF BREAST Pg. 871-881
a. TABLE 53.3 Relative risk of invasive breast carcinoma based on pathological
examination of benign breast tissue (American College of Pathologists
Consensus Statement) (for MCQs) – optional
b. Aetiological factors
c. Pathology (read once for classification)
PAGE 90 OF 115
HUMAN FOUNTAINS –
SURGERY
d. Paget‟s disease of the nipple (vv.imp)

e. The spread of breast cancer (vv.imp)
f. Clinical presentation (for making diagnosis, summarized in EFY)
g. Staging of breast cancer + TABLE 53.4 A pragmatic classification of breast
cancer (imp)
h. TNM staging (Missing | EFY 2nd Ed. SURGERY-II UNIT 8 TOPIC 8.9.)
i. Prognosis of breast cancer (vv.imp)
j. Treatment of cancer of the breast
i. Summary box 53.3: Algorithm for management of operable breast
cancer (vv.imp) – this is enough (further details are optional)
ii. The multidisciplinary team approach
iii. Local treatment of early breast cancer + Summary box 53.4:
Treatment of early breast cancer
iv. Adjuvant systemic therapy
k. Follow-up of breast cancer (imp)
l. Phenomena resulting from lymphatic obstruction in advanced breast cancer
(read)
m. Breast reconstruction (a single read for MCQs)
n. Screening for breast cancer (vvv.imp)
o. Familial breast cancer (imp)
p. Pregnancy (imp)
q. Hormone replacement therapy (imp)
r. Treatment of advanced breast cancer (v.imp)
s. Locally advanced inoperable breast cancer (vv.imp)
t. Metastatic carcinoma of the breast (vv.imp)
SECOND PRIORITY
2. INVESTIGATION OF BREAST SYMPTOMS Pg. 861-863
a. Mammography (vv.imp)
b. Ultrasound (vv.imp)
c. Magnetic resonance imaging (vv.imp)
d. Needle biopsy/cytology (v.imp)
e. Large-needle biopsy with vacuum systems (imp)
f. Triple assessment (vvvv.imp) + Figure 53.8 Triple assessment of breast
symptoms (vvv.imp)
3. DISCHARGES FROM THE NIPPLE Pg. 864-865
a. Summary box 53.1: Discharges from the nipple (vv.imp)
b. Treatment (vv.imp)
4. TRAUMATIC FAT NECROSIS Pg. 866
5. BACTERIAL MASTITIS Pg. 866-867
a. Aetiology (imp)
c. Treatment (vv.imp)
6. DUCT ECTASIA/PERIDUCTAL MASTITIS Pg. 867-868
a. Pathology (read for concepts)
b. Clinical features (for making diagnosis)
c. Treatment (vv.imp)
7. ABERRATIONS OF NORMAL DEVELOPMENT AND INVOLUTION Pg. 868-869
a. Nomenclature
PAGE 91 OF 115
HUMAN FOUNTAINS –
SURGERY
b. Aetiology
c. Pathology
d. Clinical features
e. Treatment of lumpy breasts
f. Treatment of mastalgia + TABLE 53.1 Treatment of breast pain.
8. FIBROADENOMA Pg. 870 (vv.imp)
9. PHYLLODES TUMOUR Pg. 870 (vv.imp)
10.GYNAECOMASTIA Pg. 882
a. Causes
b. Treatment
19. NEUROSURGERY
2 1 7
Chapter 24, 43
It is an extensive topic but shares a very small weightage. This topic will also cover the
Neurosurgery portion of A&Es in Surgery-I. You have to prepare a few topics but with
whole heart.
FIRST PRIORITY
1. TRAUMATIC BRAIN INJURY (CHAPTER 24)
a. The Monro Kellie doctrine and herniation syndromes | Pg. 328-329 (imp)
b. Classification of head injury | Pg. 329 (imp)
c. TABLE 24.1 Head injury classification using the Glasgow Coma Scale (GCS)
score | Pg. 329 (vv.imp)
d. Summary box 24.2: Minor and mild head injury | Pg. 329 (imp)
e. TABLE 24.3 National Institute for Health and Care Excellence guidelines for
computed tomography (CT) in head injury | Pg. 330 (vv.imp)
f. Summary box 24.4: Primary survey | Pg. 331 (imp) (Note: Primary
survey in case of neurological trauma is different)
g. TABLE 24.4 Glasgow Coma Scale score for head injury | Pg. 331 (vv. imp)
h. Summary box 24.5: Secondary survey | Pg. 332
i. Surgical management
i. Fractures: skull vault
ii. Fractures: skull base (imp)
iii. Extradural haematoma + Summary box 24.6: Extradural
haemorrhage (vvv.imp)
iv. Acute subdural haematoma + Summary box 24.7: Acute subdural
haemorrhage (vvv.imp)
v. Chronic subdural haematoma + Summary box 24.8: Chronic
subdural haemorrhage (imp)
vi. Traumatic subarachnoid haemorrhage (v.imp)
vii. Summary box 24.9: Specific head injuries (imp)
viii. Cerebral contusions (imp)
PAGE 92 OF 115
HUMAN FOUNTAINS –
SURGERY
ix. Diffuse axonal injury (leave)

x. Arterial dissection (leave)
j. Summary box 24.10: Medical management of head injury | Pg. 336 (v.imp)
k. Control of intracranial pressure | Pg. 336 (v.imp)
SECOND PRIORITY
2. CRANIAL NEUROSURGERY (CHAPTER 43)
a. Summary box 43.1: Raised intracranial pressure | Pg. 653
b. Hydrocephalus
i. Introductory paragraph | Pg. 653
ii. TABLE 43.1 Aetiology of hydrocephalus | Pg. 653
iii. Summary box 43.2: Hydrocephalus and disorders of CSF flow | Pg.
655
iv. Treatment of hydrocephalus (only headings) + Summary box 43.3:
Treating hydrocephalus | Pg. 655-656
c. Intracerebral haemorrhage + Summary box 43.8: Intracerebral
haemorrhage | Pg. 661
d. Figure 43.20 Brain tumour classification | Pg. 663
e. Summary box 43.9: Brain tumours | Pg. 664
f. TABLE 43.5 Tissue of origin for brain metastases (approximate) | Pg. 664
g. Brainstem death | Pg. 671 (vv.imp)
PAGE 93 OF 115
HUMAN FOUNTAINS –
GYNAECOLOGY & OBSTETRICS
GYNAECOLOGY & OBSTETRICS

GYNAECOLOGY
# Topic MCQS SEQS
(35 x 1) (10 x 3)
1 Anatomy of Genital Tract 2 1
2 Disorders of Menstruation 8 1
3 Abortions & Ectopic Pregnancy 3 1
4 Infertility & Endometriosis 3 1
5 Infections of Genital Tract 3 1
6 Urogynaecology 2 1
7 Benign tumours of Genital Tract 4 1
8 Malignancies of Genital Tract 4 1
9 Common Gynaecological Procedures 3 1
10 Contraception 3 1
OBSTETRICS
# Topic MCQS SEQS
(35 x 1) (7 x 5)
1 Physiology of Pregnancy 2 1
2 Antenatal Care & Investigation 7 1
3 Assessment of Fetal Well Being 7 1
4 Medical Disorders in Pregnancy 4 1
5 Emergency & Postpartum Disorders 6 1
6 Intrapartum care – Normal Labour 5 1
7 Abnormal Labour 4 1
WRITTEN
Gynaecology (G) 35 (1 each) 10 (3 each) 65
Obstetrics (O) 35 (1 each) 7 (5 each) 70 150
OSCE/VIVA
10 static (5G + 5O) & 5 interactive
OSCE 75
(2G + 3O) stations (5 each)
150
Long Case 2 (30 each) – 1G + 1O 60
SUBJECT TOTAL 300
GENERAL GUIDELINES
Gynaecology and Obstetrics (G&O) is minor subject of Final Year MBBS. It is basically
allied of Surgery. Gynaecology is basically Pathology of Female Reproductive System and
Obstetrics is study of Pregnancy. For most of students (likely boys), this subject remains
PAGE 94 OF 115
HUMAN FOUNTAINS –
uninteresting throughout the Final Year including prof. Even the course is easy to cover.
Well! You can prepare it in 2-3 weeks of your academic year (mostly in ward duration
e.g. ward duration in Nishtar Hospital is of 4-6 weeks on average). SEQs in Gynaecology
are of only 3 marks (each), so you have to prepare topics wisely. While in Obstetrics SEQs
hold same weightage like other subjects of MBBS i.e. 5 marks (each).
SUBJECT DIVISION
Gynaecology and Obstetrics (G&O) has been divided into two parts but in annual exam you
have to pass it jointly (not separately)
 Gynaecology (G)
 Obstetrics (O)
In total you have to prepare 56 topics in Gynaecology and 62 topics in Obstetrics.
BOOKS TO FOLLOW
TEN TEACHERS 20TH ED. + EPISODE FINAL YEAR 2nd ED. PAST PAPERS
WHY NOT ANY OTHER BOOK THAN TEN TEACHERS? I know Ten Teachers is a dry sort
of book with rough layout. But People! Paper setters use Ten Teachers as main course
book. Do not rush over the short books like Irfan Masood, when your recommended book
is enough to cover things well.
WE HAVE TO DO WHOLE TEN TEACHERS? No, only the topics I am mentioning below.
HOW TO COVER MCQS

in May 2023.
PAGE 95 OF 115
HUMAN FOUNTAINS –
 GYNAECOLOGY
1. ANATOMY OF GENITAL TRACT
Gynaecology Ten Teacher
2 1 5
20th Ed. Chapter 1
It is a small topic. Just do the mentioned topics. There is no need to remember doses at
the level of FINAL YEAR MBBS.
FIRST PRIORITY
10.DEVELOPMENT OF FEMALE SEXUAL ORGANS Pg. 2-3
a. Figure 1.2 Caudal parts of the paramesonephric ducts (top) fuse to form the
uterus and Fallopian tubes (imp)
11.EXTERNAL FEMALE GENITALIA Pg. 3
12.MÜLLERIAN ANOMALIES Pg. 15-16
a. Figure 1.9 Müllerian structural abnormalities (vv.imp)
b. Müllerian obstruction (vv.imp)
c. Müllerian duplication
d. Müllerian agenesis (vv.imp)
SECOND PRIORITY
13.INTERNAL REPRODUCTIVE ORGANS Pg. 4-15
a. The vagina (leave)
b. The uterus (imp)
c. The cervix (leave)
d. The fallopian tubes (imp)
e. The ovaries (leave)
f. The urinary bladder, urethra & ureter + Box 1.1 Ureteric damage during
Hysterectomy (vvv.imp)
g. The rectum (leave)
h. The pelvic muscles, ligaments and fascia (vvv.imp)
i. The ovarian ligament and round ligament (imp)
j. The pelvic fascia and pelvic cellular tissue (imp)
k. The blood supply (vv.imp)
l. The lymphatics (vv.imp)
m. The nerves (leave)
 Key learning points (Pg. 3)
Consult GYNAECOLOGY UNIT 1 in EPISODE FINAL YEAR ED. 2ND
PAGE 96 OF 115
HUMAN FOUNTAINS –
2. DISORDERS OF MENSTRUATION
8 1 11
20th Ed. Chapter 2, 3, 4, 8
It is an extensive topic covering various chapters of Ten Teachers but you have to work
smartly. Just do the mentioned topics. There is no need to remember doses at the level of
FINAL YEAR MBBS.
FIRST PRIORITY
1. POLYCYSTIC OVARY SYNDROME Pg. 43-44 (CHAPTER 3)
b. Diagnosis (vv.imp)
2. PREMENSTRUAL SYNDROME Pg. 44-46 (CHAPTER 3)
a. Aetiology
b. History and examination (for making diagnosis)
c. Management + Figure 3.7 Algorithm for the treatment of premenstrual
syndrome (PMS) (make it short) (vv.imp)
3. HEAVY MENSTRUAL BLEEDING Pg. 50-54 (CHAPTER 4)
a. History and examination + Table 4.1 Symptoms that may be associated with
HMB and related pathologies (for making diagnosis)
b. Investigations + Box: Role of EB in HMB (vv.imp)
c. Management (only names) + Box: Management of HMB (vv.imp)
d. Acute HMB + Box: Management of acute HMB (imp)
4. DYSMENORRHEA Pg. 54-55 (CHAPTER 4)
a. Aetiology of secondary dysmenorrhoea
b. History and examination (for making diagnosis, summarized in EFY)
SECOND PRIORITY
5. TURNER SYNDROME Pg. 39-40 (CHAPTER 3)
6. 46XY DSD Pg. 40 (CHAPTER 3)
7. AMENORRHEA AND OLIGOMENORRHEA Pg. 41-43 (CHAPTER 3)
a. Box 3.2 Amenorrhoea (vv.imp)
b. Hypothalamic disorders
c. Pituitary disorders
d. Ovarian disorders
e. Endometrial disorders
f. Investigation of amenorrhoea/oligomenorrhoea + Table 3.2 History and
examination of patient with amenorrhoea/oligomenorrhoea (vv.imp)
g. Table 3.3 Management of amenorrhoea/oligomenorrhoea (vv.imp)
 Box 2.1 Glossary (Pg. 20)
 Box 2.3 How to determine if there is HMB (Pg. 21)
 Normal puberty (Pg. 37-38)
PAGE 97 OF 115
HUMAN FOUNTAINS –
 Table 3.1 Summary of terminology for disorders of sex development (DSD) (Pg.
39)
 PALM COEIN (Pg. 49 – in introduction)
 Box: Accepted terminology for common types of AUB (Pg. 50)
 Premature ovarian insufficiency (Pg. 107-108)
 Table 8.3 Effects of the menopause by time of onset (Pg. 109)
 Box: Hormones used in HRT (Pg. 115)
 Box: Key benefits of HRT (Pg. 116)
 Box: Contraindications and potential side-effects of HRT (Pg. 117)
3. ABORTIONS & ECTOPIC PREGNANCY

3 1 6
20th Ed. Chapter 5
FIRST PRIORITY
1. MISCARRIAGE Pg. 60-62
a. Clinical presentation + Table 5.1 Types of miscarriages with the relevant
ultrasound findings and clinical presentation (vvvv.imp) (for making
b. Incidence and aetiology (imp)
c. Aetiological factors
d. Investigations (v.imp)
2. ECTOPIC PREGNANCY Pg. 62-64
a. Definition
b. Incidence and aetiology + Box: Aetiological factors for ectopic pregnancy
(vv.imp)
c. Clinical presentation (for making diagnosis, summarized in EFY)
d. Investigations (v.imp)
e. Box: Pregnancy of unknown location (imp)
f. Management (vvv.imp)
g. Box: Anti-D administration (give a single read)
SECOND PRIORITY
3. RECURRENT MISCARRIAGE Pg. 62
PAGE 98 OF 115
HUMAN FOUNTAINS –
4. INFERTILITY & ENDOMETRIOSIS

3 1 6
20th Ed. Chapter 7, 11, 12
It is again a small topic. Just do the mentioned topics. There is no need to remember
FIRST PRIORITY
1. SUBFERTILITY Pg. 91-101 (CHAPTER 7)
a. Causes of subfertility (single read)
b. History and examination + Table 7.1 Key points to cover in history and
examination of patients presenting with subfertility (vvv.imp)
c. Investigations
i. Female investigations
 Box: Measurement of ovarian reserve (imp)
 Tubal assessment (vv.imp)
ii. Male investigations
 Table 7.2 World Health Organization parameters for semen
analysis – 5th centile (also prepare values) (vv.imp)
d. Management
i. Table 7.3 Summary of the medical and surgical management of
subfertility (vvv.imp)
ii. Ovulation induction (vv.imp)
iii. Surgery
iv. Figure 7.5 Pictorial in-vitro fertilization (IVF) cycle
e. You may leave
i. Introduction
ii. Natural conception
iii. Intrauterine insemination
iv. In-vitro fertilization
v. Fertility preservation
2. ENDOMETRIOSIS Pg. 158-162 (CHAPTER 11)
a. Incidence (imp)
b. Aetiology (imp)
c. Clinical features + Table 11.3 Symptoms of endometriosis in relation to site
of lesion (for making diagnosis, summarized in EFY)
d. Diagnosis (just headings)
e. Endometriosis and infertility + Table 11.4 Infertility and endometriosis –
possible mechanisms (v.imp)
f. Management (make it short) (vv.imp)
SECOND PRIORITY
3. ADENOMYOSIS Pg. 175-176 (CHAPTER 12)
PAGE 99 OF 115
HUMAN FOUNTAINS –
5. INFECTIONS OF GENITAL TRACT

3 1 6
20th Ed. Chapter 9
FIRST PRIORITY
1. BACTERIAL VAGINOSIS Pg. 123-124
2. VULVOVAGINAL CANDIDIASIS Pg. 124
3. TRICHOMONIASIS Pg. 124-125
4. PELVIC INFLAMMATORY DISEASE Pg. 126
SECOND PRIORITY
5. GONORRHEA Pg. 125
6. CHLAMYDIA Pg. 125-126
7. GENITAL HERPES Pg. 126-127
8. GENITAL WARTS Pg. 127-128
6. UROGYNAECOLOGY
2 1 5
20th Ed. Chapter 10
FIRST PRIORITY
1. STRESS URINARY INCONTINENCE Pg. 136-146
a. Box: Risk factors for stress urinary incontinence (vv.imp)
b. Clinical assessment of incontinence (quick read)
c. Figure 10.3 Flowchart of patient management (based upon UK NICE
guidance) (vv.imp)
d. Treatment for incontinence
i. Conservative treatment and the role of urodynamic assessment
(leave)
ii. Box: Elements of conservative treatment for urinary incontinence
(imp)
iii. Box: Common urodynamic diagnoses + Figure 10.5 The relationship
between symptoms and urodynamic diagnosis (imp)
iv. Medical treatment (imp)
v. Box: Anticholinergic medications (only names)
vi. Surgical treatment of stress incontinence (make it short) (imp)
PAGE 100 OF 115

HUMAN FOUNTAINS –
2. UTEROVAGINAL PROLAPSE Pg. 146-141

a. Symptoms from pelvic organ prolapse (for making diagnosis, summarized in
EFY)
b. Relevant anatomy + Figure 10.9 Fascial supports of the pelvic organs +
Figure 10.10 Development of prolapse (for making concept of prolapse)
c. Clinical assessment of prolapse (vvv.imp)
d. Treatment for prolapse
i. Conservative treatment (vv.imp)
ii. Surgery for pelvic organ prolapsed (leave)
iii. Box: Principles of prolapse surgery (imp)
SECOND PRIORITY
3. DETRUSOR OVERACTIVITY (URGE URINARY INCONTINENCE) Pg. 137-138
+ Pg. 146
a. Box: Risk factors for detrusor overactivity
b. Surgical treatment of detrusor overactivity
7. BENIGN TUMOURS OF GENITAL TRACT

4 1 7
It is comparatively a lengthy topic but only selective topics are important. Just do the
mentioned topics. There is no need to remember doses at the level of FINAL YEAR MBBS.
FIRST PRIORITY
1. FIBROIDS Pg. 172-175 (CHAPTER 12)
a. Classification + Box: Symptoms caused by fibroids + Natural history +
Clinical features + Examination findings suggestive of uterine fibroids (for
b. Diagnosis + Box: Useful tests where uterine fibroids are suspected (only
names) (vv.imp)
c. Treatment of fibroids (make it short) + Box: Relative advantages and
disadvantages of treatments for symptomatic uterine fibroids (only names)
(vvvv.imp)
SECOND PRIORITY
2. BENIGN DISEASES OF THE OVARY Pg. 155-158 (CHAPTER 11)
a. Box: The differential diagnosis of a pelvic mass (give a read)
b. Table 11.1 Types of benign ovarian cyst (vv.imp)
c. Box: Ovarian torsion (vv.imp)
PAGE 101 OF 115

HUMAN FOUNTAINS –
d. Table 11.2 Tumour markers used in the investigation and follow-up of

ovarian cysts (v.imp)
e. Functional ovarian cysts (imp)
f. Inflammatory ovarian cysts (imp)
g. Germ cell tumours (vvvv.imp)
h. Epithelial tumours (vv.imp)
i. Sex cord stromal tumours (imp)
j. Other ovarian cysts (leave)
 Cervical ectropion (Pg. 169-170)
 Cervical polyps (Pg. 170)
 Cervical stenosis (Pg. 170)
 Asherman syndrome (Pg. 171)
 Key learning points (Pg. 176-177)
 Lichen sclerosus (Pg. 184)
 Vulval cysts (Pg. 184-185)
8. MALIGNANCIES OF GENITAL TRACT

4 1 7
It is again comparatively a lengthy topic but only selective topics are important. Just do
the mentioned topics. There is no need to remember doses at the level of FINAL YEAR
MBBS.
FIRST PRIORITY
1. OVARIAN CANCER Pg. 193-199 (CHAPTER 14)
a. Incidence (imp)
b. Classification of ovarian cancer + Table 14.1 Histological classification of
malignant ovarian tumours (vv.imp)
c. Epithelial tumours
i. Aetiology and risk factors (a single read)
ii. Table 14.2 Risk factors in ovarian cancer (vv.imp)
iii. Genetic factors in ovarian cancer (vv.imp)
iv. Preventing ovarian cancer (v.imp)
v. Clinical features (for making diagnosis, summarized in EFY)
vi. Table 14.3 Tumour markers used in ovarian cancer diagnosis and
follow-up (vv.imp)
vii. Diagnosis and investigations (v.imp)
viii. Staging + Table 14.4 International Federation of Gynecology and
Obstetrics (FIGO) staging of ovarian cancer (vv.imp)
ix. Management (make it short) + Box: Surgical management of ovarian
cancer (vvv.imp)
PAGE 102 OF 115

HUMAN FOUNTAINS –
x. Prognosis + Table 14.5 Prognostic factors in ovarian cancer + Table

14.6 Ovarian cancer survival by stage at diagnosis (vvv.imp)
2. ENDOMETRIAL CANCER Pg. 205-209 (CHAPTER 15)
a. Incidence (imp)
b. Classification (imp)
c. Aetiology (a single read) + Table 15.1 Risk and protective factors for type 1
endometrial cancer (vv.imp)
d. Prevention (imp)
e. Clinical features (for making diagnosis, summarized in EFY)
f. Diagnosis and investigations + Box: Postmenopausal bleeding (vv.imp)
g. Staging + Box: Pathological terminology in endometrial cancer + Table 15.2
International Federation of Gynecology and Obstetrics (FIGO) staging of
carcinoma of the uterus (vv.imp)
h. Management (make it short) (vvv.imp)
i. Box: Endometrial cancer and fertility (imp)
j. Prognosis + Table 15.3 Five-year survival for women with endometrial
cancer (vvv.imp)
3. MALIGNANT DISEASE OF THE CERVIX Pg. 218-222 (CHAPTER 16)
a. Pathophysiology (a single read)
b. Clinical presentation (for making diagnosis, summarized in EFY)
c. Investigation and the importance of staging + Table 16.1 Staging and
prognosis of cervical cancer (vv.imp)
d. Treatment (make it short) (imp)
SECOND PRIORITY
4. PREMALIGNANT DISEASE OF THE CERVIX Pg. 213-218 (CHAPTER 16)
a. Introduction (a single read)
b. Epidemiology and aetiology (a single read)
c. Pathophysiology (a single read)
d. Natural history of CIN (a single read)
e. Diagnosis and investigations (make it short) (imp)
f. Treatment of premalignant disease of the cervix (make it short) (imp)
5. MALIGNANT DISEASE OF THE VULVA Pg. 223-226 (CHAPTER 16)
a. Epidemiology and aetiology (a single read)
b. Clinical presentation (for making diagnosis, summarized in EFY)
c. Investigation
d. Treatment (only headings)
e. Table 16.4 Staging and prognosis of vulval cancer (vv.imp)
6. HYDATIDIFORM MOLE (This topic is missing in Ten Teachers, prepare it
from EFY 2nd Ed. GYNAECOLOGY UNIT 8 TOPIC 8.6)
 Germ cell tumours (Pg. 200-201)
 Table 16.2 Staging and prognosis of vaginal cancer (Pg. 222)
PAGE 103 OF 115

HUMAN FOUNTAINS –
9. COMMON GYNAECOLOGICAL PROCEDURES

3 1 6
20th Ed. Chapter 17
It is again a small topic and needs only cramming. Just do the mentioned topics.
1. HYSTERECTOMY Pg. 230-233
a. Table 17.1 Hysterectomy routes (vv.imp)
b. Box: Complications of hysterectomy (imp)
c. Preassessment (a single read)
d. Box: Thromboprophylaxis in surgery
2. HYSTEROSCOPY Pg. 239 & 242
a. Indications (vv.imp)
b. Complications (vv.imp)
3. LAPAROSCOPY Pg. 242
a. Indications (vv.imp)
b. Complications (vv.imp)
 Table 17.3 Common gynaecological surgeries (Pg. 240-241)
 Table 17.4 Common gynaecological therapeutic agents (Pg. 244)
10. CONTRACEPTION
3 1 6
20th Ed. Chapter 6
mentioned topics.
FIRST PRIORITY
1. COMBINED HORMONAL CONTRACEPTION Pg. 74-77
a. Pills (vv.imp)
b. Patch and ring (leave)
c. Missed pills, patches and rings + Figure 6.3 Missed pill guidelines
d. Length of action
e. Safety of CHC (make it short) + Box: Cancer risks among users of COCPs +
Box: Risk of VTE in users and non-users of CHC (vv.imp)
2. PROGESTOGEN-ONLY CONTRACEPTIVE METHODS Pg. 77-79
a. Progestogen-only pill (imp)
b. Implant (imp)
c. Progestogen-only injectable (imp)
d. Progestogen-releasing intrauterine system + Intrauterine contraceptives
(Cu-IUD, LNG-IUS) (vvv.imp)
PAGE 104 OF 115

HUMAN FOUNTAINS –
3. INTRAUTERINE CONTRACEPTION Pg. 79-80

a. Mode of action (vvv.imp)
b. Bleeding pattern with IUD
c. Insertion of IUD (vv.imp)
SECOND PRIORITY
4. FEMALE STERILIZATION Pg. 81-82
a. Laparoscopic sterilization (a single read)
b. Box: Advice to women considering sterilization (imp)
c. Hysteroscopic sterilization (a single read)
5. VASECTOMY Pg. 82-83
6. EMERGENCY CONTRACEPTION Pg. 84
a. Box: Emergency contraception (vv.imp)
 Table 6.1 Percentage of women experiencing an unintended pregnancy within the
first year of use with typical use and perfect use (Pg. 71)
 Table 6.4 Non-contraceptive health benefits of hormonal contraception (Pg. 73)
 Table 6.5 What a woman needs to know before starting a method of contraception
(Pg. 74)
 Table 6.6 Route of administration of contraceptive and duration (Pg. 76)
 OBSTETRICS
11. PHYSIOLOGY OF PREGNANCY
EFY 2nd Ed.
2 1 7
Unit 1
This topic is missing in Ten Teachers. You have to prepare it whole from UNIT 1 in
OBSTETRICS of EFY 2nd Ed.
FIRST PRIORITY
1. CHANGES IN CARDIOVASCULAR SYSTEM (EFY OBSTETRICS TOPIC 1.1)
2. CHANGES IN RESPIRATORY SYSTEM (EFY OBSTETRICS TOPIC 1.2)
3. CHANGES IN REPRODUCTIVE SYSTEM (EFY OBSTETRICS TOPIC 1.3)
4. CHANGES IN RENAL SYSTEM (EFY OBSTETRICS TOPIC 1.4)
5. CHANGES IN HEMATOLOGICAL SYSTEM (EFY OBSTETRICS TOPIC 1.5)
SECOND PRIORITY
6. CHANGES IN GASTROINTESTINAL SYSTEM (EFY OBSTETRICS TOPIC 1.6)
7. CHANGES IN SKIN (EFY OBSTETRICS TOPIC 1.7)
8. CHANGES IN ENDOCRINE SYSTEM (EFY OBSTETRICS TOPIC 1.8)
Consult OBSTETRICS UNIT 1 in EPISODE FINAL YEAR ED. 2ND
PAGE 105 OF 115

HUMAN FOUNTAINS –
12. ANTENATAL CARE & INVESTIGATION

Obstetrics Ten Teacher 20th
7 1 12
Ed. Chapter 2, 5, 6, 7
FIRST PRIORITY
1. OVERVIEW OF ANTENATAL CARE Pg. 15-22 (CHAPTER 2)
a. Aims of antenatal care (First 5 bullets under the heading of “Overview of
antenatal care”)
b. Advice, reassurance and education (imp)
c. First trimester (leave)
d. Body mass index and weight assessment + Table 2.1 Maternal and neonatal
complications associated with increased BMI in pregnancy (imp)
e. General pregnancy dietary advice (imp)
f. General exercise advice (a single read)
g. Breastfeeding education (leave)
h. Options for pregnancy care (a single read)
i. Antenatal urine tests (leave)
j. Blood pressure assessment (leave)
k. Booking tests in pregnancy (a single read)
l. Table 2.2 Summary of booking investigations (vvv.imp)
m. Ultrasound for first trimester dating and screening (imp)
2. PRENATAL DIAGNOSIS Pg. 63-70 (CHAPTER 5)
b. Why is prenatal diagnostic testing performed? (leave)
c. Classification
i. Table 5.1 Examples of conditions and their method of diagnosis
(vv.imp)
ii. Invasive testing
 Pretest counseling (a single read)
 Chorion villus sampling (also known as chorion villus biopsy)
(imp)
 Amniocentesis (imp)
 Cordocentesis (imp)
 Table 5.2 Comparison of invasive tests (vvv.imp)
d. Down‟s syndrome and other aneuploidies (vvv.imp)
e. New developments (leave)
3. FETAL MALPRESENTATION AT TERM Pg. 90-95 (CHAPTER 6)
a. Breech presentation + Figure 6.3 (imp)
b. Box: Predisposing factors for breech presentation (imp)
c. Antenatal management of breech presentation (imp)
d. External cephalic version (vv.imp)
e. Box: Contraindications to ECV (vv.imp)
f. Box: Risks of ECV (vv.imp)
PAGE 106 OF 115

HUMAN FOUNTAINS –
g. Mode of delivery (vv.imp)

h. Pre-requisites for vaginal breech delivery (vv.imp)
i. Other fetal malpresentations (a single read)
4. RHESUS ISOIMMUNIZATION Pg. 97-102 (CHAPTER 6)
a. The aetiology of rhesus disease (a single read)
b. Box: Potential sensitizing events for rhesus disease (v.imp)
c. Prevalence of rhesus disease (leave)
d. Preventing rhesus isoimmunization (imp)
e. Box: The management of sensitizing events in the rhesus-negative pregnant
woman (v.imp)
f. Box: Signs of fetal anaemia (imp)
g. The management of rhesus disease in a sensitized woman + Table 6.2
Anti-D-rhesus titration (vvv.imp)
h. At delivery (vvv.imp)
i. ABO incompatibility (leave)
5. MULTIPLE PREGNANCY Pg. 105-112 (CHAPTER 7)
b. Epidemiology (leave)
c. Aetiology (a single read)
d. Care of women with a multiple pregnancy (leave)
e. Complications of multiple pregnancy
i. Perinatal mortality (imp)
ii. Fetal growth restriction (a single read)
iii. Complications unique to monochorionic twin pregnancies
 Twin-to-twin transfusion syndrome (vvv.imp)
 Monochorionic monoamniotic twin pregnancy (imp)
f. Antenatal care (a single read)
g. Delivery (vv.imp)
h. Higher order multiples (leave)
SECOND PRIORITY
6. HYPEREMESIS GRAVIDARUM Pg. 80 (CHAPTER 6)
7. FIBROIDS (LEIOMYOMATA) Pg. 82 (CHAPTER 6)
8. URINARY TRACT INFECTION Pg. 83-84 (CHAPTER 6)
9. VENOUS THROMBOEMBOLISM Pg. 84-87 (CHAPTER 6)
a. Box: Risk factors for thromboembolic disease (imp)
b. Thrombophilia (imp)
c. Diagnosis of acute venous thromboembolism (vv.imp)
i. Deep vein thrombosis
ii. Pulmonary embolus
d. Treatment of VTE (vv.imp)
e. Prevention of VTE in pregnancy and postpartum (vv.imp)
f. Figure 6.2 Obstetric thromboprophylaxis risk assessment and management
(leave)
PAGE 107 OF 115

HUMAN FOUNTAINS –
13. ASSESSMENT OF FETAL WELL BEING

Obstetrics Ten Teacher
7 1 12
FIRST PRIORITY
1. ASSESSMENT OF FETAL WELLBEING Pg. 45-59 (CHAPTER 4)
b. Diagnostic ultrasound in obstetric practice (only headings)
c. Ultrasound schedule in clinical practice (leave)
d. Ultrasound in the assessment of fetal wellbeing (v.imp)
e. The cardiotocograph (vvv.imp)
i. Important CTG features
 Baseline fetal heart rate
 Baseline variability
 Fetal heart rate accelerations
 Fetal heart rate decelerations
 The computerized cardiotocograph (leave)
 Biophysical profile + Figure 4.13 Biophysical profile scoring
system. (vvvv.imp); This table has mistake, kindly
consult EFY OBSTETRICS UNIT 3 TOPIC 3.4. for
correction
f. Doppler investigation
i. Umbilical artery (imp)
ii. Fetal vessels (leave)
iii. Uterine artery (leave)
iv. Cerebroplacental ratio (leave)
g. Ultrasound and invasive procedures (imp)
h. 3D and 4D ultrasound (imp)
i. Box: KEY LEARNING POINTS (vvvv.imp)
j. Magnetic resonance imaging (imp)
SECOND PRIORITY
2. AMNIOTIC FLUID Pg. 37-38 (CHAPTER 3)
3. OLIGOHYDRAMNIOS AND POLYHYDRAMNIOS Pg. 89-90 (CHAPTER 6)
a. Oligohydramnios
b. Box: Possible causes of oligohydramnios and anhydramnios (vv.imp)
c. Polyhydramnios
d. Box: Causes of polyhydramnios (vv.imp)
PAGE 108 OF 115

HUMAN FOUNTAINS –
14. MEDICAL DISORDERS IN PREGNANCY

4 1 9
FIRST PRIORITY
1. PRE-ECLAMPSIA Pg. 134-139 (CHAPTER 9)
a. Incidence (a single read)
b. Box of definition (v.imp)
c. Risk factors + Box: Risk factors for pre-eclampsia (imp)
d. Pathophysiology + Figure 9.2 The proposed aetiology of pre-eclampsia (a
single read)
e. Box: HELLP syndrome (vv.imp)
f. Clinical presentation (for making diagnosis, summarized in EFY)
g. Table 9.1 Testing for proteinuria (imp)
h. Management and treatment + Table 9.2 The management of pregnancy
complicated by pre-eclampsia (vvv.imp)
i. Investigations (imp)
j. Treatment of hypertension (vv.imp)
k. Treatment and prevention of Eclampsia (vvv.imp)
l. Screening and prevention (a single read)
m. Additional points in management (a single read)
2. ECLAMPSIA Pg. 264 (CHAPTER 14)
a. Box: Eclampsia: prevention/risk factors/warning signs (vv.imp)
3. DIABETES MELLITUS Pg. 150-152 (CHAPTER 10)
a. Prepregnancy counseling (imp)
b. Maternal and fetal complications of types 1 and 2 diabetes mellitus (vv.imp)
c. Management of types 1 and 2 diabetes in pregnancy (vv.imp)
d. Box: Effects of pregnancy on diabetes (imp)
e. Box: Effects of diabetes on pregnancy (imp)
f. Gestational diabetes (vvvv.imp)
g. Box: Factors associated with poor pregnancy outcome in diabetes (imp)
4. HEART DISEASE Pg. 155-158 (CHAPTER 10)
b. Box: Issues in prepregnancy counseling of women with heart disease (imp)
c. Antenatal management
d. Table 10.3 Stages of heart failure – New York Heart Association (NYHA)
classification (vv.imp)
e. Table 10.4 Toronto risk markers for maternal cardiac events (imp)
f. Box: High-risk cardiac conditions (vv.imp)
g. Box: Fetal risks of maternal cardiac disease (vv.imp)
h. Management of labour and delivery + Box: Management of labour in women
with heart disease (vv.imp)
PAGE 109 OF 115

HUMAN FOUNTAINS –
i. Treatment of heart failure in pregnancy (imp)

j. Box: Risk factors for the development of heart failure in pregnancy (imp)
k. Specific conditions (leave)
5. GESTATIONAL ANEMIA: This topic is missing in Ten Teachers. You have to
prepare it from EFY 2nd Ed. OBSTETRICS UNIT 4 TOPIC 4.8.
SECOND PRIORITY
6. FETAL GROWTH RESTRICTION Pg. 140-143 (CHAPTER 9)
a. Definition and incidence (a single read)
b. Aetiology + Table 9.3 Causes of fetal growth restriction (imp)
c. Pathophysiology (a single read)
e. Box: Pregnancies at risk of FGR (imp)
f. Prognosis
g. Box: Surveillance of the FGR fetus (v.imp)
7. RENAL DISEASE Pg. 148-150 (CHAPTER 10)
b. Chronic kidney disease
c. Table 10.1 Stages of chronic kidney disease (leave)
d. Box: Monitoring of patients with CKD during pregnancy (leave)
e. Table 10.2 Estimated effects of renal function on pregnancy outcome and
maternal renal function (only names)
f. Pregnancy in women with renal transplants (leave)
g. Monitoring of renal transplant patients during pregnancy (leave)
8. LIVER DISEASE Pg. 165-167 (CHAPTER 10)
a. Viral hepatitis + Table 10.5 Viral hepatitis in pregnancy (a single read)
b. Autoimmune hepatitis (a single read)
c. Gallstones (a single read)
d. Primary biliary cirrhosis (a single read)
e. Cirrhosis (a single read)
15. EMERGENCY & POSTPARTUM DISORDERS

6 1 11
20th Ed. Chapter 14, 15
FIRST PRIORITY
1. ANTEPARTUM HEMORRHAGE Pg. 259-260 (CHAPTER 14)
a. History
b. Examination
c. Investigations
2. PLACENTAL ABRUPTION Pg. 260-261 (CHAPTER 14)
a. Box: Placental abruption: prevention/ risk factors/warning signs (vv.imp)
PAGE 110 OF 115

HUMAN FOUNTAINS –
a. Clinical presentation (for making diagnosis, summarized in EFY)

3. PLACENTA PREVIA Pg. 261-262 (CHAPTER 14)
a. Box: Placenta praevia: prevention/risk factors/warning signs (vv.imp)
b. Clinical presentation and diagnosis (for making diagnosis, summarized in
EFY)
4. PRIMARY POSTPARTUM HEMORRHAGE Pg. 262-263 (CHAPTER 14)
a. Box: Postpartum haemorrhage: prevention/risk factors/warning signs
(vv.imp)
b. Figure 14.6 Algorithm for the management of obstetric haemorrhage
(vv.imp)
5. SHOULDER DYSTOCIA Pg. 266 (CHAPTER 14)
a. Box: Shoulder dystocia: prevention/ risk factors/warning signs (vv.imp)
b. Figure 14.9 Algorithm for management of shoulder dystocia (vv.imp)
6. SECONDARY POSTPARTUM HEMORRHAGE Pg. 278-279 (CHAPTER 15)
7. GENITAL TRACT INFECTION/PUERPERAL SEPSIS Pg. 280-283 (CHAPTER
15)
a. Aetiology + Box: Organisms commonly associated with puerperal genital
infection (imp)
b. Prevention (leave)
c. Clinical presentation + Box: Symptoms of puerperal pelvic infection + Box:
Signs of puerperal pelvic infection + Table 15.4 Clinical features of sepsis
and severe sepsis (for making diagnosis, summarized in EFY)
d. Table 15.3 Investigations for puerperal genital infections (vv.imp)
e. Management + Table 15.2 Diagnosis and management of puerperal sepsis
(vv.imp)
SECOND PRIORITY
8. THROMBOEMBOLISM Pg. 279 (CHAPTER 15)
9. PUERPERAL PYREXIA Pg. 279 (CHAPTER 15)
10.PSYCHIATRIC DISORDER Pg. 283-286 (CHAPTER 15)
a. The pathophysiology of postpartum affective disorders (leave)
b. Normal emotional and psychological changes during pregnancy
c. Screening for mental health problems during and after pregnancy + Table
15.5 Screening questions for mental health during and after pregnancy
(leave)
d. Postpartum (non-psychotic) depressive illness
i. Clinical features + Box: Symptoms of severe postnatal depressive
disorder (for making diagnosis, summarized in EFY)
ii. Box: Adverse sequelae of postnatal depressive illness
iii. Box: Risk factors for postnatal depressive illness (leave)
e. Puerperal psychosis
i. Box: Symptoms of puerperal psychosis (for making diagnosis,
summarized in EFY)
ii. Box: Risk factors for postpartum psychosis
iii. Management
f. Anxiety disorders (a single read)
11.THE BREASTS AND BREASTFEEDING PG. 286-291 (CHAPTER 15)
a. Anatomy (leave)
PAGE 111 OF 115

HUMAN FOUNTAINS –
b. Physiology (leave)
c. Colostrum (leave)
d. Breast milk (leave)
e. Table 15.6 Comparison between human and cow‟s milk (leave)
f. Prolactin (leave)
g. Oxytocin (leave)
h. Breastfeeding (leave)
i. Table 15.7 The use of common drugs in breastfeeding mothers (imp)
j. Box: Advantages of breastfeeding (imp)
k. Non-breastfeeding mothers (leave)
l. Breast disorders (vv.imp)
i. Blood-stained nipple discharge
ii. Painful nipples
iii. Galactocele
iv. Breast engorgement (v.imp)
v. Mastitis (vvv.imp)
 Vasa praevia (Pg. 262)
 Umbilical cord prolapse (Pg. 265-266)
 Uterine inversion (Pg. 267-268)
 Uterine rupture (Pg. 268-269)
 Lochia (Pg. 274)
 Table 15.1 Signs and symptoms of potentially life-threatening postnatal conditions
(Pg. 278)
 Perinatal death (Pg. 291-292)
16. INTRAPARTUM CARE – NORMAL LABOUR

5 1 10
20th Ed. Chapter 12
It is a very lengthy topic or you can say, it is the core of Obstetrics. Everything is
important but still you just have to do the mentioned topics. There is no need to
FIRST PRIORITY
1. NORMAL LABOUR Pg. 202-205
a. Diagnosis of labour (vvv.imp)
b. Stages of labour (vv.imp)
c. The duration of labour (vv.imp) (summarized in EFY)
d. The mechanism of labour (vvv.imp)
2. MANAGEMENT OF NORMAL LABOUR PG. 205-213
a. History + Box: Admission history (imp)
b. General examination
c. Abdominal examination (v.imp)
PAGE 112 OF 115

HUMAN FOUNTAINS –
d. Vaginal examination (v.imp)

e. Fetal assessment in labour + Box: Fetal assessment options in labour +
Box: Indications for continuous EFM (vvv.imp)
f. The partogram (v.imp) (prepare it from EFY OBSTETRICS UNIT 6 TOPIC
6.3.)
g. Management during first stage (make it short) + Box: key learning points
(vvv.imp)
h. Management during second stage (make it short) (imp)
i. Immediate care of the neonate (a single read)
j. Management of third stage
i. Box: Signs of placental separation (vv.imp)
ii. Active management + Box: Active management of the third stage
(vv.imp)
iii. Physiological management (imp)
SECOND PRIORITY
3. PAIN RELIEF IN LABOUR Pg. 220-223
a. Only headings
b. Box: Side-effects of opioid analgesia (optional)
c. Indications and contraindications for epidural analgesia (vvv.imp)
 Figure 12.14 The effect of fetal attitude on the presenting diameter (Pg. 200)
17. ABNORMAL LABOUR

4 1 9
It is again a very lengthy topic or you can say, it is also the core of Obstetrics. Everything
is important but still you just have to do the mentioned topics. There is no need to
FIRST PRIORITY
1. ABNORMAL LABOUR Pg. 213-214 (CHAPTER 12)
a. Patterns of abnormal progress in labour (single read)
2. MANAGEMENT OF ABNORMAL LABOUR Pg. 214-219 (CHAPTER 12)
a. Poor progress in the first stage of labour
i. Dysfunctional uterine activity („powers‟)
ii. Cephalopelvic disproportion („passages‟ and „passenger‟) + Box:
Findings suggestive of CPD (vv.imp)
iii. Malpresentation (the „passenger‟)
iv. Abnormalities of the birth canal („passages‟)
PAGE 113 OF 115

HUMAN FOUNTAINS –
b. Poor progress in the second stage of labour + Box: Key learning points
(imp)
c. Fetal compromise in labour
i. Box: Risk factors for fetal compromise in labour (imp)
ii. Recognition of fetal compromise
iii. Management of possible fetal compromise (vv.imp)
iv. Box: Resuscitating the fetus in labour (imp)
v. Fetal blood sampling procedure (imp)
3. INDUCTION OF LABOUR Pg. 226-229 (CHAPTER 12)
a. Introductory paragraphs before Box (leave)
b. Box: Indications for induction of labour (vv.imp)
c. The Bishop score + Table 12.1 Modified Bishop scoring system (vv.imp)
d. Methods (leave)
e. Box: Methods of induction (vvv.imp)
f. Complications of induction of labour (vv.imp)
4. PRETERM LABOUR Pg. 117-129 (CHAPTER 8)
b. Why does preterm labour occur? (a single read)
c. Endocrinology and biochemistry of labour (leave)
d. Causes of preterm labour (only names of headings) (vv.imp)
e. Management of preterm labour (make it short) (vv.imp)
f. Management of PPROM (vv.imp)
SECOND PRIORITY
5. PERINEAL REPAIR Pg. 234-235 (CHAPTER 13)
a. Table 13.1 Grading of perineal tears (vv.imp)
b. Surgical technique
c. OASI repair (v.imp)
d. OASI aftercare (a single read)
6. EPISIOTOMY Pg. 235-236 (CHAPTER 13)
a. Surgical technique (a single read)
 Cervical cerclage + Table 8.2 Types of cerclage (Pg. 128-129)
 Box: Relative contraindications to VBAC (Pg. 224)
PAGE 114 OF 115

HUMAN FOUNTAINS –

PAGE 115 OF 115

GUIDELINES Final Year by Ali Raza

Uploaded by

Copyright:

Available Formats

GUIDELINES Final Year by Ali Raza

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

GUIDELINES Final Year by Ali Raza

Uploaded by

Copyright:

Available Formats

What are the salient features of the second edition of the book?

What are the salient features of the second edition of the book?

What topics are covered under abnormal labour?

What topics are covered under abnormal labour?

In the name of Almighty Allah, the Most Gracious, the Most Beneficent

FINAL YEAR MBBS GUIDELINES

Remember my parents in your prayers.

SECOND EDITION (2023)

2ND EDITION will be available in May 2023

SAILENT FEATURES OF EPISODE FINAL

If you guys have studied Pharmacology, Pathology and Microbiology well in

As I always used to say, we don‟t need perfection. We need to be a good doctor.

1. MEDICINE (200 + 300 = 500)

1. Davidson‟s Principles and Practice of Medicine, 23rd Ed.

1. Basis of Pediatrics by Pervez Akbar Khan, Revised 10th Ed.

1. Short Practice of Surgery by Bailey & Love‟s, 27th Ed.

 GYNAECOLOGY & OBSTETRICS

1. Gynaecology by Ten Teachers, 20th Ed.

 PAST PAPERS (INCLUDING MCQS + SEQS)

HOW TO COVER MCQS

4. COMMUNITY ACQUIRED PNEUMONIA Pg 582-585

c. Management – prepare it stage-based on CXR (v.imp)

e. You may leave

d. Investigations + Box 16.68 Investigation of hypertension + Box 16.69

ii. Investigations + Box 16.78 Investigations in mitral stenosis (vv.imp)

b. Box 21.42 Disease associations of coeliac disease (any 8-10 only)

10.CARCINOID TUMOUR Pg. 678-679 (UNIT 18)

4. LIVER, PANCREAS & GALL BLADDER

3. HEPATIC ENCEPHALOPATHY Pg. 864-865 (UNIT 22)

7. NON-ALCOHOLIC FATTY LIVER DISEASE Pg. 882-885 (UNIT 22)

5. CENTRAL NERVOUS SYSTEM

ii. Box 25.63 Bacterial causes of meningitis (vvv.imp)

8. MULTIPLE SCLEROSIS (MS) Pg. 1106-1110 (UNIT 25)

2. MEGALOBLASTIC ANEMIA Pg. 943-945

8. CHRONIC MYELOID LEUKEMIA (CML) Pg. 958-959

iii. Box 24.43 Gout in old age

8. GIANT CELL ARTERITIS Pg. 1042-1043

4. DENGUE Pg. 243-244

c. Diagnosis and Management (v.imp)

9. NEPHROLOGY & CLINICAL BIOCHEMISTRY

TOPICS EXCLUSIVELY FOR SEQS + MCQS

c. Box 14.11 Causes and diagnosis of syndrome of inappropriate antidiuretic

c. Investigations + Fig. 18.5 Establishing the differential diagnosis in

ii. Diagnosis + Box 28.32 Diagnostic criteria for eating disorders

ii. Fig. 29.37 Developments in understanding of key pathways and drug

HOW TO COVER MCQS

1. ENDOCRINOLOGY & GENETICS

TOPICS (OPTIONAL) FOR MCQS ONLY

4. CARDIOLOGY & HEMATOLOGY

p. Hypernatremic dehydration (leave)

7. IMMUNIZATION & INFECTIONS

3. POLIOMYELITIS Pg. 195-198 (UNIT 10)

8. NEUROLOGY & NEUROMUSCULAR DISORDERS

10. NEONATOLOGY & OTHERS

HOW TO COVER MCQS

b. Basic anatomy of the inguinal canal | Pg. 1029-1030 (vv.imp)

2. A&E SURGERY; TISSUE REPAIR

3. TRAUMATIC BRAIN INJURY (will be covered in SURGERY-II GUIDELINES |

b. Body weight and anthropometry

4. FLUID & ELECTROLYTES; SHOCK